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UNIVERSITY OF SOUTHAMPTON 
ABSTRACT 
FACULTY OF NATURAL & ENVIRONMENTAL SCIENCES 
DEPARTMENT OF CHEMISTRY 
Doctor of Philosophy 
STUDIES DIRECTED TOWARDS THE NATURAL PRODUCT NOMININE 
by Wendy Yee Lee Goh 
 
Natural product synthesis is a highly regarded and essential aspect of organic chemistry. Its 
challenging nature requires a wide spectrum of reactions to be performed with a broad set 
of skills being developed throughout each project.  This thesis describes studies towards the 
total synthesis of nominine, an indole diterpenoid which exhibits antiinsectant properties.  
Synthesis of this natural product could provide entry into this family of indole diterpenoids 
allowing several natural products to be accessed. 
 
Chapter  1  introduces  this  natural  product and  its proposed  synthetic  route.    Two  total 
syntheses,  by  Bonjoch  and  Nicolaou  published  after  this  project  had  ceased,  are  also 
presented. 
 
Chapter 2 discusses the methods of constructing key intermediate enone 1.1 and describes 
its successful efficient synthesis on a multigram scale.  The synthesis of natural products 
dehydrofukinone and fukinone using this key intermediate follows in chapter 3. 
 
Chapter  4  details  the  challenges  and  successes  of  the  investigations  towards  the  total 
synthesis of nominine.  Future work for its completion and other possible related indole 
diterpenoids  are  described  in  chapter  5.    A  conclusion  to  the  project  and  a  chapter 
containing experimental details conclude this thesis. 
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Chapter 1.  Introduction 
1.1.  Natural products and their syntheses 
Natural product synthesis is a vital aspect of organic chemistry in which molecules of nature 
are  recreated  in  the  laboratory  for  a  whole  host  of  applications.    For  example,  the  true 
structure of a natural product may only be fully elucidated through its total synthesis.
1 
Some natural products which are found to have biological activity are only isolated in minute 
quantities,  therefore  there  is  a  need  to  synthesise  the  compound  for  extensive  biological 
testing or medicinal applications.
2 The activity of biologically active natural compounds can be 
investigated by manipulating the synthetic route to construct analogues of the natural product 
to form more potent or selective compounds with improved ADME properties for therapeutic 
purposes.  Total synthesis has also been used to construct analogues to probe mechanistic 
aspects of biological systems and determine how they interact with nature.
3   
The journey which is undertaken is often fraught with unexpected problems and surprises, 
leading to the discovery of new methodology, strategies and novel compounds which have 
increased  the  capabilities and  power  of  synthetic  chemistry.
4  These  are  just  a  few  of  the 
reasons why natural product synthesis is such an active and important discipline. 
It has been estimated that at least 60% of approximately 860 new therapeutic agents, for the 
treatment of human diseases, introduced worldwide over the last 20 years up to 2003 have 
had their origins in natural products chemistry.
5 Particularly noteworthy, in the area of cancer, 
from the 1940s to date, 47% of small molecule drugs were actually either natural products or 
directly derived from them.
6 Natural products continue to be an important source of leads for 
drug  discovery
7  and  interest  in  total  synthesis  continues  to  be  strong  as  evident  by  the 
numerous total synthesis papers that are published each year. 
 
The use of natural products in developing pesticides is not as well acknowledged or recognised 
compared to the use of natural products in human therapeutics, however pesticides are an 
essential  part  of  modern  agriculture.    Where  pests  and  disease  are  not  systematically 
controlled, an estimated one-third of a typical crop is lost.  Over the past half century, much of 
the  increase  in  agricultural  productivity  has  been  due  to  the  control  of  these  pests  with 
chemical pesticides.
8 1. Introduction 
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There are several examples of the use of natural products in crop protection as discussed in a 
review  by  Copping  and  Duke.
9  Two  examples  of  well  known  natural  products  used  as 
insecticides in agriculture are the pyrethrins and rotenone (figure 1). 
Figure 1: Structure of well known insecticides; the pyrethrins and rotenone. 
 
The  pyrethrins  were  isolated  from  the  seeds  of  Chrysanthemum  cinerariaefolium  and 
Tanacetum cinerariaefolium (pyrethrum) as plant extracts and have been used since the end of 
the 19
th century against various insect pests.
10 They have been shown to be toxic in low doses 
and  degrade  quickly  therefore  they  do  not  persist  in  the  environment.    Pyrethrins  act  as 
contact poisons affecting the central nervous system of insects.  For doses too low to kill the 
insects, pyrethrins can act as an insect repellent.   
Rotenone  has  been  isolated  from  a  variety  of  sources  including  Cracca  virginiana,  Deiris  
elliptica and  Lonchocarpus  nicou from the bean family.
11  Rotenone and related substances 
have been used for centuries as a piscicide and pesticide.  Rotenone was found to be toxic 
against a wide range of pests but did not affect mammals when ingested by mouth.  It is 
biodegradable and breaks down within six days.  Its toxic effect on pests is due to its inhibitory 
effect on cellular respiration. 
However,  resistance  has  been  developing  to  current  insecticides  and  there  is  a  growing 
awareness of the negative environmental impact of the long term use of certain synthetic 
compounds. Therefore there is a vital interest in discovering new insecticides to which there is 
no resistance and with fewer environmental and toxicological risks.
12 In the search to discover 
new prototype insecticides, one of the methods is to use natural products themselves or as a 
model.  For  example,  natural  products  obtained  from  marine  sources  covering  many 
structurally diverse scaffolds, have been tested for insecticidal activity.
13 Chinese medicinal 
plants traditionally used for human ailments has also been investigated as a source of possible 
antiinsectant  compounds.
14  These  types  of  compounds  have  been  postulated  to  be 
environmentally friendly as they are naturally occurring as well as providing the opportunity to 
investigate new modes of action. 1. Introduction 
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1.2.  Nominine 
Nominine  was  first  isolated  and  characterized  by  the  Gloer  group  in  1989.
15 This  indole 
diterpenoid  alkaloid  was  isolated  from  hexane  extracts  of  the  sclerotia  of  the  fungus 
Aspergillus nomius. Sclerotia are reproductive masses produced by some fungi as a mechanism 
for  survival  and  propagation  of  the  species.    They  often  contain  unique  antiinsectant 
metabolites that can help to protect them from predation.  Many compounds isolated from 
fungal sclerotia have shown antiinsectant activity.
16 
The  structure  of  nominine  was  elucidated  through  various  spectroscopic  techniques  and 
comparison of spectral data with aflavinine derivatives isolated from Aspergillus flavus, which 
is closely related to Aspergillus nomius.  The absolute stereochemistry was not determined at 
this  point.    Nominine  consists  of  a  congested  bicyclic  system  with  five  contiguous  cis 
stereocentres, two of which are quaternary carbons at ring junctions (figure 2). 
Figure 2: Nominine. 
 
Nominine  was  found  to  exhibit  potent  antiinsectant  activity  against  Heliothis  zea  (corn 
earworm)
17 which is a severe pest in field corn of the southern states of the United States of 
America.  Heliothis zea also feeds on other crops such as cotton, green beans, soybean and 
peppers. Nominine was found to cause 38% mortality at a dietary concentration of 25 ppm, 
and for those insects which survived after seven days on the test diet, the average weight was 
found  to  be  3% of  the  bodyweight  of  the control insects.   This  indicated  nominine  to  be 
substantially more active than the standard broad spectrum insecticide rotenone.  At the time 
this project commenced, a total synthesis had yet to be reported for nominine*. 
 
 
                                                           
* It should be noted that another natural product exists  by the name of nominine.   This unrelated 
hetisine-type aconite alkaloid was first isolated in 1959
18 and its first total synthesis was reported by 
Muratake and Natsume in 2004.
19 1. Introduction 
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1.3.  Proposed synthetic route to nominine 
The proposed synthetic route to nominine was initially based on research by Bonjoch
20 during 
their total synthesis of (-)-nakamurol A.  This marine sponge diterpenoid contains a similar 
scaffold to nominine with the same contiguous cis stereochemistry. 
Bonjoch’s synthetic plan was based on the use of the enantiopure bicyclic enone (1.1) as a 
synthetic intermediate.  This would  provide stereocontrol in the  subsequent 1,4-conjugate 
addition and enolate trapping with formaldehyde, which attaches the relevant side chains 
(Scheme 1.1).  Compound 1.2 was then elaborated further to give (-)-nakamurol A after six 
steps. 
Scheme 1.1: Initial steps in the synthesis of (-)-nakamurol A by Bonjoch et al. 
 
Using a similar concept, it was proposed that the key step would consist of the alkylation of 
compound 1.1 with the alkene moiety  under copper catalysed conditions and the enolate 
trapped  with  a  halogenated  indole  moiety  which  may  require  protection  (scheme  1.2).  
However, as nominine contains an additional hydroxy group on the central ring system, this 
functionality would have to be incorporated before the 1,4-conjugate addition.  This alcohol 
1.3 would  require  protection  1.4  before the 1,4-conjugate  addition with  the  alkyl  cuprate 
followed by trapping of the enolate with a halogenated indole moiety 1.5.  It was proposed 
that the oxygen could chelate to the copper facilitating a facial specific reaction thus ensuring 
cis alkylation.  A Wittig olefination with methyltriphenylphsophonium bromide would then 
transform the carbonyl into the required alkene 1.6, followed by the final deprotection of the 
alcohol to afford the natural product nominine. 
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Scheme 1.2: Retrosynthetic route to nominine based on the use of the bicyclic enone 1.1.   
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1.4.  1st Total synthesis of ent-anominine by Bonjoch et al. 
During the course of the PhD, Bonjoch published a paper detailing his attempts towards the 
total synthesis of nominine (which he renamed anominine).
21 This was followed by a full paper 
detailing the first total synthesis of ent-anominine in 2010,
22 a year after practical work had 
ceased on this project. 
Bonjoch has published a number of natural product syntheses, for example (+)-xylarenal A,
23 (-
)-nakamurol A,
20 aeruginosin 298-A
24 and (-)-strychnine.
25  Bonjoch first expressed an interest 
in  nominine  in  1999  when  a  stereoselective  synthesis  of  enone  1.1  from  (R)-(+)-3-
methylcyclohexanone was published by his group, stating that this could be an appropriate 
chiral building block for the total synthesis of nominine.   
In the first generation synthesis, compound 1.8 was identified as a key synthetic intermediate 
which was proposed to be synthesised from enone 1.1 (scheme 1.3).  Bonjoch utilized his 
previously  published  procedure  to  compound  1.7  from  (R)-(+)-3-methylcyclohexanone.
20  
However  this  procedure  did  not  allow  for  the  introduction  of  the  hydroxyl  group.    A 
subsequent paper detailed the synthesis of 1.3
23 with the synthesis of enone 1.1 starting from 
the Wieland-Miescher ketone (Paquette’s procedure).
26 However, they were unable to affect 
the required 1,4-addition of 1.3 with various organometallics to afford compound 1.8. 
 
Scheme 1.3: Bonjoch’s first generation synthesis towards nominine based on key intermediate 
1.8. 
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In the first generation synthesis of compound 1.7, Bonjoch installed the methyl group in the 
quaternary  position  via  1,4-addition  of  methylzinc  to  enone  1.1  in  the  presence  of  nickel 
acetylacetonate, and trapping of the enolate with formaldehyde to give the alcohol 1.9 as a 
single  diastereoisomer.    Mesylation  and  subsequent  elimination  afforded  the  desired 
compound 1.7 in 11 steps with an overall yield of 12% from (R)-(+)-3-methylcyclohexanone 
(scheme 1.4).   
 
Scheme 1.4: Key steps of Bonjoch’s first generation synthesis of intermediate 1.7. 
 
 
A second generation synthesis of 1.7 was developed starting from racemic Wieland-Miescher 
ketone (scheme 1.5).  The second quaternary methyl group was once again installed via a 1,4-
addition although this time using organocopper reagents.  Protection of the less hindered 
carbonyl group afforded compound 1.11.  Initial attempts to hydrogenate the Wittig product 
1.12 resulted in a majority of the undesired trans diastereoisomer.  Therefore compound 1.12 
was subjected to hydroboration followed by reduction to give the alcohol 1.13, which was 
eliminated via the mesylate to afford 1.14.  Oxidation with o-iodoxybenzoic acid formed the 
enone  1.15.    This  allowed  for  the  regiospecific  alkylation  via  the  lithium  enolate  with 
Eschenmoser’s salt to afford the amine 1.16.  Hydrogenation and subsequent oxidation with 
m-CPBA generated the exocyclic enone 1.7 in 11 steps (from Wieland-Miescher ketone) with 
an overall yield of 18%.  Including the synthetic steps towards the formation of the Wieland-
Miescher ketone, this second generation synthesis is no more efficient nor higher yielding than 
the previous synthesis.  The installation of the required hydroxyl group to form the desired 1.8 
was not detailed. 
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Scheme 1.5: Second generation synthesis to intermediate 1.7. 
 
Nevertheless,  Bonjoch  utilised  intermediate  1.7  to  build  up  the  polycyclic  skeleton  of 
nominine.  Conjugate addition of indole to the exocyclic enone 1.7 gave 1.17 as a 1:2 mixture 
of diastereoisomers with the trans product favoured, however this epimer was isomerised to 
the desired cis product using KF in refluxing EtOH.  The subsequent Wittig reaction furnished 
the polycyclic framework of nominine 1.18 (scheme 1.6). 
Scheme 1.6: Formation of the polycyclic framework of nominine 1.18. 
 
In the final successful total synthesis of ent-anominine,
22 Bonjoch modified his route once 
more to develop the third generation synthesis based on a Wieland-Miescher ketone analogue 
1.21.  This was synthesised using methodology his group had recently developed for highly 
efficient and enantioselective synthesis of Wieland-Miescher ketone and analogues.
27 After 
screening many conditions and organocatalysts for the Robinson annulation, the optimum 
procedure for the Michael addition of 1.19 and MVK was found to be with the use of 1 mol% 
Et3N to give the triketone 1.20 followed by the aldol condensation in the presence of 2.5 mol% 
benzoic acid and 1 mol% of N-Ts-(Sa)-binam-L-Pro (scheme 1.7).  Both steps were achieved 1. Introduction 
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without  the  use  of  solvent  although  the  aldol  condensation  required  six  days  at  room 
temperature to afford a 91% yield with 94% ee of (R)-1.21. 
Scheme 1.7: Synthesis of key Wieland-Miescher ketone analogue 1.21. 
 
A second quaternary centre was achieved by conjugate addition with dimethyllithium cuprate 
to afford 1.22.  The less hindered carbonyl was protected which allowed for the regioselective 
Wittig methylenation followed by removal of the protecting group to give 1.23.   Oxidation of 
1.23 with IBX in the presence of TsOH afforded the enone 1.24 which ensured alkylation with 
Eschenmoser’s salt of the lithium anion occurred at the desired position.  This was followed by 
oxidation of the β-aminoketone with m-CPBA and elimination to afford the exocyclic ketone 
1.25.  Reduction with L-Selectride afforded the cis dimethyl compound 1.26 after equilibration 
(scheme 1.8). 
Scheme 1.8: Installation of the two required cis methyl groups to give 1.26. 
 
The next task was to install the hydroxyl moiety.  Compound 1.26 was reduced to the alcohol 
and subsequently converted to the allylic selenide 1.27 by Grieco’s protocol.  This compound 
underwent  [2,3]-sigmatropic  rearrangement  in  the  presence  of  water  and  subsequently 
afforded  the  allylic  alcohol  1.28.    After  protecting  the  alcohol,  hydroboration  occurred 
selectively at the allyl side chain due to steric hindrance of the congested bicyclic to give 1. Introduction 
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alcohol 1.29.  Hydrogenation reduced the endo methylene selectively as the exo methylene 
was protected by the bulk of the folded molecule.  Protection of the alcohol then afforded 1.30 
which underwent allylic oxidation followed by Dess-Martin oxidation to give exocyclic enone 
1.31.    Coupling  of  indole  with  1.31  in  the  presence  of  Lewis  acid  catalyst  zirconium 
tetrachloride afforded 1.32 after deprotection (scheme 1.9). 
Scheme 1.9: Installation of the remaining cis stereocentres to afford 1.32. 
 
Oxidation of the alcohol with Ley’s perruthenate to give the aldehyde followed by a Wittig 
reaction converted both carbonyl groups into methylene groups to afford compound 1.33.  
Selective  alkene  cross-metathesis  using  Grubbs  2
nd  generation  catalyst  followed  by 
deprotection of the alcohol afforded ent-anominine ([α]D  −21.0 (c 0.3, MeOH)) in 24 steps 
from  the  Wieland-Miescher  ketone  analogue  1.19  (scheme  1.10).    Compound  1.19  is  not 
commercially  available  and  the  procedure  for  its  synthesis  was  not  included  in  the 
experimental so the overall yield cannot be calculated.  This total synthesis resulted in the 
assignment of the absolute stereochemistry of nominine ([α]D
25 +23.6 (MeOH, c 0.85)). 
 
Scheme 1.10: Final steps of total synthesis of ent-anominine by Bonjoch et al. 
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1.5.  2nd Total synthesis of anominine by Nicolaou et al. 
A 2
nd total synthesis was recently achieved by Nicolaou et al. in 2012, along with the first total 
synthesis of tubingensin A, another member of this indole diterpenoid family.
28  Starting from 
the  natural  product  (R)-(+)-pulegone,  alkylation  followed  by  an  acid  catalysed  retro-aldol 
reaction afforded compound 1.34.
29  Duhamel’s method for a selective Mukaiyama-Michael 
addition followed by a Robinson annulation allowed compound 1.34 (after TMS enol ether 
formation) to be transformed into Bicyclic enone 1.1.
30 Installation of the hydroxy group was 
accomplished via the dienol ether to give compound 1.3 (Scheme 1.11).
23 
Scheme 1.11: Nicolaou’s route to compound 1.3 
 
The  iodoacetal  1.35,  formed  using  N-iodosuccinimide  and  ethyl  vinylether,  underwent  an 
Ueno-Stork radical cyclisation to afford the tricyclic ketone 1.36.  Deprotonation of compound 
1.36 was found to be regioselective with LiHMDS and the enolate trapped with TMSCl.  This 
silyl enol ether was subjected to Sc(OTf)3 mediated aqueous Mukaiyama aldol conditions to 
afford  the  alcohol  1.37  in  which  all  the  stereogenic  centres  of  anominine  core  had  been 
installed (scheme 1.12).   
 
Scheme 1.12: Installation of remaining stereogenic centres for anominine core 
 
 
Compound 1.37 was subjected to the necessary protection, Wittig reaction, deprotection and 
oxidation to give compound 1.38 which allowed for the installation of the indole group via a 
Gignard reaction to afford intermediate 1.39 as the major epimer in 88% yield (scheme 1.13). 
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Scheme 1.13: Formation of intermediate 1.39 
 
Xanthate formation followed by radical deoxygenation cleaved off the superfluous hydroxy 
group and indole deprotection afforded compound 1.38.  Acid hydrolysis with perchloric acid 
revealed lactol 1.39 (scheme 1.14).   
Scheme 1.14: Removal of superfluous OH and acidic hydrolysis to reveal lactol 1.39 
 
The lactol was ring opened with the Grignard reagent vinylmagnesium bromide and the diol 
immediately taken on to be bisacetylated.  The allylic acetate was selectively cleaved using 
Tsuji’s reduction conditions employing Pd(PPh3)4 and ammonium formate to give compound 
1.40.
31  A cross-metathesis with 2-methyl-2-butene and Hoveyda-Grubbs II catalyst completed 
the side chain and cleavage of the acetyl group furnished anominine in 26 steps from (R)-(+)-
pulegone (scheme 1.15).  Experimental was not published for every compound so an overall 
yield could not be calculated.   
 
Scheme 1.15: Final steps of 2
nd total synthesis of anominine 
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1.6.  Conclusion to chapter 1. 
 
New natural product targets set out a challenge to organic chemists to synthesis it in as few 
steps as possible, utilising the broad array of reactions available in the most efficient manner.  
Often, novel methodology is developed to suit each strategy.  Analogues of natural products 
are essential in research & development work with a developed total synthesis route allowing 
for specific modifications as necessary. 
 
Nominine  is  part  of  a  family  of  indole  diterpenoids  which  have  shown  potent  biological 
properties.  Nominine was chosen for this project due to its interest as an antiinsectant and a 
total synthesis had yet to be achieved in 2005.  In addition, the total synthesis of nominine 
could lead to the synthesis of other members of the family by replicating the biosynthetic 
pathway linking the family of compounds. 
 
The key step in the proposed route to nominine consists of a 1,4-addition to key intermediate 
1.3  followed  by  trapping  of  the  enolate  in  the  indole  moiety.    This  would  allow  for  the 
installation of two side chains in one step in a stereoselective manner due to the conformation 
of the bicyclic rings. 
 
At  the  commencement  of  this  project,  the  total  synthesis  of  (a)nominine  had  yet  to  be 
achieved.  However, a year after practical work had ceased on this project, Bonjoch et al. 
published the first total synthesis of ent-anominine in 2010, followed by a 2
nd total synthesis in 
2012 by Nicolaou et al.   
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Chapter 2.  Bicyclic enone intermediate 1.1 
 
Bicyclic enone 1.1 is a versatile intermediate that has been used in several natural product 
syntheses, for example, (+)-xylarenal A,
1 R-(-)-ligularenolide,
2 (+)-cleomeolide,
3 (-)-nakamurol 
A,
4 fukinone
5 and dehydrofukinone
6 (scheme 2.1). 
 
Scheme 2.1: Examples of natural products synthesised from bicyclic enone 1.1 
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2.1.  Literature review 
Bicyclic enone 1.1 was considered to be a vital intermediate in our proposed synthetic route to 
nominine.  Nine previous routes to enone 1.1 are discussed in section 2.1 in chronological 
order.  Literature which influenced our work is discussed in section 2.2. 
Piers, Britton & De Waal (1969) 
Enone 1.1 was used to synthetically prove the relative stereochemistry of aristolone by Piers, 
Britton  and  De  Waal  in  1969.
7  In  their  synthesis  of  enone  1.1,  the  n-butylthiomethylene 
fragment was utilised as a blocking group
8 to ensure alkylation at the desired C2 position of 
2,3-dimethylcyclohexanone 2.1.  This was installed via the hydroxymethylene compound 2.2.
9 
Alkylation with ethyl 3-bromopropionate was carried out to form the keto-esters 2.4.  Removal 
of the blocking group under basic conditions followed by the hydrolysis of the ester group gave 
keto-acids 2.5.  Annulation occurred under refluxing acetic anhydride and sodium acetate to 
form the enol lactones 2.6 and 2.7 in a 9:1 ratio.  The cis epimer 2.6 was converted to enone 
(±)-1.1 in the presence of methyllithium followed by acid hydrolysis and base catalysed aldol 
cyclisation.  This six step synthesis was carried out on the 100 g scale with an overall yield of 
29% (scheme 2.2). 
Scheme 2.2: Synthesis of (±)-enone 1.1 by Piers, Britton & De Waal 
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Torrence & Pinder (1971) 
Starting  with  2,3-dimethylphenol,  Torrence  and  Pinder
10  initially  carried  out  an  annulation 
reaction of MVK with 2,3-dimethylcyclohexenone 2.1 to synthesise enone 1.1, however a poor 
yield and diastereoselectivity was obtained.  They then utilised the method of Piers et al. 
although they modified the blocking group to N-methylanilinomethylene 2.9.  (±)-Enone 1.1 
was synthesised in eight steps from 2,3-dimethylphenol although an overall yield could not be 
ascertained as no experimental was included (scheme 2.3). 
 
Scheme 2.3: Torrence and Pinder’s synthesis of (±)-enone 1.1 
 
 
Torii (1979) 
As part of their studies towards development of a stereocontrolled construction of a set of 
vicinal  cis  methyl  groups  on  an  eremophilane  skeleton,  Torii,  Inokuchi  and  Yamafuji
11 
synthesised (±)-enone 1.1.  The significant transformations included a Diels-Alder reaction of 
2.14 with butadiene to form the bicyclic core structure 2.15, installation of the cis methyl 
group at the ring junction via reduction of the cyclopropyl ketone of 2.20, selective reductive 
cleavage of 2.23 to give the alcohol 2.24 in the desired position due to the axial ring opening 
rule (in which axial groups can be more readily replaced than equatorial, as these are more 
stable) and pyrolysis of the mesylate 2.27 to achieve (±)-enone 1.1 in an overall yield of 3% in 
19 steps starting with 2-methylcyclohexanone (scheme 2.4). 
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Scheme 2.4: Torii’s synthesis to (±)-enone 1.1 
 
 
Zoretic, Golen and Saltzman (1981) 
This  seemingly  simple  route  to  enone  (±)-1.1  is  based  on  the  acid-catalysed  Robinson 
annulation reaction (scheme 2.5).  Michael addition of MVK to 2,3-dimethyl cyclohexanone 
catalysed by concentrated H2SO4 (additional aliquots of MVK and H2SO4 added in two hour 
intervals)  yielded  a mixture  of the octalone  and  diketone 2.27  as  well as  36% of  starting 
material.  The crude mixture of octalone and diketone 2.27 underwent aldol condensation in 
the presence of sodium methoxide in methanol to give a 33% yield of enone (±)-1.1 in a 
cis:trans ratio of 9:1 as determined by 
13C NMR analysis.  However, it was later reported by 
Huffman, Potnis and Satish
12 that this ratio was not reproducible.  In their hands, they could 
only obtain a cis:trans ratio of 2.3:1. 
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Scheme 2.5: Zoretic et al.’s route to enone 1.1 based on the acid catalysed Robinson annulation 
reaction 
 
 
Huffman, Potnis and Satish (1985) 
A variation to the traditional Robinson annulation procedure was developed by Huffman et 
al.
12 in which the silyl enol ether of 2,3-dimethyl cyclohexanone 2.28 was used to direct the 
alkylation of the vinyl ketone.  Traditionally, MVK is used as the Michael acceptor, however 
they  found  that this  led to  frequent  polymerisation  problems,  therefore the ketal version 
2.29
13 was utilised in the presence of titanium chloride and titanium isopropoxide to form 
diketone 2.27 after acid hydrolysis.  Typical cyclisation conditions yielded the bicyclic enone 
1.1 as a cis:trans mixture, the ratio of which varied depending on the method used for analysis.  
As  no  experimental  was  given  for  the  formation  of  2.28  and  no  yield  reported  for  the 
formation of enone (±)-1.1, no conclusion can be obtained regarding the efficiency of this 
route (scheme 2.6). 
 
Scheme 2.6: Huffman et al.’s route to enone 1.1 based on silyl enol ether chemistry 
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Duhamel et al. (1992) 
In their investigations towards the synthesis of octalones and hydrindenones, Duhamel et al.
14 
developed a novel annulation method which included the synthesis of (±)-enone 1.1,  based on 
their  previous  studies  on  Lewis  acid  catalysed  Michael-type  additions  to  silyl  enol  ethers, 
similar to Huffman et al.’s strategy.  Acid catalysed Michael addition of compound 2.32 to MVK 
in nitromethane in the presence of boron-trifluoride and acetic acid formed intermediate 2.27, 
which  was  not  isolated  before  cyclisation  induced  by  a  basic  medium  (freshly  prepared 
methanolic  solution  of  methoxide)  gave  the  desired  product  (±)-1.1  in  a  mixture  of  97:3 
cis:trans ratio (scheme 2.7) in an overall yield of 19% in five steps. 
 
Scheme  2.7:  Duhamel’s  novel  synthesis  to  enone  1.1  based  on  an  acid-catalysed  Michael 
addition reaction. 
 
 
The stereocontrol of the formation of intermediate 2.27 was rationalised due to the starting 
conformation  of  enol  ether  2.32.
15  1,2-allylic  strain  of  the  two  methyl  groups  in  the 
cyclohexene ring results in conformation B as the preferred conformer with electrophilic attack 
on the less hindered face leading to the two methyl groups cis to one another preferentially 
(scheme 2.8). 
 
Scheme 2.8: Structure B as the preferred conformation of 2.32 leading to cis methyl groups 
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de Groot et al. (1998) 
 The known stereochemistry of S-(+)-carvone (Sigma Aldrich, approximately £50 for 25 mL) was 
utilised in de Groot et al.’s syntheses of various functionalised decalones including enone (+)-
1.1 (scheme 2.9).
16  Using chemistry similar to that of Huffman
12 and Duhamel
14, S-(+)-carvone 
underwent  conjugate  addition  of  methyl  magnesium  bromide  in  the  presence  of  catalytic 
copper bromide followed by trapping of the enolate with trimethylsilyl chloride to give the silyl 
enol ether 2.33.  de Groot found that lowering the temperature to -65 °C (instead of -20 °C as 
reported  by  Duhamel)  improved  their  yields  of  the  diketone  2.34.    Cyclisation  in  basic 
conditions yielded 2.35 which underwent ozonolysis, followed by addition of acetic anhydride, 
Et3N, and DMAP.  This formed the 5-acetoxy enone in situ which gave the dienone 2.36, upon 
treatment with NaOMe.  Conjugate reduction of 2.36 with L-Selectride® in the presence of 
DMPU, followed by treatment with NaOMe resulted in (+)-1.1 with an overall yield of 17% in 
five steps. 
 
Scheme 2.9: de Groot’s synthesis of (+)-1.1 from S-(+)-carvone 
 
 
Bonjoch (1999) 
Bonjoch et al.
17  developed a stereoselective synthesis to enone (-)-1.1 utilising the known 
absolute  stereochemistry  of  commercially  available  (R)-(+)-3-methylcyclohexanone  (Sigma 
Aldrich, approximately £100 for 5 g) (scheme 2.10).  Their route is very similar to that of Piers 
et  al.  with  the  exception  of  the  type  of  blocking  group  they  utilized  to  ensure  alkylation 
occurred at the desired position.  Their chosen blocking group is the same used by Torrence 
and Pinder previously.
4 The regioselectivity of the installation of the ethyl formate group is 
attributed  to  the  1,3-allylic  strain  in  the  enolate  formation  step  under  thermodynamic 2. Bicyclic enone intermediate 1.1 
24 
 
conditions.  Subsequent alkylation with MeI furnished the cis (2S,3R) product as the major 
isomer  2.38  as  both  methyl  groups  are  in  the  equatorial  position  which  is  more  stable.  
Alkylation with ethyl bromopropionate followed by hydrolysis formed the acid 2.5 which was 
transformed into the enol lactone 2.6 at which point the cis:trans isomers could be separated 
by crystallization.  Methyllithium addition followed by aldol cyclisation gave enone (-)-1.1 in an 
overall yield of 25% in seven steps which is a slightly lower yield than Piers et al.  In 2003, 
Bonjoch  reported  a  modification  to  this  route  in  which  the  lithium  salt  of  dimethyl 
methylphosphonate was used instead of methyllithium for a more reproducible yield of 60% in 
the last step.
 18 
 
Scheme 2.10: Bonjoch’s stereoselective synthesis to enone (-)-1.1 
 
 
Tenius (2001) 
Tenius et al.
19 also utilised the known absolute stereochemistry of (R)-3-methylcyclohexanone 
2.39 in their synthetic route, however they began with the natural product R-(+)-pulegone, 
presumably due to its lower cost (Sigma Aldrich, approximately £60 for 5 g) (scheme 2.11).  (R)-
(+)-Pulegone underwent retro-aldolisation to give 2.39 followed by an alkylation step to form 
(3R)-2,3-dimethylcyclohexane 2.1 which was not described in the experimental so the exact 
conditions  are  unknown.    (S)-Phenylethylamine  ((S)-PEA)  was  used  as  a  chiral  auxiliary  to 
control the stereochemistry of the alkylation step of 2.40 with MVK followed by hydrolysis to 
give a mixture of 2.27 and 2.41.  Base-catalysed aldol-condensation resulted in 43% of the 
desired (-)-enone 1.1.  The overall yield achieved was 16% in six steps.  Although this route is 
shorter by one step compared to Bonjoch’s route, the overall yield is lower. 
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Scheme 2.11:  Tenius’s route to enone (-)-1.1 from R-(+)-pulegone 
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2.2.  Formation of bicyclic enone intermediate 1.1 
Several routes towards the formation of bicyclic enone 1.1 were investigated concurrently.  
The  strategies  were  based  upon  previously  published  literature.    While  there  are  various 
procedures reported in the literature for the synthesis of this enone, they often start with 
expensive starting materials or their reported yields or ratio of the relative stereochemistry of 
the methyl groups were thought to be unsatisfactory.  In view of the fact that this was the 
beginning of the total synthesis, we wanted to develop a procedure with  inexpensive and 
readily available starting materials with reproducible results to allow for large scale synthesis 
of this important intermediate.  Three main routes were investigated. 
Route 1: 1,4-addition of an organocopper reagent to compound 2.31 followed by trapping of 
the enolate with a Michael acceptor (2.46 or 2.49). 
 
Route 2: Use of ethyl 3-methyl-1-oxo-2-cyclohexene-2-carboxylate (2.49). 
 
Route 3: Use of Wieland-Miescher Ketone (2.66) 
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2.2.1.  Route 1: 1,4-addition & trapping of enolate method 
This  route  was  inspired  by  the  work  by  Coelho  and  Diaz.
20  In  their  studies  towards  the 
synthesis of (±)-pathylactone A, compound 2.31 undergoes conjugate addition with lithium 
dimethylcuprate  followed by  trapping  of  the  enolate  intermediate with  allyl bromide  in  a 
cis:trans ratio of 1:4 (scheme 2.12). 
 
Scheme 2.12: Initial steps to the synthesis of (±)-pathylactone A by Coelho & Diaz. 
 
In our route, trapping of the enolate would occur with MVK or similar electrophile providing 
intermediate 2.44.  This would then undergo a Robinson annulation type reaction forming the 
desired  bicyclic  enone  1.1  (scheme  2.13).  This  proposed  route  is  similar  to  that  used  by 
Duhamel and de Groot who also use copper chemistry although they trap the enolate with silyl 
enol ether and isolate the intermediate before alkylation.  Coelho and Diaz’s method would be 
more efficient with two steps occurring in one pot.  
 
Scheme 2.13: Proposed route 1 to the bicyclic enone 1.1 
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The  synthesis  of  2-methyl-2-cyclohexen-1-one  2.31  was  required  as  it  is  not  commercially 
available.    In  a  paper  by  Hua  and  co-workers,
21  commercially  available  2-methyl-1-
cyclohexanone  was  brominated  using  freshly  recrystallised  N-bromosuccinimide  in  carbon 
tetrachloride  to  form  2-bromo-2-methyl-1-cyclohexanone  2.45  regioselectively  in  a 
quantitative yield.  Compound 2.45 subsequently underwent dehydrobromination to afford 
the desired enone 2.31 with an overall yield of 46% (scheme 2.14). 
 
Scheme 2.14: Formation of enone 2.1 
 
 
As  carbon tetrachloride  (bp  77  °C)  is  a  known  carcinogen and ozone  depletor,  alternative 
solvents were investigated,  dichloroethane (bp 84 °C) and toluene (bp 110 °C).  However, 
these experiments failed to yield any brominated product.  As a result, the bromination was 
carried out in carbon tetrachloride.   
 
On the first attempt of the dehydrobomination step, a 22% yield was obtained although this 
was on a very small scale (scaled down 30 times from literature quantities).  In the second 
attempt in which the reaction was scaled down five times, a 46% yield was obtained.  This was 
still lower then the reported yield of 72%.  This low yield may have been due to a smaller scale 
reaction being carried out. 
 
Despite the lower yields, sufficient quantities of enone 2.31 were synthesised to continue with 
the  synthetic  route.  However,  literature  precedent  for  the  use  of  MVK  in  1,4-addition 
reactions described issues of decomposition due to polymerization. Therefore an alternative to 
MVK was sought. 
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2.2.2.  Route 1A: With 4-chlorobutanone/4-chlorobutenone. 
2.2.2.1. Route inspired by Dancer et al. 
The  bicyclic  enone  1.1  synthesised  by  Dancer  et  al.
22  employed  a  similar  route.    This 
methodology  paper  investigated  trapping  of  ketone  enolates  with  β-sulfonylacrylate 
thioesters, β-sulfonyl-, β-sulfinyl- and β-chlorovinyl ketones.  For enone (±)-1.1 Dancer et al. 
used (E)-4-chlorobut-3-en-2-one 2.46 to trap the enolate generated from conjugate addition of 
methylcuprate to compound 2.31 and report an overall yield of 66% over three steps (scheme 
2.15).   
Scheme 2.15: Route 1B to the bicyclic enone (±)-1.1 
 
Although this route appears to be relatively simple with an adequate yield, it was thought to 
be quite time consuming with the last two steps taking six days.  It was proposed that the 
enolate formed from compound 2.1 could be trapped with 4-chloro-2-butanone 2.47 instead 
of (E)-4-chlorobut-3-en-2-one 2.46 to form compound 2.27, thereby removing the need for the 
hydrogenation step. 
 
4-Chloro-2-butanone 2.47 was readily synthesised according to the method of Boudjouk, Kim 
and  Han  (scheme  2.16).
23  This  procedure  was  reproduced  with  a  yield  of  86%  after 
optimisation of conditions.  A longer reaction time was required; overnight compared to the 
five hours stated in the literature, and the careful use of the rotary evaporator as the product 
was found to be quite volatile.   
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Scheme 2.16: Formation of compound 2.47 
 
 
Two methods of forming compound 2.27 were investigated simultaneously.  The first was 
based  on  methodology  by  Dancer  and  coworkers,
24  although  initially  methylmagnesium 
bromide was used from a commercial source instead of being made in situ (scheme 2.17).  The 
reaction was repeated several times but no product was observed. The original method of 
forming the Grignard reagent using magnesium, methyl iodide and copper cyanide, followed 
by the addition of chlorobutanone was also investigated, however this too failed to give any 
compound 2.27.  The main product isolated after work up was found to be the starting enone 
2.31. 
 
Scheme 2.17: Attempt at the formation of compound 2.27 using MeMgBr 
 
The second method of forming compound 2.27 was based on work by Coelho and Diaz
20 in 
which the enone 2.31 is added to lithium dimethylcuprate which was formed in situ, then the 
enolate is trapped with compound 2.27 (scheme 2.18). 
 
Scheme 2.18: Attempt at the formation of compound 2.27 using Me2CuLi 
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No product was identifiable by 
1H NMR spectroscopy.  It was thought that the chlorobutanone 
moiety  was  too  unreactive  under  the  reaction  conditions  as  some  of  the  dimethyl 
cyclohexanone  intermediate  was  identified  indicating  the  1,4-addition  of  the  lithium 
dimethylcuprate was successful but quenching of the enolate was not. The original method 
employed the use of (E)-4-chlorobut-3-en-2-one, however literature precedence relating to the 
formation  of  this  enone  detailed  procedures  requiring  gaseous  compounds  which  were 
thought to be problematic to work with.  As experiments with chlorobutanone 2.47 were 
found  to  be  unsuccessful,  attempts  at  synthesising  chlorobutenone  2.46  was  then 
investigated. 
 
Dancer et al. utilised the procedure reported by Benson and Pohland
25 to synthesise 2.46, in 
which acetyl chloride was added to acetylene in carbon tetrachloride followed by the addition 
of  aluminium  chloride.    In  an  attempt  to  avoid  hazardous  solvents  and  gaseous  starting 
materials,  further  literature  searches  were  carried  out  to  find  an  alternative.    Only  one 
procedure was found which did not involve the use of gaseous starting materials.  In a brief 
communication by Naser-Ud-din and Skattebøl,
26 3-butyn-2-one was added to a suspension of 
PCl5 in Et2O and stirred overnight forming two products (scheme 2.19) with (E)-4-chlorobut-3-
en-2-one as the major product 2.46. 
 
Scheme 2.19: Formation of (E)-4-chlorobut-3-en-2-one 2.46 by Naser-Ud-din and Skattebøl 
 
 
The 
1H NMR spectra of the crude mixture indicated both products present, although the 4,4-
dichlorobutan-2-one was found to be the major product.  However, only 4,4-dichlorobutan-2-
one was isolated by column chromatography. It was speculated that compound 2.46 is not 
stable under chromatographic conditions.  Further attempts at synthesising compound 2.46 
were suspended as more viable reaction routes emerged. 
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2.2.2.2. Alternative use of chlorobutanone 
 
Further investigations on the transformation of enone 2.31 to form the bicyclic enone 1.1 
revealed  a  synthetic  procedure  by  Paquette,  Belmont  and  Hsu
27  which  had  a  similar 
transformation utilising chlorobutanone (scheme 2.20). 
 
Scheme 2.20: Annulation reaction carried out by Paquette, Belmont and Hsu 
 
This procedure was adapted using readily available materials (scheme 2.21).  Enone 2.31 was 
methylated  with  dimethyllithium  cuprate  to  form  intermediate  2.48  which  resembles  the 
starting material used by Paquette et al.  Compound 2.48 was isolated as a mixture of cis and 
trans  isomers  with  spectroscopic  data  in  accordance  with  literature  values.
28  Due  to  the 
overlap of signals, the ratio of diastereoisomers was not ascertained. 
 
Compound 2.48 was reacted with chlorobutanone but failed to yield the bicyclic enone after 
three days heating to reflux.  No product signals could be identified by 
1H NMR spectroscopy 
although dimethylcyclohexanone signals were thought to be present. 
 
Scheme 2.21: Formation of bicyclic enone based on Paquette, Belmont and Hsu method 
 
It was  thought that compound  2.47 was not a reactive enough system for  these reaction 
conditions so this route was halted.  
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2.2.3.  Route 1B: With trimethylsilyl-3-buten-2-one. 
 
Further investigations yielded another synthetic route (scheme 2.22) to the bicyclic enone (±)-
1.1  by  Boeckman,  Blum  and  Ganem.
29  The  enolate  generated  by  the  1,4-addition  of 
dimethyllithium cuprate to enone 2.31 is trapped by the Michael acceptor, 3-trimethylsilyl-3-
buten-2-one 2.49, in an annulation reaction to form intermediate 2.50.  Treatment of this 
intermediate with potassium hydroxide and methanol generates the desired bicyclic enone (±)-
1.1 in yields of 43-57%. 
 
Scheme 2.22: Formation of bicyclic enone 1.1 by Boeckman, Blum and Ganem 
 
 
The  overall  procedure  for  this  synthetic  route  appeared  to  be  quite  simple,  although  the 
challenge was found to be in the formation of the Michael acceptor 2.49.  It was soon realised 
that  synthesising  trimethylsilyl  enones  is  a  very  challenging  task  with  various  published 
procedures reporting low yields, multiple steps or specialist starting materials required. 
 
Several  methods  for  the  synthesis  of  trimethylsilyl  butenone  2.49  were  investigated 
simultaneously. 
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2.2.3.1. Trimethylsilylbutenone synthesis – method A. 
 
The procedure used by Boeckman, Blum and Ganem (scheme 2.23) to synthesise trimethylsilyl 
butenone 2.49 contained four steps with a reported overall yield of 37-38%.
30 Attempts to 
repeat this procedure resulted in limited success.  Reaction of vinylbromide with magnesium in 
THF  and  chlorotrimethylsilane  yielded  the  desired  product,  vinyltrimethylsilane  2.51  in  a 
maximum yield of 38%, although reported yields for this first step was 67-78%.  There was 
much difficulty in the distillation of the product from the solvent THF, as there is only a 2 °C 
difference in boiling point.  Despite repeating the experiment multiple times, compound 2.51 
could only be obtained dissolved in THF (approximately 90% THF). 
 
Scheme 2.23: Formation of trimethylsilyl butenone (2.49) used by Boeckman, Blum and Ganem 
 
 
Compound 2.51 was used in the next step despite containing large amounts of THF.   The 
addition of bromine and diethylamine yielded compound 2.52 in an approximate yield of 29%.  
By 
1H NMR spectroscopy, no starting material was found to be present but other unexpected 
impurity peaks were observed.  As the initial steps of this synthetic route were found to be 
already  low  yielding  and  time  consuming,  this  synthetic  route  for  the  formation  of 
trimethylsilyl butenone was suspended. 
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2.2.3.2. Trimethylsilylbutenone synthesis – method B. 
 
This synthetic route (scheme 2.24) was devised using a combination of published methods.  
Bromination of MVK would form 3-bromo-but-3-en-2-one 2.54.
31 The ketone would then be 
protected with trimethyl orthoformate to form compound 2.55.
32 This product would then 
undergo  lithium-halogen  exchange  with  the  resulting  anion  being  quenched  with  TMSCl.  
Subsequent deprotection
33 of the carbonyl moiety would form the desired compound 2.49. 
 
Compound 2.54 was successfully synthesised in a yield of 90%.  As it was found to decompose 
under chromatographic conditions, it was used without further purification.  Impurities in the 
crude reaction material were estimated to be negligible by 
1H NMR spectroscopy.  Enone 2.54 
was also found to decompose readily at room temperature and even when stored at low 
temperatures  wrapped  in  foil,  which  resulted  in  the  need  for  multiple  batches  being 
synthesised. 
 
Scheme 2.24: Method B to trimethylsilylbutenone. 
 
Several procedures (table 2.1) were carried out in an attempt to synthesise compound 2.55 
from  compound  2.54,  however  none  were  successful  in  forming  the  desired  product  in 
satisfactory yields.  Although in some cases the ketone did appear to have been protected with 
the orthoformate, 
1H NMR spectroscopy indicated the loss of the alkene protons. 
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Table 2.1: Conditions used to form compound 2.55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ref.  Reagents  Conditions  Results 
34  1.25  equiv.  HC(OEt)3  + NH4NO3  in 
EtOH 
Reflux  Possible trace amounts of 
product + SM 
35  2.4 equiv. HC(OEt)3 + H2SO4  rt  Decomposition 
36  20 equiv. K2CO3 in EtOH  reflux  No SM or product 
37  1.1 equiv. HC(OEt)3 + 2 equiv. EtOH 
+ 0.1 equiv. TsOH 
rt  No SM or product 
38  1.3  equiv.  HC(OEt) 3  +  NH4NO3  in 
EtOH 
Heated to reflux with heat 
gun, left for 15 mins, 
repeat and left stirring at 
rt for 2 days 
Possible trace of product 
but many compounds 
present 
 
This synthetic route was put on hold as a new route was investigated. 
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2.2.3.3. Trimethylsilybutenone synthesis – method C (Acetyltrimethylsilane 
method) 
 
A third synthetic route was devised for the formation of compound 2.49 (scheme 2.25). 
Scheme 2.25: Method C to trimethylsilyl butenone 
 
 
Acetyltrimethylsilane was shown to react with ethynylmagnesium bromide to form compound 
2.57, which further reacts with trimethylsilyl cyanide to form compound 2.58 in a synthetic 
procedure described by R.Cunico.
39  Compounds 2.57 and 2.58 were synthesised successfully 
using this procedure with good yields.  
 
The full procedure had not been published for the transformation of 2.58 to 2.49, although 
Enda  and  Kuwajima  claim  an  85%  yield.
40  They  claim  that  “on  exposure  to  an  equimolar 
amount of methylaluminium dichloride, the ethers [ie. compounds of the type 2.58] undergo 
rapid  isomerisation  and  afford  the  corresponding  structures  [i.e.  compound  2.49]  after 
quenching with water”.  
 
The reaction was carried out in Et2O, CH2Cl2 or THF.  MeAlCl2 was added at 0 °C in all reactions.  
No reaction occurred in Et2O with only starting material being recovered after two days stirring 
at room temperature.  In both CH2Cl2 and THF reactions, no starting material was found to be 
present after overnight reaction at room temperature; no product was detected by 
1H NMR 
spectroscopy.  Heating to reflux for varying time periods (30 mins to 4 hours) yielded no 
product.  No further publications utilising this transformation have been found therefore this 
particular synthetic route was discontinued. 
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2.2.4.  Route 2 – Use of ethyl 3-Methyl-1-oxo-2-cyclohexene-2-carboxylate 
(2.59) 
As previous attempts to form nominine using enone 2.31 had proved to be problematic, a new 
synthetic route was developed based on compound 2.59, which would require hydrogenation 
of the double bond to form compound 2.60  (scheme 2.26).   This would then undergo an 
annulation reaction with MVK in the presence of a base such as NaH to form compound 2.61.  
It  was  believed  that  compound  2.60  would  be  a  more  reactive  alternative  to 
dimethylcyclohexanone  2.48  due  to  the  increased  acidity  of  the  hydrogen  between  the 
carbonyl  groups.  Protection  of  ketone  2.61  would  be  required  to  facilitate  the  complete 
reduction of the ester moiety of 2.62.  Subsequent deprotection would furnish the desired 
enone 1.1. 
 
Scheme 2.26: Proposed synthetic route to enone 1.1 using ethyl 3-Methyl-1-oxo-2-cyclohexene-
2-carboxylate 2.59. 
 
The  formation  of  compound  2.59  was  initially  based  on  a  procedure  by  Kato,  Kamat  and 
Yoshikoshi in their investigations towards useful synthetic intermediates.
41 Ethyl acetoacetate 
is  a  readily  available  starting  material,  however  compound  2.63  required  synthesis.    2-(2-
Bromoethyl)-2-methyl-1,3-dioxolane 2.63 was synthesised from MVK, trimethylsilyl bromide 
and ethylene glycol in a method described by Hsung,
42 obtaining a yield of 77% (scheme 2.27).  
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Scheme 2.27: Formation of 2-(2-bromoethyl)-2-methyl-1,3-dioxolane 2.63 
 
Deprotonation  of  ethyl  acetoacetate  with  sodium  hydride  and  butyllithium,  followed  by 
addition of compound 2.63 as described in the original method by Kato et al. (scheme 2.28) 
yielded only starting materials in all attempts.  Despite drying the ethyl acetoacetate over 
magnesium sulphate, increasing the number of equivalents of compound 2.63, using a new 
batch  of  sodium  hydride,  purifying  the  sodium  hydride  from  mineral  oil  with  hexane  and 
adding sodium sulphate to the reaction mixture to remove any water present, no product was 
isolated in any of these experiments.  However, the reaction was found to be successful on 
addition of 0.5 equivalents of anhydrous HMPA and compound 2.64 was synthesised in a 65% 
yield.  HMPA is known as a useful additive in reactions with BuLi as it complexes to lithium 
cations further polarising the Li-C bond accelerating metalation. 
 
Scheme 2.28: Formation of compound 2.64 using Kato et al. method 
 
To facilitate the deprotection of the ketal followed by subsequent ring closure to form 2.59, 
Kato’s procedure reported the use of 50% aqueous acetic acid for 30 hours under nitrogen at 
room temperature (scheme 2.29).  However, after this period of time, TLC indicated multiple 
products with starting material still present.  After 105 hours, reaction was worked up to give 
only 34 mg of a crude yellow oil (after starting with 100 mg of compound 2.64).  
1H NMR 
spectroscopy  indicated  no  product  peaks.    The  conditions  used  appeared  to  be  causing 
decomposition of the starting material after prolonged periods of time. 
Scheme 2.29: Formation of compound 2.59 using Kato et al. method 
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An  alternative  procedure  by  Ikeda  et  al.
43  for  the  synthesis  of  compound  2.59  was  also 
investigated, which proved to be more successful.  Compound 2.59 was synthesised (scheme 
2.30) in a 74% yield (literature yield 80%).  This one step procedure was found to be a simpler 
(all reagents commercially available) and a faster method compared to Kato et al.’s procedure.  
Carbonyldiimidazole is used to couple acetobutyric acid with the magnesium salt of monoethyl 
malonate. 
 
Scheme 2.30: Formation of compound 2.59 using Ikeda’s method 
 
Reduction of the double bond of 2.59 was facilitated by hydrogenation with Pd/C (20 wt%) in 
EtOAc  (scheme  2.31).  After  2.5  hours  at  room  temperature,  TLC  indicated  no  starting 
compound  2.59  present  but  three  products  was  observed.  The 
1H  NMR  spectra  was  too 
complex to determine whether or not the desired product was present.  Unfortunately, after 
multiple attempts at column chromatography, the compounds could not be separated despite 
varying solvent systems. 
 
Scheme 2.31: Hydrogenation of compound 2.59 to form compound 2.60 
 
The experiment was repeated a second time for only 40 minutes. The crude 
1H NMR spectra  
was again too complicated to determine whether or not product was present but this time  
starting compound  2.59 could be seen by TLC, as well as only two other compounds.   
 
It  was  realised  at  this  time  that  another  route  which  was  being  investigated  concurrently 
would  be  more  successful,  therefore  this  route  was  discontinued  and  efforts  were 
concentrated on route 3. 
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2.2.5.  Route 3 – Use of Wieland-Miescher Ketone 
 
A different strategy to bicyclic enone 1.1 was developed by Paquette et al.
44 which they used in 
their total synthesis of the macrocyclic (+)-cleomeolide (scheme 2.32). 
Scheme 2.32: Paquette’s use of enone 1.1 to synthesise(+)-cleomeolide 
 
Despite containing several steps, this synthetic route was found to be reproducible and after 
some development of the steps, it was found to be suitable for large scale synthesis of enone 
1.1 (scheme 2.33).  Large scale synthesis of enone 1.1 was carried out using available facilities 
at Pfizer such as the 5 L automated reactor vessel.  This allowed up to 0.4 moles (50 g) of 
starting material to be used per batch increasing the efficiency of this route. 
 
Scheme 2.33: Modified Paquette’s method to enone (±)-1.1 
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Compound 2.65 was successfully synthesised using a procedure described by Buchschacher et 
al.
45 Michael addition of 2-methyl-1,3-cyclohexanedione and MVK, in the presence of catalytic 
amounts of acetic acid and hydroquinone in water at 74 
°C
 for one hour afforded compound 
2.65 in 97% yields after removal of a white solid impurity by filtration which was thought to be 
polymerisation of the MVK.   
 
Buchschacher  et  al.  also  described  an  asymmetric  procedure  for  the  aldol  addition  and 
subsequent elimination to furnish compound 2.66 (also known as the S-(+)-Wieland-Miescher 
ketone) with the use of L-proline (scheme 2.34).  Compound 2.65 was stirred with 5 mol % of L-
proline  in  DMSO  for  five  days  at  room  temperature.    The  crude  was  purified  by  column 
chromatography to give S/R-enedione 2.66 (0.56 g, 43%).   
 
Scheme 2.34: Formation of compound 2.66 – chiral product 
 
Buchschacher’s enantiomeric purification utilised pure  S-enedione crystals to seed the  S/R 
enedione, dissolving the product in Et2O and the mixture left undisturbed at -20 °C for 18 
hours.  The crystals were collected by filtration and the re-crystallisation procedure repeated 
with the filtrate.  However, when this was carried out, no crystals formed, despite leaving 
mixture at -20 °C for extended periods of time.  As the experimental scale (1.5 g) carried out 
was considerably less then the published procedure (154.2 g), this could be a possible reason 
for the failure in recrystallisation. 
 
This method was later repeated on a larger scale at the Pfizer laboratories.  The residue was 
distilled and crystallised using pure seed crystals (obtained from Sigma Aldrich).  Although 3.10 
g (42% (65% ee)) of crystals were obtained from repeated recrystallisations, it was discovered 
that the crystals contained 17% of the R enantiomer, as shown by chiral HPLC. 
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Another method of recrystallisation by Harada et al.
46 was also attempted.  This involved the 
S/R enedione to be dissolved in a 10:1 mixture of diethyl ether and ethylacetate and left at -70 
°C (cardice box) for five hours, however this failed to yield any crystals despite extending the 
time left in the box. The mixture gave [α]D
25 +8.36 (toluene, c 1.0), whereas the published 
value of the pure crystals was [α]D
25 +97.3 (toluene, c 1.0) indicating a large amount of the R 
enantiomer present.  However, the procedure stated a 56.8% yield of the (S)-enedione.  It is 
unclear  if  the  yield  is  a  result  of  just  the  asymmetric  process  or  how  efficient  the 
recrystallisation process is.   
 
As the formation of the asymmetric enedione was quite time consuming, the racemic version 
was synthesised to be used in the continuation of scheme 2.33.  In a procedure described by 
Ramachandran and Newman,
47  compound 2.65 was azeotroped under Dean-Stark conditions 
in benzene with 10 mol% pyrrolidine for 1.5 hours.  It was found that replacing benzene with 
the  more environmentally  preferred  toluene  did  not  affect  the  yield.    The crude  reaction 
material was purified by column chromatography to isolate a yield of 74% of compound (±)-
2.66. 
 
The  racemic  Wieland-Miescher  ketone  was  selectively  protected  with  1,2-ethanedithiol  to 
obtain compound 2.67 in 95% yield.  The published procedure
44 did not purify this compound 
before the next step; however it was found that column chromatography was required to 
remove small amounts of the diprotected bicyclic impurity. 
 
With  the  carbonyl  of  the  enone  masked  as  a  dithiolane,  this  resulted  in  the  selective 
transformation of the remaining carbonyl into the desired methyl group.  Literature procedure 
then described a Wittig reaction of compound 2.67 with potassium hexamethyldisilazane and 
(methoxymethyl) triphenylphosphonium chloride for 24 hours to  form the methoxymethylene 
intermediate,  which  was  hydrolysed  without  isolation  with  4N  HCl  and  MeOH:THF  (1:1) 
mixture (36 hours stirring at room temperature).  Initial experiments obtained a low yield of 
14% of the aldehyde 2.69 (literature yields 93%).  With further repetitions of the reaction, it 
was discovered the yield increased if the methoxymethylene intermediates (2.68A and 2.68B) 
were isolated and purified before the hydrolysis step.   
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It was believed that the excess (methoxymethyl) triphenylphosphonium chloride interfered 
with the hydrolysis step therefore reducing overall yields particularly in larger scale reactions.  
Two Wittig products 2.68A and 2.68B were isolated in a total yield of 96% (scheme 2.35). 
 
Scheme 2.35: Formation of compound 2.69 
 
Of the two alkene isomers, the major product 2.68B (E alkene) is the more stable as there are  
less steric constraints due to the methoxy group pointing away from the methyl group.  It was 
found that samples of pure 2.68A decomposed over time to the aldehyde product as well as 
some isomerisation to 2.68B.   
 
As KHMDS was required in excess, various bases were investigated to find a more inexpensive 
alternative for large scale synthesis.  However, it was found that the reaction did not form any 
product with NaHMDS, n-BuLi or NaH.  (Methoxymethyl) triphenylphosphonium chloride in 
THF was cooled to 0 °C before the addition of the base and stirred.  A colour change from a 
white suspension to an orange/red colour indicated the formation of the ylide.  No ylide was 
formed with NaHMDS or NaH even when the reaction with NaH was refluxed for two hours.  
Although an orange solution formed immediately with the addition of n-BuLi, after addition of 
compound 2.67, no Wittig product or starting material was isolated.  It was concluded that 
KHMDS must be used in this Wittig reaction. 
 
The Wittig products were hydrolysed affording the aldehyde 2.69 in 96% yield.  From the 
1H 
NMR  spectra,  it  was  concluded  that  only  one  diastereoisomer  was  formed  as  only  one 
aldehyde  proton  was  observed  forming  selectively  the  desired  cis  stereochemistry  as 
confirmed by comparison with literature data. 
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Reduction  of  compound  2.69  with  sodium  borohydride  resulted  in  a  quantitative  yield  of 
compound  2.70.    The  alcohol  was  mesylated  with  methanesulfonyl  chloride  to  afford 
compound 2.71 in a quantitative yield which was taken on crude in the next step. 
 
To cleave the sulfonyl group to form compound 2.72, literature procedure stated the addition 
of two equivalents of Superhydride® (lithium triethylborohydride) and stirred for 20 hours at 
room temperature.  However, when this was carried out, no product was formed and only 
starting  material  was  recovered.    Additional  equivalents  of  Superhydride®  and  prolonged 
reaction times at room temperature did not affect the outcome.  Only starting material was 
recovered.  As the reaction did not appear to work at room temperature, the reaction was 
heated to reflux.  After six hours, starting material was still present although a less polar spot 
was prominent by TLC, so the reaction was left under reflux conditions for a total of 24 hours 
to ensure completion.  The product was obtained in 11% after column chromatography.  In 
further repetitions of this reaction, 60% of product was isolated after five hours of heating to 
reflux and 66% isolated after two hours, indicating that the reaction does not fully consume all 
starting  material  and  prolonged  refluxing  caused  decomposition  of  product  or  starting 
materials.  After  screening  of  conditions,  optimal  conditions  were  found  to  be  three 
equivalents of Superhydride® heating to reflux for two hours achieving an optimum yield of 
96% of compound 2.72. 
 
Deprotection of the dithiolane group was initially carried out with thallium trinitrate trihydrate 
(Tl(NO3)3.3H2O) as reported by Paquette.  Literature procedure reported a 90% yield after 
stirring compound 2.72 in THF and H2O with Tl(NO3)3.3H2O in MeOH for only ten minutes at 
room temperature.  However, when this reaction was carried out (experiment 1 of table 2.2), 
after  two  hours  starting  material  was  still  present  by  TLC  so  another  equivalent  of 
Tl(NO3)3.3H2O in MeOH was added.  After an additional hour of stirring, TLC indicated more 
products as well as the starting material indicating additional equivalents of Tl(NO3)3.3H2O has 
a  negative  effect  on  the  reaction.    Approximately  39%  of  product  was  isolated  from  this 
attempt.   
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Table 2.2: Investigating deprotection methods of compound 2.72 
Ref.  Experiment #  Conditions  Yield  Notes 
44  Literature 
reported 
1.2 equiv. Tl(NO3)3.3H2O in MeOH 
THF/H2O, rt, 10 min 
90%   
44  1 (i)  2 equiv. Tl(NO3)3.3H2O in MeOH 
THF/H2O, rt, 2 hr 
Then additional 1 equiv. Tl(NO3)3.3H2O,  
rt, 1 hr 
39%  Varying  yields 
obtained - not 
reproducible.  
Reagent is highly 
toxic and harmful to 
the environment 
1 (ii)  1.3 equiv. Tl(NO3)3.3H2O in MeOH 
THF/H2O, rt, 1 hr 
71% 
1 (iii)  1.3 equiv. Tl(NO3)3.3H2O in MeOH 
THF/H2O, rt, 1 hr 
58% 
1 (iv)  1.3 equiv. Tl(NO3)3.3H2O in MeOH 
THF/H2O, rt, 3 hr 
60% 
1 (v)  1.3 equiv. Tl(NO3)3.3H2O in MeOH 
THF/H2O, rt, 1 hr 
23% 
48  2 (i)   1 equiv. FeCl3, 1 equiv. KI 
Anhydrous MeOH, reflux, 6.5 hr 
46%  Other unidentified 
impurity formed – 
bicyclic like product 
but could not be 
identified.  Alcohol 
product sometimes 
isolated instead of 
enone. 
 
2 (ii)  1 equiv. FeCl3, 1 equiv. KI 
Anhydrous MeOH, reflux, 6 hr 
Then additional 1 equiv. FeCl3, rt, o/w 
45% 
2 (iii)  1 equiv. FeCl3, 1 equiv. KI 
Anhydrous MeOH, reflux, 4.5 hr 
Then additional 1 equiv. FeCl3,  
reflux 2 hr 
Then additional 1 equiv. KI, rt, o/n 
50% 
49  3  4 equiv. NCS, 4.5 equiv. AgNO3 
70 % aqueous CH3CN, 0 °C,  25 mins 
28%  Solubility issues.   
50  4 (i)  2.5 equiv. diacetoxyiodobenzene 
(CH3)2CO:H2O, rt, o/n 
29%  Solubility issues. 
Another compound 
isolated where 
alkene proton is 
missing. 
4 (ii)  2.5 equiv. diacetoxyiodobenzene 
(CH3)2CO:H2O, rt, 1 hr 
33% 
51  5 (i)  2 equiv. mCPBA, CH2Cl2, -20 °C  
15  mins  then  rt,  15  mins.  Quench  with 
NaHCO3 and crude isolated. 
(CH3CO)2O: Et3N: THF(aq) 3:4:10,  
40 °C o/n  
Failed  Mostly starting 
material isolated. 
Crude 
1H NMR 
spectra very messy. 
52  5 (ii)  1.5 equiv. mCPBA, 2 equiv. TFA 
CH2Cl2, 0 °C to rt o/n 
Failed  Only starting material 
isolated 
53  6  1.5 equiv. DDQ 
(CH3)2CO/H2O, rt, o/n 
Reflux 7 hr, rt o/n 
21%  More starting 
material isolated 
than product 
54 
55 
7  After optimisation; 
3 equiv. MeI 
MeOH and 10 % H2O, reflux,  24 hr   
90%   Successful simple 
procedure. 
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While there are many reported methods for the deprotection of dithioacetals, we wanted to 
avoid  the  use  of  any  toxic  transition  metals  in  stoichiometric  amounts  at  elevated 
temperatures  which  is  common  for  this  type  of  deprotection.    Several  methods  of 
deprotection  were  subsequently  investigated  to  achieve  a  higher  yielding  and  less  toxic 
method (table 2.2). 
 
Success was found by heating to reflux compound 2.72 in a solution of 10% H2O in MeOH and 
three equivalents MeI for 24 hours.  Yields were improved from 45% to 90% of (±)-1.1 after 
optimisation of parameters.  MeI is a cheaper alternative to the thallium reagent especially 
when working on a large scale. 
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2.2.6.  Large scale synthesis of enone 1.1 
 
The  three  month  placement  at  the  Pfizer  laboratories  (Sandwich,  Kent)  gave  us  the 
opportunity to carry out the synthesis of enone (±)-1.1 on a large scale making use of their 
superior resources such as large scale equipment, automated reactor vessels and funding for 
chemicals and reagents. 
 
During the placement it was discovered that large scale chemistry is physically demanding and 
very time consuming.  For example, after the Wittig reaction on compound 2.67, a large silica 
plug was required to remove excess reagent which took many litres of solvent per batch which 
also required evaporation under reduced pressure.   
 
Although  equipment  available  at  Pfizer  allowed  work  on  a  much  larger  scale,  there  were 
limitations due to sharing of equipment and maximum volume in reactor including work up 
solutions, which restricted progress.  The largest reaction carried out at Pfizer was 0.4 mol (50 
g) of the starting 2-methyl-1,3-cyclohexanedione compared to 0.1 mol (14 g) carried out at 
university.  A total of 1.57 mol (198 g) of starting cyclohexanedione was taken through during 
the placement. 
 
Alternative purification methods had to be investigated as column chromatography would be 
too time consuming for each step and waste a lot of solvent on this scale.  The use of toluene 
instead  of  benzene,  which  is  prohibited  at  Pfizer,  did  not  seem  to  affect  yields  for  the 
formation of compound 2.66.  The large scale batches allowed for an efficient short path 
distillation  of  compound  2.66  which  reduced  purification  times.    Recrystallisation  of  the 
distilled  residue  was  successful  and  white  crystals  were  formed,  although  the  remaining 
residue was also used to increase yields.   
 
An  alternative  purification  method  used  at  Pfizer  to  isolate  aldehyde  compounds  was 
investigated in which the bisulfite adduct of the aldehyde is formed using sodium metabisulfite 
(Na2S2O5) so it could be extracted from the organic solution into the aqueous phase (scheme 
3.36).  The aldehyde would then be reformed by refluxing with aqueous sodium carbonate.   2. Bicyclic enone intermediate 1.1 
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Scheme 2.36: Alternative aldehyde purification method 
 
 
However, the aldehyde failed to form the bisulfite adduct despite varying conditions including 
stirring for extended periods of time and even refluxing overnight in different solvents.  It was 
concluded that compound 2.69 was too sterically hindered for this method to be successful. 
 
Recrystallisation of aldehyde 2.69 was partially successful.  On leaving the crude liquid at room 
temperature overnight, some of the pure product precipitated out as a white powdery solid.  
The  remaining  residue  was  recrystallised  from  diethyl  ether  to  remove  the 
triphenylphosphonium  oxide  impurity.    Some  batches  which  contained  a  small  amount  of 
impurity were further purified by column chromatography. 
 
A large amount of time was spent synthesising enone (±)-1.1 on a large scale as it is a vital 
intermediate.  It was discovered that after prolonged storage in the fridge, enone 1.1 started 
to decompose whereas its precursor could be kept at room temperature as a pure white solid 
without noticeable signs of decomposition.  Overall, 32 g of pure enone (±)-1.1 and 14 g of the 
protected compound 2.72 was synthesised. 
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2.3.  Conclusion to chapter 2 
 
Different routes to enone 1.1 were investigated with varying success depending on availability 
of starting materials and complexity of reactions.  Initially, we wanted to develop a novel 
method  to  this  intermediate  based  on  readily  available  starting  materials  but  as  time 
progressed and the lack of success with proposed routes were revealed, it was decided we 
would focus on Paquette’s method (route 3).   
 
We had by no means exhausted the possibilities of each route, for example in route 1, we 
could have used Michael acceptors such as Huffman’s methyl vinyl ketal 2.29 or the protected 
bromo  butanone  2.63.    However,  Paquette’s  method  gave  us  the  option  for  synthesising 
enone 1.1 in its optically pure form (either enantiomer depending on which proline catalyst 
was  used),  especially  at  a  later  date  when  the  route  to  nominine  had  been  established.  
Although this route was already published and was composed of several steps, it was found to 
be reproducible with excellent yields and in the interest of progress it was taken on for large 
scale synthesis. 
 
We  have  adapted  Paquette’s  synthesis  of  enone  1.1  with  modification  of  solvents  and 
purification  procedures.  For  example,  the  use  of  benzene  was  replaced  by  the  less  toxic 
toluene  and  recrystallisation  or  distillation  was  favoured  over  column  chromatography.  In 
some cases, reaction times were extended or reaction temperatures increased in order to 
increase yields. 
 
The  most  significant  difference  was  the  deprotection  of  the  dithioacetal  group  in  which 
Paquette et al. used 1.3 equivalents of thallium trinitrate trihydrate.  On a large scale, this 
would be too expensive and toxic therefore several different methods were investigated.  It 
was found that refluxing compound 2.72 with the inexpensive MeI in MeOH with 10% H2O 
gave excellent yields.  Large scale synthesis of intermediate (±)-1.1 was successful with an 
overall yield of 53% over nine steps.  Although the number of steps may be considered quite 
high, the overall yield is superior in comparison to previously published procedures. 
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Chapter 3.  Total synthesis of 
dehydrofukinone and fukinone 
 
3.1.  Introduction 
Dehydrofukinone  and  fukinone  are  fragrant  compounds  which  belong  to  a  family  of 
sesquiterpenes  derived  from  eremophilane  type  compounds.  These  natural  products 
comprise of a decalin core with an isopropylidene unit and differ by an additional alkene in 
dehydrofukinone.   
 
Fukinone was first isolated and its structure determined in 1968 by Naya et al.
1 It was obtained 
as  a  colourless  oil  from  the  methanolic  extract  of  Petasites  japonicus  Maxim  (sweet 
coltsfoot/butterbur) which grows wild in Japan and is often cultivated as a leafy vegetable.  
Fukinone was shown to exhibit inhibitory activity on mast cell degranulation (IC50 19.1 μM),
2 
one of the symptoms of pollenosis, in a study on the effects of Japanese butterbur extract on 
type  I  allergic  symptoms.      Fukinone  has  also  been  isolated  from  Arctium  lappa  (Japan),
3 
Ligularia  persica (Iran)
4 and Calcalia hastate L.(Japan).
5   
 
Dehydrofukinone was first isolated from the leaves of Arctium lappa L. in 1972 also by Naya et 
al.
1 It has since been isolated in numerous instances from a variety of species around the world 
such as Cacalia hastate L. (Japan),
6 Senecio aureus L (USA),
7 Senecio glaucus (Egypt),
8 in which 
it was reported to smell apricot-like, Ligularia dictyoneura (China)
9 and Senecio adenotrichius 
(Chile)
10  in  which  a  surprisingly  high  amount  of  70.9%  was  isolated.  It  is  also  known  as 
dihydrokaranone. 
 
Although  no  biological  activity  has  so  far  been  reported,  the  enzymatic  synthesis  of 
furanoterpenes  from  dehydrofukinone  using  cytochrome  P450  has  been  investigated.
11 
Furanoterpenes have been found to be toxic and used as defence compounds by plants.
12 In 
the previous chapter, we achieved a multigram synthesis of enone 1.1. In tandem with studies 
towards nominine, we were interested in investigating other applications of 1.1 and chose to 
carry out total syntheses of fukinone and dehydrofukinone. 3. Total synthesis of dehydrofukinone and fukinone 
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3.2.  Review of published syntheses of dehydrofukinone and 
fukinone 
3.2.1.  Previous syntheses of dehydrofukinone 
There are eight previous syntheses reported with the first synthesis occurring four years prior 
to  the  original  natural  isolation  of  dehydrofukinone.    It  was  first  synthesised  during  the 
isolation and characterisation experiments of fukinone in 1968 by Naya et al.
1 In a one step 
dehydrogenation  reaction,  fukinone  was  transformed  into  (+)-dehydrofukinone  using  HCl(g) 
and DDQ in dioxane in a 70.6% yield (scheme 3.1).  
 
Scheme 3.1: First synthesis of dehydrofukinone from fukinone by Naya et al. in 1968. 
 
 
Ohashi (1969) 
The first fully synthetic route to dehydrofukinone was completed by Ohashi in 1969.
13 In his 
investigations into the synthesis of sesquiterpenes related to eremophilone, a new general 
synthetic method to these structures was developed via isoxazole annelation.  The starting 
isoxazole 3.1 was prepared by the alkylation of Hagemann’s ester,
14 (a versatile intermediate 
which  has  been  used  in  several  natural  product  syntheses),
15  with  4-chloromethyl-3,5-
dimethylisoxazole followed by the removal of the ethoxycarbonyl group with KOH.  The double 
bond  was  hydrogenated  and  the  methylene  group  was  protected  using  an  isopropyl 
oxymethylene method in a two step process.
 16 This intermediate allowed for the methylation 
at  the  desired  position  and  after  deprotection  gave  compound  3.2  which  was  cyclised  to 
compound 3.3 using triethyloxonium fluorborate and NaOH in ethanol.  The enol ether 3.4 was 
formed and successive treatment with MeLi, dilute HCl and POCl3 in pyridine gave the natural 
product (±)-dehydrofukinone.  This brief publication did not include an experimental so an 
overall yield could not be ascertained but its estimated total number of steps was 12 or more 
(scheme 3.2).   3. Total synthesis of dehydrofukinone and fukinone 
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Scheme3.2: First total synthesis of dehydrofukinone by Ohashi – minimum 12 steps 
 
Torii (1979) 
Using  the  novel  procedure  they  developed  towards  the  synthesis  of  (±)-enone  1.1,  Torii, 
Inokuchi and Yamafuji
17 then carried out an aldol reaction to install the isopropenyl moiety.  
Subsequent dehydration of the mesylate of 3.5 gave (±)-dehydrofukinone in an overall yield of 
2% in 22 steps starting with 2-methylcyclohexanone (scheme 3.3). 
 
Scheme 3.3: Synthesis of dehydrofukinone by Torii et al.  
 
 
Hagiwara (1980) 
Hagiwara, Uda and Kodama
18 developed syntheses to five eremophilane sesquiterpenes which 
involved the aldol condensation of the kinetic enolate of intermediate 1.1 (using Piers, Britton 
& De Waal’s synthesis of the enone) using the same strategy as Torii.  The aldol product 3.5 
was formed from the treatment of enone 1.1 with LDA and acetone in the presence of ZnCl2 
(which was found to be essential in obtaining high yields).  Dehydration of 3.5 generated (±)-
dehydrofukinone in an overall yield of 22% in eight steps (scheme 3.4).   
 
 3. Total synthesis of dehydrofukinone and fukinone 
58 
 
Scheme 3.4: Hagiwara’s procedure to (±)-dehydrofukinone from enone 1.1. 
 
Reich (1986) 
This synthesis by Reich et al.
19 was based on the intramolecular Diels-Alder reactions of siloxy 
vinylallenes.  The key intermediate 3.11 was set up for a Diels-Alder cyclisation under Lewis 
acid  catalysis  with  diethylaluminium  chloride  to  form  intermediate  3.12.    Methylenation 
followed  by  selenylation-selenoxide  elimination  gave  intermediate  3.14  which  was 
hydrogenated  to  give  the  desired  product  in  a  2:1  cis:trans  ratio.    This  15  step  synthesis 
afforded (±)-dehydrofukinone in an overall yield of 7% (scheme 3.5). 
 
Scheme 3.5: Reich’s synthesis of (±)-dehydrofukinone based on Diels-Alder reactions of siloxy 
vinyallenes. 
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Duhamel (1992) 
Using their novel synthesis of enone 1.1, Duhamel
20 then utilized Hagiwara’s procedures to 
synthesise (±)-dehydrofukinone in 14% overall yield over seven steps with 2% of trans product 
as identified by 
1H NMR spectroscopy (scheme 3.6).   
Scheme 3.6: Duhamel’s use of Hagiwara’s procedures to form (±)-dehydrofukinone from their 
novel synthesis of enone 1.1. 
 
 
Ishihara (1993) 
(+)-Dehydrofukinone  was  synthesised  in  a  one  step  acid  catalysed  isomerisation  of 
neopetasane in order to establish the structure of this natural product (no yield was given; 
scheme 3.7). 
 
Scheme 3.7: Synthesis of (+)-dehydrofukinone from neopetasane 
 
 
Tenius (2001) 
Tenius et al.
21 used their novel route to enone R-(-)-1.1 and Hagiwara’s procedure to prepare (-
)-dehydrofukinone in an overall yield of 12% in eight steps (scheme 3.8). 
Scheme 3.8: Tenius’s synthesis of (-)-dehydrofukinone 
 
 3. Total synthesis of dehydrofukinone and fukinone 
60 
 
3.2.2.  Previous syntheses of fukinone 
There are six previous total syntheses reported for fukinone. 
Piers & Smillie (1970) 
The first approach to the total synthesis of fukinone was carried out by Piers and Smillie
22 who 
utilised their synthesis of enone 1.1 previously reported in 1969.  The hydroxy methylene 
derivative 3.15 was hydrogenated to give the cis-decalin 3.16 which was oxidised with DDQ to 
afford the aldehyde 3.17 (scheme 3.9).  Further oxidation with silver nitrate gave the acid 3.18 
which underwent esterification 3.19 before hydrogenation to afford the keto ester 3.20.  The 
keto  alcohol  3.21 was  obtained  after  treatment  with  sodium  hydride  and  trapping  of this 
enolate with methyllithium.  Although the stereochemistry of the alcohol was indicated as cis 
in their reaction scheme, Piers and Smillie did not provide an explanation for their reasoning 
nor did they provide any spectroscopic data.  Alcohol 3.21 was used crude; it was treated with 
thionyl chloride which gave isofukinone which was converted to fukinone in refluxing benzene 
in the presence of p-toluenesulfonic acid.  This 15 step synthesis afforded (±)-fukinone in an 
overall yield of 6%. 
 
Scheme 3.9: Piers & Smillie’s synthesis to (±)-fukinone. 
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Marshall & Cohen (1970-1971) 
This novel strategy began with 2-methoxybenzaldehyde (scheme 3.10).
23  The key steps of this 
lengthy preparation included a Birch reduction of the benzylic alcohol 3.23, an allyl-cation 
initiated alkene cyclisation to form 3.27 in which cis fusion of the rings was established from 
previous studies.
24  Conjugate methylation of compound 3.30 with lithium dimethylcuprate to 
give the cis product as a single stereoisomer, a Wolff-Kishner reduction followed by oxidation 
with  Jones  reagent  afforded  the  intermediate  3.33.    Installation  of  the  α-isopropylidene 
functionality  began  with  the  use  of  a  bulky  base  to  direct  the  desired  enolate  formation 
followed by acid catalysed enol acetylation to form 3.34, thermal rearrangement of epoxide 
3.35 afforded the acetoxy ketone 3.36.  Addition of isopropenyllithium, oxidation, acetylation 
and reduction to remove the acetoxy group followed by isomerisation afforded (±)-fukinone in 
23 steps with a 0.2% overall yield. 
 
Scheme 3.10: Marshall & Cohen’s synthesis to (±)-fukinone. 
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Torrence & Pinder (1971) 
Utilising  their  novel  synthesis  to  enone  1.1,  Torrence  and  Pinder
25  further  elaborated this 
compound to install the required isopropylidene functionality for the synthesis of fukinone 
(scheme 3.11).  Installation of the ester functionality afforded 3.40 which was hydrogenated in 
acidic medium (not specified which) to give the desired cis decalone 3.41 with apparently little 
evidence of the trans isomer.  The ketone was protected prior to the addition of methylithium 
to form the carbinol 3.43, which after hydrolysis and dehydration afforded (±)-fukinone in 13 
steps.  An overall yield could not be ascertained as an experimental was not published. 
Scheme 3.11: Torrence & Pinder’s synthesis to fukinone. 
 
 
Chan & Prasad (1987) 
Chan  and  Prasad’s  route  to  fukinone
26  was  based  on  intermediate  3.46  which  they  had 
developed using a novel annulation reaction based on the Michael reaction of butadiene 3.45 
with α,β-unsaturated ketone 3.44 under Lewis acid conditions.  The cis-stereochemistry of 
3.46 was selectively synthesised under these annulation conditions.  Installation of the second 
methyl group was accomplished using methylmagnesium bromide 3.47 which was followed by 
dehydration to form compound 3.48.  A methoxy moiety replaced the sulphur group and the 
ensuing hydrogenation afforded the enones 3.50 and 3.51 in quantitative yield in a 1:1 ratio.  
After column chromatography, the desired cis epimer 3.50 was taken on and reduced followed 
by acid hydrolysis to form compound 3.52.  Treatment with Li-NH3 generated the required 
enolate which was quenched with chlorotrimethylsilane to form 3.53.  This enol silyl ether 
underwent Mukaiyama Aldol addition with acetone in the presence of titanium chloride which 
gave the aldol 3.21.  As with Piers and Smillie’s route, this was dehydrated and isomerised, 
using alumina oxide, to afford (±)-fukinone in 12 steps from 2-methyl-2-cyclohexenone with an 
overall yield of 8% (scheme 3.12). 3. Total synthesis of dehydrofukinone and fukinone 
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Scheme 3.12: Chan & Prasad’s route to (±)-fukinone. 
 
 
Kozmin (2004) 
This  approach  to  fukinone  was  based  on  siloxyalkyne-alkene  metathesis  chemistry  which 
Kozmin  and  Reddy
27  had  developed  towards  the  synthesis  of  eremophilane  type  natural 
products (scheme 3.13).  The key siloxy-alkyne intermediate 3.59 was synthesised from a route 
beginning  with  the  diastereoselective  endo-selective  Diels-Alder  reaction  of  commercially 
available trans-2-methly-2-butenal and diene 3.54 to furnish the aldehyde 3.55.  Subsequent 
conversion of the aldehyde to the ester 3.56 allowed for the hydrogenation of the alkene as 
well as the benzyl protecting group, followed by oxidation of the alcohol gave compound 3.57.  
A  Wittig  reaction  was  used  to  convert  the  aldehyde  using  triphenylphosphonium  methyl 
bromide to the require alkene 3.58.  Installation of the siloxyalkyne moiety was achieved via 
the dibromomethyl ketone which was subjected to LHMDS and n-BuLi to install the alkyne 
which was silylated to afford the intermediate 3.59.  Ring closing metathesis was affected by 
the use of Grubbs ruthenium catalyst followed by removal of the protecting group using HF to 
give the enone 3.60.  This intermediate was used to synthesise several eremophilane natural 3. Total synthesis of dehydrofukinone and fukinone 
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products  including  fukinone.    1,2-Addition  of  methyllithium  to  compound  3.60  gave  the 
alcohol 3.61 which underwent hydroboration, Jones oxidation and dehydration to afford (±)-
fukinone.    The  overall  yield  and  total  number  of  steps  could  not  be  calculated  as  no 
information was published relating to the synthesis of the starting diene 3.54. 
 
Scheme 3.13: Kozmin & Reddy’s route to fukinone. 
 
Das (2009) 
Reddy also worked on this most recent synthesis of fukinone in Das’s group.
28  This synthesis 
started with a stereoselective Diels-Alder reaction similar to the previous synthesis with the 
exception that carboxylic ester diene 3.62 was used as an alternative to the benzyl diene 3.54 
(scheme 3.14).  Elongation of the carbon chain was achieved via hydrolysis of the ester to form 
the acid 3.66 which was coupled with N,O-dimethylhydroxylamine hydrochloride to afford the 
Weinreb amide 3.67 and addition of a Grignard gave the methyl ketone 3.68.  Deprotonation 
with  LiHMDS  and  subsequent  addition  of  methylchloroformate  afforded  the  desired  chain 
length  in  3.69  which  underwent  an  acid  mediated  aldol  condensation  to  form  the  bicylic 
intermediate  3.70.    Protection  of  the  carbonyl  followed  by  hydrogenation  to  remove  the 
double  bond  formed  compound  3.72  which  was  reacted  with  four  equivalents  of 
methylmagnesium bromide, followed by treatment with 6M hydrochloric acid afforded (±)-
fukinone.  Once again, the overall yield and total number of steps could not be calculated as no 
information was published relating to the synthesis of the starting diene 3.62. 3. Total synthesis of dehydrofukinone and fukinone 
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Scheme 3.14: Das et al.’s route to fukinone. 
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3.3.  Synthesis of dehydrofukinone 
 
Fukinone  and  dehydrofukinone  can  easily  be  accessed  from  intermediate  1.1  as  previous 
syntheses have shown, although their route to compound 1.1 differed to ours.
17,18,20,21,25 The 
vital intermediate to these natural products was identified as the aldol compound 3.5 which 
after dehydration would afford dehydrofukinone.  The aldol condensation of compound 1.1 to 
form intermediate 3.5 was investigated.   
 
Utilising Hagiwara’s
18 conditions of LDA in THF at -50 °C, followed by the addition of the Lewis 
acid ZnCl2 and freshly distilled acetone, intermediate 3.5 was formed in a 37% yield (scheme 
3.15).  It was observed that yields decreased with time which could be due to the ageing bottle 
of ZnCl2 in THF.  The yield did not improve when freshly prepared LDA was used although it 
was later noted that an improved method of forming LDA would be to stir the n-BuLi and 
DIPEA at 0 °C for half an hour instead of at -78 °C.  This could have attributed to the lower 
yields of compound 3.5.  Only one diastereoisomer of compound 3.5 was observed by 
1H NMR 
spectroscopy. It was proposed that the isopropyl group would be trans relative to the methyl 
groups due to steric considerations although this was not formally determined as the following 
step would be dehydration which would remove that particular stereocentre.  Data obtained 
for this intermediate corresponded to previously reported values.
17 
 
Scheme 3.15: Formation of intermediate 3.5 from compound 1.1 via an aldol condensation 
reaction using Hagiwara’s conditions. 
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An alternative method was developed which involved trapping the lithium enolate with TMSCl 
for  a  more  stable  intermediate  before  reacting  with  an  alternative  Lewis  acid  titanium 
tetrachloride and acetone (scheme 3.16).
29 
 
Scheme 3.16: Alternative method to the formation of compound 3.5. 
 
Formation of compound 3.73 was based on a procedure used to form the silyl enol ether of 
the Wieland-Miescher ketone,
30 and this was taken onto the next step without purification.  An 
additional olefinic proton as well as a singlet corresponding to 9H of the TMS group  was 
observed in the crude 
1H NMR spectra.  The following aldol reaction using the silyl enol ether 
compound 3.73 and acetone which was activated by titanium tetrachloride.  Yields of up to 
48% were obtained which was an improvement to the previous aldol procedure. 
 
Dehydration of the aldol product 3.5 to afford dehydrofukinone was initially carried out using 
microwave  dried  molecular  sieves  and  camphorsulfonic  acid  as  a  miniature  Dean-stark 
apparatus suitable for test reactions on a small scale was not available.  This method did form 
dehydrofukinone but the yield obtained was found to be moderate at 30%.   
 
An improved method was found through mesylation of the alcohol to form a better leaving 
group, although the mesylate 3.74 was not isolated, before eliminating in the presence of 
excess base.  This afforded (±)-dehydrofukinone in increased yields of 66% (scheme 3.17). 
 
Scheme 3.17: Formation of(±)-dehydrofukinone from aldol product 3.5 
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3.4.  Synthesis of fukinone 
 
The synthesis of fukinone could also be readily accomplished from intermediate 3.5, with the 
addition of a reduction step prior to dehydration (scheme 3.18).  The challenge was in the 
selective reduction of the α,β-unsaturated ketone to give only the desired cis isomer therefore 
a variety of conditions were investigated. 
 
Scheme 3.18: Route to (±)-fukinone 
 
There  have  been  several  examples  of  bicyclic  enone  systems  which  have  been  selectively 
reduced to  give the  desired  cis  isomer as the  major  product.    For  example,  the  Wieland-
Miescher ketone was reduced using Stryker’s reagent to give 17:1 cis:trans ratio in 82% yield
31 
(scheme 3.19). 
 
Scheme 3.19: Reduction of Wieland-Miescher ketone with Stryker’s reagent 
 
 
Stryker’s  reagent  [(Ph3P)CuH]6  is  a  mild  hydride  source  shown  to  be  effective  in  the 
chemoselective reduction of conjugate systems such as α,β-unsaturated ketones.  However, 
no reaction was observed when these conditions were carried out on compound 3.5 (table 
3.1).  Modifications of these conditions later report the use of silanes to facilitate the 1,4-
hydride addition,
32 however this also gave no reaction with only starting material obtained 
after prolonged periods.   
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The use of palladium catalysts were then investigated.  (R)-(+)-Limonene has been used as a 
source of hydrogen in the presence of Pd/C to afford excellent selectivity for the cis isomer in 
the  reduction  of  Wieland-Miescher  ketone  (scheme  3.20).
33  However,  once  again,  these 
conditions resulted only in starting material despite prolonged heating. 
 
Scheme 3.20: Reduction of Wieland-Miescher ketone with limonene 
 
It was the simple hydrogenation conditions of Pd/C or Pd/CaCO3 under H2 atmosphere that 
resulted in the desired reduced product 3.75.  Literature conditions using palladium in various 
solvents on bicyclic enones giving a majority of the cis isomer were tested (entry 4-10 of table 
3.1).  A clear ratio of cis/trans products obtained after the reduction could not be ascertained 
due to their inseparable nature and the complex 
1H NMR spectra obtained, but the presence 
of the desired product was confirmed by the loss of the alkene proton and the correct mass 
observed  in  LCMS.  This  crude  material  was  taken  on  for  dehydration  to  give  the  natural 
product fukinone as the minor product in a mixture of two compounds (scheme 3.21). 
 
Scheme 3.21: Synthesis of (±)-fukinone from intermediate 3.5 
 
Changing the reduction conditions resulted in varying ratios of isomers but fukinone was found 
to be the minor product in each case.  The other isomer obtained along with fukinone was 
proposed  to  be  the  trans  diastereoisomer  obtained  as  a  result of  the  reduction.   Despite 
traditional  column  chromatography  as  well  as  reverse  phase  HPLC  (CH3CN/H2O)  the  two 
isomers could not be separated (seen as a single peak).  Only the correct mass for the desired 
product was observed by LCMS.  It should be noted that fukinone, and its isomer, is prone to 
autoxidation
34  so  prolonged  purification  attempts  lead  to  decomposition  of  material.  
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The dehydration conditions did not greatly affect the ratio of product or yield obtained.   The 
optimum conditions were found to be reduction with Pd/C in ethanol followed by dehydration 
via the mesylate to give 53% of products in a 1:3 ratio (entry 10 of table 3.1). 
 
Table 3.1: Synthesis of fukinone from intermediate 3.5. 
Entry  Reduction conditions  Dehydration conditions  Result  
% over 2 steps 
(fukinone:other) 
1  32  mol%  Stryker’s  reagent, 
benzene,  H2O, rt, 72 hr
31  
-  No reaction 
2  5  mol%  Stryker’s  reagent, 
PhSiH3, toluene, 72 hr
32 
-  No reaction 
3  Pd/C, (R)+limonene, reflux, 18 
hr
33 
-  No reaction 
4  Pd/C, H2, 95 % ethanolic NaOH, 
rt, 22 hr
22 
-  Decomposition 
5  Pd/C, H2, EtOAc, rt, 48 hr  CsOH,  benzene,  mol.  sieves, 
reflux 6hr 
39% (1:5) 
 
6  Pd/C, H2, MeOH, rt, 20 hr
35  Et3N, CH3SO2Cl, CH2Cl2, 0°C to rt 
o/n 
40% (1:4) 
7  Pd/CaCO3, H2, py, rt, 72 hr
36  Et3N, CH3SO2Cl, CH2Cl2, 0°C to rt 
6hr 
47% (1:3) 
 
8  Pd/CaCO3, H2, py, rt, 72 hr  SOCl2, pyridine then alumina  50% (1:3) 
 
9  Pd/C, H2, EtOH, rt, 16 hr
30  SOCl2, pyridine then alumina  45% (1:3) 
 
10  Pd/C, H2, EtOH, rt, 16 hr  Et3N, CH3SO2Cl, CH2Cl2, 0°C to rt 
6hr 
53% (1:3) 
 
 
There have been reports that illustrate the sensitivity of reactions to changes in functional 
groups on the molecule of the decalin structure.  For example, in the hydrogenation of the 
Wieland-Miescher ketone, a 85:15 cis:trans isomer ratio was observed;
36 however, when the 
C-9 ketone was protected with the dioxolane group, the cis isomer was formed exclusively 
(scheme 3.22). 
 
 
 
 3. Total synthesis of dehydrofukinone and fukinone 
71 
 
Scheme 3.22: Hydrogenation of Wieland-Miescher ketone & analogue 
 
 
It is interesting to observe that the reduction of progesterone by Capitaine & Engel
37 with 
Pd/CaCO3 gave a higher stereoselectivity when the non participating carbonyl was protected 
with a diol even though it is not close to the enone undergoing reduction (scheme 3.23). 
 
Scheme 3.23: Reduction of progesterone by Capitaine & Engel. 
 
Yet, with a compound towards the synthesis of an analogue of squalamine, where there is a 
ketal present much closer to the reacting enone, the trans isomer is preferred (scheme 3.24).
38 
 
Scheme 3.24: Reduction of a compound synthesised enroute to the synthesis of a squalamine 
analogue. 
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Despite there being less steric hindrance with the reduction of a ketocholesteryl acetate,
39  the 
trans isomer was still predominantly formed in the presence of Pd/C in CH2Cl2 (scheme 3.25). 
 
Scheme 3.25: Reduction of a ketocholesteryl acetate. 
 
These literature results have shown that different bicyclic systems will give different ratios of 
cis:trans isomers when reduced and that no single condition will give the same result for all 
systems.    The  electronics,  conformation  and  sterics  of  a  system  greatly  affects  the  ratio 
outcome as well as the type of catalyst and solvent used, so a more thorough screening is 
required to obtain selective cis formation of our particular system to give cis 3.75. 
 
. 
 
 
 
 
 
 
 
 
 
 
 3. Total synthesis of dehydrofukinone and fukinone 
73 
 
3.5.  Conclusion to chapter 3 
 
Although dehydrofukinone and fukinone have been previously synthesised,
 ours is a different 
fully  synthetic  route  with  a  comparable  number  of  steps  and  yield  (scheme  3.26).    This 
divergent pathway allowed us to synthesise two natural products from intermediate 1.1 in a 
quick and simple manner. 
 
Scheme 3.26: Synthesis of dehydrofukinone and fukinone from intermediate 1.1. 
 
 
Dehydrofukinone was synthesised with an overall yield of 17% in 12 steps and fukinone was 
synthesised with an overall yield of 4% in 13 steps.  Duhamel reported the shortest route to 
(±)-dehydrofukinone  14%  overall  in  7  steps.    Tenius  achieved  the  shortest  stereospecific 
synthesis of the enantiomer of the natural product dehydrofukinone in 12 % yield over 8 steps.  
Chan  &  Prasad  synthesised  (±)-fukinone  in  the  shortest  route  12  steps  from  2-methyl-2-
cyclohexenone with the highest overall yield of 8%.  There has not been a stereoselective 
synthesis of fukinone published so its absolute stereochemistry has yet to be determined. 
 
The synthetic route was not optimised due to time restraints.  There are several opportunities 
for improvements to the reaction conditions but as this was not the main goal of this project, 
we decided to refocus our attention onto the total synthesis of nominine. 
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As  the  use  of  palladium  catalysts  appears  to  form  the  trans  isomer  preferentially  in  the 
reduction of compound 3.5, an example of further work would be to screen stereoselective 
reduction conditions for the synthesis of compound 3.75 to ensure the cis stereocentre at the 
ring junction is formed for the natural product fukinone.  Organocatalysis using chiral amines 
and  Hantzsch  esters  as  the  hydride  source  has  been  shown  to  regioselectively  and 
stereoselectively reduce Wieland-Miescher ketone analogues in good yield (scheme 3.27).
40 
 
Scheme 3.27: Reduction of Wieland-Miescher ketone using organocatalysis. 
 
 
The  use  of  enantioselective  chromatography  using  chiral  columns  could  also  give  better 
separation of the isomers formed.   
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Chapter 4.  Studies towards total synthesis of 
nominine 
 
4.1.  1,4-Addition reactions. 
 
The key step in the proposed synthetic route to nominine involves the regioselective 1,4-
addition of the alkene moiety to the bicyclic intermediate enone 1.3 (or enone 1.1), followed 
by  trapping  of  the  enolate  with  the  halogenated  indole  moiety  while  ensuring  that  cis 
stereochemistry is achieved. 
 
Scheme 4.1: Proposed 1,4-addition: key step to synthesis of nominine 
 
 
This vicinal difunctionalisation would involve the initial Michael addition of the alkyl metal 
(most commonly cuprate) nucleophile to a Michael acceptor (enone 1.3 or enone 1.1) which 
would cause the β-carbon to be substituted with the alkyl group.  The resulting nucleophilic α-
carbon is now enolate 4.1 which could then be trapped with the indole halide electrophile to 
give compound 4.2 (scheme 4.1).   
 
It was proposed that the 1,4-addition would occur in a cis fashion due to the conformation of 
bicyclic enone 1.1 in which addition on the convex face would be preferred due to less steric 
hindrance.  The  hydroxyl  group  in  enone  1.3  could  aid  in  the  cis  addition  of  the  alkyl 
nucleophile by acting as a directing group and coordinating with it.  Literature precedence 4. Studies towards total synthesis of nominine 
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supports  this  proposal  in  which  Tokoroyama  et  al.
1  utilised  vicinal  difunctionalisation  of 
decalins  to  give  the  desired  cis  stereochemistry  enroute  to  their  synthesis  of  natural  cis-
clerodane  diterpenoids  (scheme  4.2).    Conjugate  addition  of  dimethyl  lithium  in  ether  to 
intermediate  4.3  followed  by  trapping  of  the  enolate  with  formaldehyde  gave  the 
difunctionalised decalin 4.4 as a single diastereoisomer.  The stereochemistry was confirmed 
by conformational analysis and comparison with similar compounds. 
Scheme 4.2: Tokoroyama’s synthesis of cis-clerodane utilising vicinal difunctionalisation 
 
Bonjoch et al.
2 also utilised this method in their total synthesis of (-)-nakamurol A (scheme 4.3) 
although  they  modified  the  conjugate  addition  procedure  in  which  Me2Zn  and  a  Ni(acac)2 
complex were used instead of Me2CuLi.MeS.  
 
Scheme 4.3: Initial steps in the synthesis of (-)-nakamurol A by Bonjoch et al. 
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4.1.1.  Model studies using 3-methyl-cyclohexenone and Grignard reagents: 
Trapping enolate with MeI 
 
The  traditional  method  of  1,4-additions  using  catalytic  amounts  of  copper  was  first 
investigated.  Kharasch and Tawney first showed in 1941
3 that selective 1,4-addition occurred 
when a Grignard and an α,β-unsaturated carbonyl were combined in the presence of catalytic 
CuCl.  Test reactions were carried out to determine the success of this crucial step using MeI as 
a substitute for the indole moiety as it had not yet been synthesised as well as the fact that 
MeI is an excellent electrophile.  The test system used was 3-methyl-2-cyclohexenone as it was 
readily available and has a fair resemblance to the actual intermediate to be used.   
 
The initial procedure was based on a synthetic route by Williams et al.
4 with the exception that 
Williams et al. quenched the enolate instead of trapping it with another reactant.  The alkenyl 
cuprate  used  was  synthesised  in  situ  from  the  brominated  alkene,  which  was  purchased 
relatively inexpensively, in a metal exchange reaction from the Grignard compound. 
 
Scheme 4.4: Modified 1,4-addition test reactions 
 
Reaction conditions were varied however the MeI failed to trap the enolate and no compound 
4.5 was observed (scheme 4.4).  After optimisation only compound 4.6 was isolated as well as 
trace amounts of the 1,2-addition reaction product 4.7.   4. Studies towards total synthesis of nominine 
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Despite this finding, the experiments carried out (table 4.1) have resulted in an increase of 
yield of the 1,4-addition step from 22% to 91%.  It was discovered that doubling reaction 
times, 2 equivalents of Grignard reagent and only 10 mol% of the CuBr.S(CH3)2 reagent gave 
the highest yield (literature yield reported 85%).  Any larger amount and the yield decreased 
accordingly  as  the  cuprate  and  Grignard  coupled  together.  Changing  the  electrophile  to 
benzylbromide to trap the enolate also failed to give the desired product.   
 
Table 4.1: Varying conditions for 1,4-addition reaction using test enone 
 
Entry  Conditions  Yield  of  compound 
4.6 % 
1  Literature method* + 1.05 equiv MeI  22 
2  Double reaction times after Grignard formation + 1.05 equiv 
MeI 
23 
3  2 equiv Grignard + 10 mol % Cu reagent and double reaction 
times + 2 equiv MeI 
91 
4  2 equiv Grignard + 2.1 equiv Cu reagent and double reaction 
times + 2 equiv MeI 
12 
5  2 equiv Grignard + 30 mol% Cu reagent and double reaction 
times + 2 equiv MeI 
84 
6  Repeat exp. 3 + 4 equiv MeI  No product** 
7  Repeat exp. 3 + 4 equiv benzylbromide  No product** 
 
* Literature method: 1.05 equiv Grignard + 5 mol% CuBr.S(CH3)2 for ½ hr at 
-20°c, add 1 equiv enone and 
stir 15 mins at -20 °C then warm to room temperature. 
** Crude NMR spectroscopy and mass spectrometry indicated no desired product present so crude was 
not purified. 
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4.1.2.  Model studies using 3-methyl-cyclohexenone and Grignard reagents: 
Trapping enolate with TBDMSCl/TMSCl 
 
Difficulties have been encountered with conjugate additions of organocopper reagents with 
bulky  groups  or  when  there  is  steric  hindrance  at  the  reaction  centre  of  the  enone.    To 
overcome  this,  addition  of  alkylsilanes  is  added  to  accelerate  the  conjugate  additions  by 
activating the carbonyl group.
 5 As trapping of the enolate with MeI failed to succeed, it was 
thought that the enolate should be trapped with a more reactive species such as TBDMSCl or 
TMSCl.  Alkylsilanes have a high affinity for oxygen therefore addition of TBDMSCl or TMSCl 
would alkylate the oxygen to form a more stable compound (silyl enol ether 4.8) that can be 
isolated before reacting with an indole moiety.  Several procedures were investigated (table 
4.2).
6 Despite the varying conditions only starting materials were obtained for most, indicating 
that neither the 1,4-addition reaction was occurring nor the trapping of the enolate.  Only the 
1,4-addition product 4.6 was obtained with the previously described procedure when MeI was 
present (entry 4).  
Table 4.2: Model compound reactions with Grignard reagents followed by trapping of enolate 
with silyl compounds 
 
Entry   Conditions  Result 
1   3.2  equiv  Mg,  2.1  equiv.  bromo-2-methyl-2-pentene,  10mol% 
CuBr.S(CH3)2 at -20 °C.  At 0 °C add TBDMSCl, Et3N, HMPA,  
SM 
2   5.6 equiv Mg, 1.1 equiv. bromo-2-methyl-2-pentene, 53mol% CuI  SM 
3   Repeat  of  exp.  2  with  extra-dried  CuI  and  more  concentrated 
solution 
SM 
4   3.2  equiv  Mg,  2.1  equiv.  bromo-2-methyl-2-pentene,  10mol% 
CuBr.S(CH3)2, 4 equiv. MeI 
44%  
compound 4.6 
5  3.2  equiv  Mg,  2.1  equiv.  bromo-2-methyl-2-pentene,  10mol% 
CuBr.S(CH3)2 at -78  °C  was  added  HMPA,  then  TBDMSCl  with 
enone.  30 min at -40 °C followed by Et3N. 
SM 
6   2.1 equiv. Grignard, 5mol% CuBr.S(CH3)2 at -78 °C, then HMPA, 
TMSCl and enone added together followed by addition of Et3N at 
-40 °C. 
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The formation of the quaternary carbon appears to require specific conditions and in this case, 
trapping of the enolate failed, possibly due to the steric hindrance of the alkyl chain that was 
added in the 1,4-addition. 
 
Suzuki and Noyori
6 do mention the difficulty of alkylation of ketone enolates in cyclohexanone 
enolates and ascribe this to “proton exchange between the enolates and alkylated products 
leading  to  polyalkylation  or  other  side  reactions”.    HMPA  is  often  added  to  the  reaction 
medium in an attempt to solve this problem by creating a more polar medium.  However this 
appeared to have no effect on the reactions carried out with only starting materials observed. 
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4.1.3.  Model studies using 3-methyl-cyclohexenone and Gilman’s reagents. 
 
As the use of Grignard reagents failed to afford the desired product, the Gilman’s reagents 
were then investigated.  Several procedures describe the use of stoichiometric amounts of 
organocopper reagents known as Gilman’s reagents (R2CuLi), in a conjugate addition on similar 
compounds  followed  by  trapping  of  the  enolate  with  improved  yields  and  regioselectivity 
compared to catalytic copper procedures.  These compounds are prepared by the reaction of 
organolithium reagents (RLi) with copper(I) halides (CuX). 
 
The  initially  formed  (RCu)n  are  polymeric  and  insoluble  in  Et2O  and  THF  but  dissolve  on 
addition of a second equivalent of RLi or RMgX.  The resulting lower order organocuprates are 
thermally labile and therefore need to be prepared at low temperatures. 
 
The  first  task  was  to  synthesise  4-methyl-3-pentenyllithium  4.9,  from  bromo-2-methyl-2-
pentene,  as  it  was  not  commercially  available.    Several  procedures  were  carried  out  and 
reacted with benzaldehyde to confirm its success.  Only two procedures were successful in 
forming  compound  4.10.    The  first
7  using  lithium  metal  in  Et2O  at  -20  °C  and  1,2-
dibromoethane to initiate the reaction, gave only 8% product.  The second
8 utilised tert-butyl 
lithium 1.5M in Et2O at -78 °C and gave 44% product 4.10 (scheme 4.5).  No product was 
observed with n-BuLi. 
 
Scheme 4.5: Confirmation of the formation of 4-methyl-3-pentenyllithium 4.9 by trapping with 
benzaldehyde 
 
 Compound 4.9 was added to a suspension of CuI in Et2O at 0 °C and then added to the model 
compound, warming to room temperature over two hours.
6 However, only starting material 
was detected.  Subsequent reactions using further purified CuI and then a new bottle of 99.9 % 4. Studies towards total synthesis of nominine 
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CuI, dried on the high-vac line for 24 hours gave no improvement to the reaction (scheme 4.6).  
Addition of di-n-butyl sulfide (twice the number of equivalents compared to CuI) was also 
added to aid solubility of the copper salt but this had no effect. 
 
Scheme 4.6: Reaction of model compound with Gilmans reagent 
 
 
If transmetallation with CuI did not occur, compound 4.9 could still react in a 1,2-addition but 
since no reaction is seen at all, it was deduced that the enone is not very active.  It was also 
thought that any water present, in solvent or reagents would immediately quench compound 
4.9 so every step was taken to ensure an anhydrous reaction. 
 
The Lewis acid 10 mol% of BF3.OEt2 was chosen to activate the enone.
9 However, only starting 
materials were recovered.  CuI was dissolved in di-n-butyl sulphide to increase its solubility and 
varying temperatures were tested, however no reaction occurred. 
 
With compound 4.9 and the test enone, addition of TMSCl or even TBDMSCl/HMPA, no effect 
was found on the reaction.  It was concluded that the reaction of compound 4.9 with this 
particular model system is particularly challenging. 
 
It was also proposed that the failure of these 1,4-addition-alkylation reactions could have been 
due to the purity of the reagents.  HMPA is often freshly distilled before use, however this 
process has been recently discouraged due to the hazards involved.  While the TBDMSCl and 
TMSCl were obtained from commercial sources, they were used without further purification as 
the bottles were newly acquired. 
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4.1.4.  Investigations of 1,4-addition reactions with enone 1.1 
Despite the lack of success with the model compound, it was decided to carry out 1,4-addition-
alkylation investigations on the actual enone 1.1 as it was thought that this system could react 
differently  to  the  model  (scheme  4.7).  At  this  point  in  the  investigations,  there  was  an 
abundance of enone 1.1 from the large scale synthesis that was carried out.  Enone 1.1 was 
investigated with both Grignard as well as Gilman reagents for the 1,4-addition. 
 
Scheme 4.7: Proposed 1,4-addition-alkylation reaction of enone 1.1. 
 
The reaction of enone 1.1 with Gilman reagent gave no reaction, despite the addition of Lewis 
acids  to  activate  the  carbonyl  (such  as  BF3.OEt2,  AlCl3)  or  even  the  addition  of 
tributylphosphine which was reported to be essential in the 1,4-addition of Gilman’s reagents 
to sterically hindered enolates such as neopentylether-shielded trans-enolates.
10  Large excess 
of the reagents were used in both THF and Et2O but no reaction occurred. 
 
As  the  1,4-addition  with  the  Grignard  reagent  was  found  to  be  successful  for  the  model 
compound, this procedure was carried out on enone 1.1, however it was found that it was not 
suitable for this system as no product was obtained.  The model compound is a flat system 
whereas enone 1.1 comprises of two rings which would be in a chair formation, creating more 
steric hindrance at the site of attack.  Despite the addition of TMSCl and HMPA, or BF3.OEt2 to 
activate the enone,
9 or excesses of the Grignard and CuBr.S(CH3)2, only starting materials were 
obtained. 
 
Due  to  the  lack of  positive  results with  bromo-2-methyl-2-pentene,  it  was  thought  that a 
smaller and more reactive species (allylbromide) could be used for the 1,4-addition and then 
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Scheme 4.8: Proposed route to compound 4.15 using allylbromide 
 
The allylbromide was tested in both the Gilmans reagent
11 and the Grignard reagent
6 method 
of copper 1,4-addition (as described for the model compound) including the addition of HMPA 
and TMSCl, however all reactions recovered only starting materials.  Compound 4.12 was not 
observed under any reaction conditions. 
 
As  previously  mentioned,  in  the  synthesis  of  (+)-nakamurol  A  Bonjoch  et  al.
2  successfully 
managed to add a methyl group to enone 1.1 via a 1,4-addition and trapping the enolate with 
formaldehyde.  Dialkyzinc reagents were used instead of copper with a catalytic amount of 
Ni(acac)2  for  the  1,4-additon  due  to  problems  with  reproducibility  of  results  with  the 
organocuprate conditions (scheme 4.9). 
 
Scheme 4.9: Successful 1,4-addition to enone 1.1 by Bonjoch et al. towards the synthesis of (+)-
nakamurol A. 
 
These  conditions  were  investigated  in  a stepwise manner  to  ensure  its  success.   The 1,4-
addition step was first adapted to suit our synthesis.  The dialkylzinc reagent was synthesised 
using an adapted procedure by Schulz et al.
12 in which bromo-2-methyl-2-pentene was reacted 
with magnesium to form the Grignard reagent, which was added to a solution of ZnCl2 in THF 
at  room  temperature  and  stirred  overnight  to  form  the  dialkylzinc  reagent.    A  premixed 
suspension of enone 1.1, 1 mol% of Ni(acac)2 and LiBr in Et2O was added to the dialkylzinc 
solution at 0 °C and stirred at room temperature.  Even after 24 hours, only starting material 4. Studies towards total synthesis of nominine 
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was isolated; no reaction occurred (scheme 4.10).  Repetition of these conditions on hydroxy 
enone 1.3 also failed to give any product. 
Scheme 4.10: Bonjoch’s conjugate addition conditions with the dialkyl zinc compound 
 
It is uncertain whether the failure of the reaction was due to the lack of formation of the 
dialkylzinc compound or the sterically hindered position at the bicyclic ring junction and the 
size of the addition compound.  While, there are several examples of the addition of a methyl 
group at this position in octalone compounds such as enone 1.1, using both zinc reagents and 
copper reagents,
13  there is no literature indicating the successful addition of larger groups at 
this position. 
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4.1.5.  Conclusion to chapter 4.1 
 
The 1,4-addition step followed by trapping of the enolate was thoroughly investigated both on 
a  model  compound  and  enone  1.1,  however    these  reactions  failed  to  form  any  desired 
product.  In many cases, starting material was isolated indicating the lack of reactivity in that 
system and despite the addition of activating Lewis acids, no product was formed.  Had more 
time  been  available,  the  use  of  a  more  electrophilic  reagent  to  trap  the  enolate  such  as 
formaldehyde  (as  used  by  Tokoroyama  and  Bonjoch)  could  have  been  tested  as  proof  of 
concept that trapping of the enolate is possible with these systems. 
 
Particularly for enone 1.1, the site of 1,4-addition would be sterically hindered particularly for 
the long alkyl chain that is required for the synthesis of nominine.  There have not been any 
literature precedent for conjugate addition at that hindered position of a decalin with anything 
larger than a single carbon group (ie. methyl or nitrile). 
 
At  this  point,  a  new  paper  was  discovered  by  Bonjoch  et  al.
14  who  were  also  currently 
attempting  the  total  synthesis  of  nominine.    They  had  been  investigating  the  addition  of 
various organometallics to the hydroxy enone 1.3, however they found the 1,4-addition to be 
unsuccessful also.  As a result of this,  investigations of  the 1,4-addition reaction on these 
decalins was suspended while other routes were investigated. 
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4.2.  Synthesis of hydroxy bicyclic enone 1.3 
 
 
Several procedures were investigated towards the synthesis of hydroxy bicyclic enone  1.3.  
Installation of the hydroxy group onto enone 1.1 was revealed to be a non-trivial step as 
investigations proceeded.  The required cis orientation of the hydroxy to the methyl groups 
coupled with the conformation of the decalin rings resulted in difficulties with this step.  The 
reported  literature  procedures  tended  to  be  low  yielding,  contain  multiple  steps  and/or 
require very carefully controlled conditions. 
4.2.1.  Kishi’s method 
This method was based on a procedure by Kishi et al.
15 who installed a hydroxyl group on a 
similar intermediate (i) during their total synthesis of (±)-batrachotoxinin A (scheme 4.11).  The 
carbonyl was protected with dimethyl propandiol causing the migration of the double bond to 
the β,γ-position (ii). Control of the alkene regiochemistry is determined by the acidity of the 
acid catalysts used in this step.  Highly acidic catalysts (pKa ~ 1) tend to cause the double bond 
to migrate whereas low acidity catalysts do not.
16 The migrated double bond is epoxidised (iii) 
and the carbonyl deprotected before DBU deprotonates to reinstall the double bond causing 
the opening of the epoxide to form the hydroxy group in the desired position (iv).  Although 
we required the hydroxy to be in a cis position whereas Kishi obtained a trans hydroxy, we felt 
this could be remedied during the epoxidation step.   
Scheme  4.11:  Kishi’s  use  of  ketalisation  to  install  a  hydroxy  group  enroute  to  (±)-
batrachotoxinin A 
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For the formation of the 1,3-dioxane with double bond migration to the β,γ-position 4.16, we 
used camphorsulfonic acid (CSA) as 2-naphthalenesulfonic acid (NSA) was not readily available 
at the time of our investigations.  We found a small percentage of the products obtained 
retained the double bond regiochemistry of the starting material (4.17 5-10%) and attributed 
this to the fact that CSA is not as acidic as NSA (scheme 4.12).  However, as yields obtained for 
the desired product 4.16 were acceptable, this matter was not pursued.  Out of interest, we 
also tested ethylene glycol and diethyl propanediol in this step and found that while they 
formed the desired product with migration of the double bond, higher yields were obtained 
with dimethyl propandiol.  We varied the number of equivalents of dimethyl propandiol and 
the concentration used.  Optimum yields were obtained with 2.5 equivalents of the diol in a 
0.37 M solution for 24 hours in which 79% of the desired product 4.16 was obtained.   
 
Scheme 4.12: Ketalisation of enone 1.1 using CSA resulted in two products 
 
Kishi utilised the very powerful oxidising agent peroxy-trifluoroacetic acid (formed in situ from 
sodium percarbonate and trifluroacetic anhydride) to form the trans epoxide.  However, as we 
required a cis epoxide, alternative reagents were investigated. 
Dimethyldioxirane (DMD) is a common reagent for epoxidation along with mCPBA although it 
often shows superior yields and stereoselectivity in comparison.  It has also been shown to be 
more tolerant of other functional groups which are sensitive to temperature or acid/base.
17 
Whilst DMD is often synthesised and distilled before addition to the reaction mixture,
18 Ferraz 
et al. described a simple procedure for its synthesis and use in situ.
19  They also described the 
use of this procedure on substrates similar to that of enone 1.1 indicating a high ratio of the cis 
epoxide formation in high yields (table 4.3). 
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Table 4.3: Epoxidation of Δ
4-octalin derivatives by Ferraz et al. 
Entry  Substrate  Products (ratio)  Yield 
 
1 
   
 
91% 
 
 
2     
 
90% 
 
3 
   
 
95% 
 
DMD is a three membered cyclic peroxide formed from addition of Oxone® (active component 
KHSO5) to acetone in the presence of water and NaHCO3.  A by-product of the reaction is 
sulfuric acid therefore at least one equivalent of base is required as Oxone® will decompose at 
a pH lower then 7.  DMD is used as an oxygen-transfer agent as well as an oxidising agent.  In 
this case, DMD transfers an oxygen atom to the alkene forming the epoxide 4.18 and acetone.  
Epoxide 4.18 is then deprotected before a base is used to open the epoxide forming the 
desired hydroxy compound 1.3 (scheme 4.13).  It was proposed that the small size of DMD 
would allow for attack of the top face of 4.16 resulting in the desired cis epoxide. 
Scheme 4.13: Use of DMD to form hydroxy compound 1.3 
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Ferraz  et  al.’s  general  procedure  describe  the  dropwise  addition  of  Oxone®  in  water to a 
stirred solution of the alkene and NaHCO3 in acetone at 0 °C, and stirring of reaction mixture at 
room temperature until consumption of starting material.  After overnight stirring, starting 
material was still recovered (entry 1 of table 4.4).  Extended reaction times in entries 2 and 3 
indicated no starting material by TLC although many other products were present.  The crude 
reaction mixture was found to be only partially soluble in CDCl3 which was puzzling as the 
desired  product  4.18  was  expected  to  be  quite  non-polar.    This 
1H  NMR  spectra  in  CDCl3 
showed no identifiable products so a second extraction of the aqueous layer with addition of 
brine as well as copious washes with EtOAc was required to extract the products.  After a long 
column with multiple products, compound 4.19 (confirmed by 
1H NMR spectroscopy in MeOD 
and ESI+) was identified as the major product in these reactions.  This is a surprisingly polar 
compound preferring to stay in the aqueous layer during work up with an Rf = 0.12 in 50% 
EtOAc/hexane.  These  initial  results  indicated  that  deprotection  of  the  ketal  as  well  as 
decomposition of products occurred with time at room temperature. 
Table 4.4: Epoxidation of 4.16 with DMD 
 
Entry  Reagents & Conditions 
(addition  of  Oxone®  over  this  period  of 
time) 
Products obtained (yields) 
 
 
1 
 
2 equiv. NaHCO3 
Acetone/H2O 
1.2 equiv. Oxone® (10 min) 
o/n, rt 
 
 
 
2 
 
1.8 equiv. NaHCO3 
Acetone/H2O  
1.1 equiv. Oxone® (10 min) 
52 hr, rt 
 
 
 
3 
 
2 equiv. NaHCO3 
Acetone/H2O  
1.2 equiv. Oxone® (10 min) 
91 hr, rt 
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4 
 
2 equiv. NaHCO3 
Acetone/H2O 
1.2 equiv. Oxone® (10 min) 
5 hr, 0 °C 
 
 
 
5 
 
2 equiv. NaHCO3 
Acetone/H2O 
1.2 equiv. Oxone® (10 min) 
7 h, 0 °C 
 
 
 
6 
 
2 eq. NaHCO3 
Acetone/H2O 
1.2 eq. Oxone® (10 min) 
5 hr, 0 °C then o/n rt 
 
 
 
7 
3 equiv. NaHCO3 
Benzene/Acetone/H2O 
Phosphate buffer pH 7-8 
0.2 equiv. 18-crown-6 (PTC) 
2.3 equiv. Oxone® (30 min) 
Addition at 6-8 °C, o/n rt 
 
 
 
8 
1.1 equiv. 4.16 
5 equiv. NaHCO3 
EtOAc/Acetone/H2O 
0.9 equiv. Oxone® (1 hr) 
2hr, rt   
 
 
9 
1 equiv. 4.16 
5 equiv NaHCO3 
EtOAc/Acetone/H2O 
1 equiv. Oxone® (30 mins) 
2.5hr, rt   
 
In light of the decomposition of the products at room temperature, the reaction temperature 
was reduced to 0 °C which slowed down the reactio n as indicated by the recovery of 41% of 
starting alkene in entry 4.  Extended reaction time at 0 °C reduced the amount of starting 
alkene recovered but deprotection of the ketal is also seen in entry 5 and 6.  
In an attempt to increase yields of  4.18, reaction conditions were modified
17 to include an 
organic solvent with PTC buffered to pH 7, however yields were still quite low at 31% (entry 7).  
Success was found using conditions developed by Hashimoto and Kanda
20 in which they show 
that DMD has a high affinity for EtOAc in a two-phase system and the addition of Oxone® in 
H2O  over  a  long  period  of  time  gives  high  yields  of  expoxidation  without  the  need  for 
temperature or pH control.  When Oxone® was added over a period of one hour to a slight 4. Studies towards total synthesis of nominine 
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excess of compound 4.16, 95 % of 4.18 was formed (entry 8).  A shorter addition time of 30 
minutes and use of equimolar quantities of starting 4.16 and Oxone® reduced yields to 68% 
(entry 9). Only one isomer of the epoxide was observed by NMR analysis. 
 
Opening of the epoxide was investigated using the batches of compound 4.19 formed from 
experiments in table 4.4.  Kishi’s procedure describes the addition of DBU to the epoxide in 
benzene at room temperature.  However, the solubility of 4.19 was found to be very poor in 
benzene and required several drops of MeOH to solubilise.  After overnight stirring, 33% of 
hydroxy enone 1.3 was isolated (entry 1 table 4.5).  Initially, we proposed the low yields were 
due to solubility issues so we changed the solvent to acetone in which 4.19 dissolves well in.  
However, only starting material was isolated even when we changed the base.  We eventually 
concluded that the base can also deprotonate acetone as the estimated pKa of 4.19 is similar 
to that of acetone.  As the solvent, acetone would be easier and faster to deprotonate due to 
its abundance, therefore no reaction was seen in these experiments (entry 2 and 3).  Changing 
the base and solvent in entries 4 and 5 only caused decomposition of starting material and 
products. 
Table 4.5: Investigating the ring opening of epoxide 4.19 
Entry  Base  Solvent  Conditions  Result 
1  DBU  Benzene 
+ drops of MeOH 
until 4.19 
solubilised 
Room temperature 
overnight 
 
2  DBU  Acetone  Room temperature 
overnight 
Starting material 
recovered 
3  Et3N  Acetone  Room temperature 
overnight 
Starting material 
recovered 
4  K
tOBu  t-butanol  Room temperature 
overnight 
Decomposition 
5  DBU  MeOH  Room temperature 
24 hr 
Decomposition 
 
Concurrently, we were also investigating the deprotection of the ketal to form 4.19.  Using 
Kishi’s method to form the hydroxy group using 5% HCl in THF followed by DBU in benzene 
gave poor yields (scheme 4.14).  Increasing the reaction time (24 hours and 48 hours) of the 4. Studies towards total synthesis of nominine 
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deprotection step (4.18 to 4.19) caused decomposition of products and starting material with 
no increase in yield. 
Scheme 4.14: Formation of enone 1.3 via Kishi conditions 
 
Screening of conditions revealed the use of 0.02 equivalents TsOH in anhydrous acetone for 
the hydrolysis of the protecting group
21 which was then quenched with Et3N.  Concentration of 
this reaction mixture to remove the acetone caused the epoxide to ring open giving enone 1.3 
in  up  to  40%  yields  over  the  two  steps  (scheme  4.15).    Only  the  cis  hydroxy  enone  was 
obtained (by comparison of data with literature)
22 which confirmed that the cis epoxide was 
formed exclusively in the previous step.   
 
Scheme 4.15: Formation of enone 1.3 via adapted Kishi conditions to give higher yields 
 
 
Although it would appear to be beneficial for the epoxidation step to also deprotect the ketal 
so that compound 4.19 could be formed from 4.16 in one step, it was found that the product 
formed was not 100% pure and was often very difficult to isolate, so a crude form of 4.19 had 
to be taken onto the next step.  The highest yield achieved over the three steps from alkene 
4.16 to hydroxy enone 1.3 was 34%. 
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4.2.2.  Dienol ether intermediate 
The installation of a 6β-hydroxy group onto bicyclic enones via dienol ether intermediates has 
been reported in literature since the 1950’s.
23 This two step transformation occurs through 
dienol ether intermediates which are oxidised to give the hydroxy compound. 
4.2.2.1. Dienol ether intermediate 
Suryawanshi  and  Fuchs
24  investigated  optimum  conditions  for  the  installation  of  the  6β-
hydroxy  group  onto  bicyclic  intermediates  during  their  investigations  towards  the  total 
synthesis of bruceantin.  The corresponding dienol ether, dienyl acetate and silyldienyl ether 
intermediates were prepared and different oxidation reagents (MCPBA, O2 in presence of hυ, 
iodosobenzene and Oxone®) were evaluated (scheme 4.16).  Oxone® was found to afford the 
highest yields of axial hydroxy group in mild and efficient conditions. 
Scheme 4.16: Investigating optimal conditions for the installation of a 6β-hydroxy group by 
Suryawanshi and Fuchs towards the total synthesis of bruceantin 
 
Based on this work, Bonjoch et al.
22 installed a hydroxy group onto enone 1.1 to form 1.3 
enroute to the total synthesis of (+)-xylarenal A (scheme 4.17). 
Scheme  4.17:  Bonjoch’s  formation  of  hydroxy  enone  1.3  from  enone  1.1  enroute  to  (+)-
xylarenal A. 
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This two step transformation involved the oxidation of compound 1.1 to install the hydroxyl 
group  which  was  carried  out  through  its  dienol  ether  intermediate
25  4.20  with  Oxone®.   
Although Suryawanshi and Fuchs did not report the isolation of the equatorial epimer, Bonjoch 
obtained a 4:1 ratio of axial:equatorial epimers (1.3A:1.3B) for this particular substrate. 
 
Bonjoch reported the use of trimethyl orthoformate, MeOH and DMF with TsOH for 24 hours 
in the dark to form the dienol ether intermediate which was isolated but not purified due to its 
instability.  Selected signals from the 
1H NMR spectrum were reported.  Oxone® in H2O was 
then added to the crude dienol ether in THF at 0 °C over half an hour and the reaction mixture 
stirred  for  five  hours.  This  method  was  carried  out  with  initially  poor  results  due  to the 
sensitivity  of  the  reaction  and  the  need  for  extremely  carefully  controlled  conditions.  
However, upon repetition and modification of some reagents/conditions, higher yields were 
obtained (table 4.6). 
Table 4.6: Optimising yields for the formation of hydroxy enone 1.3A 
Entry  Conditions  Result 
1  Step 1 – 0.95 mmol 1.1, 4:4:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 24 
hr, dark 
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 1.5 equiv. Oxone® in H2O dropwise, 
5.5 hr at 0 °C 
1.3A 6% 
2  Step 1 –2 mmol 1.1, 5:5:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 24 hr, 
dark 
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 1.5 equiv. Oxone® in H2O dropwise, 
5 hr at 0 °C 
1.3A 20% 
1.3B 5% 
3  Step 1 – 1.4 mmol 1.1, 6:6:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 24 
hr, dark 
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 1.5 equiv. Oxone® in H2O dropwise, 
7 hr at 0 °C followed by 1 hr at rt 
1.3A 18% 
1.3B 5% 
4  Step 1 – 1.1 mmol 1.1, 6:6:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 46 
hr, dark – new bottles of solvent and freshly dried TsOH 
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 2 equiv. Oxone® in H2O dropwise, 
5.5 hr at 0 °C 
1.3A 21% 
1.3B 9% 
5  Step 1 – 1.1 mmol 1.1, 6:6:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 24 
hr, dark – new bottles of solvent and freshly dried TsOH 
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 2 equiv. Oxone® in H2O dropwise, 
5.5 hr at 0 °C 
1.3A 28% 
1.3B 6% 
6  Step 1 – 1.1 mmol 1.1, 6:6:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 24 
hr,  dark  –  new  bottles  of  solvent,    freshly  dried  TsOH  and  freshly 
distilled C(OCH3)3 
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 2 equiv. Oxone® in H2O dropwise, 
5.5 hr at 0 °C 
1.3A 31% 
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7  Step 1 – 7.9 mmol 1.1, 4:5:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 28 
hr, dark  –  new  bottles  of  solvent,    freshly  dried  TsOH  and  freshly 
distilled C(OCH3)3 
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 1.5 equiv. Oxone® in H2O over 35 
mins then 6 hr at 0 °C 
1.3A 38% 
1.3B 23% 
8  Step 1 – 8.2 mmol 1.1, 4:5:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 24 
hr, dark  
Step 2 – THF, 0 °C, 3 equiv. NaHCO3, 0.02 equiv. PTC, 2 equiv. Oxone® in 
H2O over 30 mins then 3 hr at 0 °C, 2 hr at rt 
1.3A 32% 
1.3B 11% 
9  Step 1 – 7.8 mmol 1.1, 4:5:1 C(OCH3)3:DMF:MeOH, 0.2 equiv. TsOH, 24 
hr, dark  
Step 2 – 3:1 EtOAC:acetone, 0 °C, 5 equiv. NaHCO3, 1 equiv. Oxone® in 
H2O over 30 mins then 1 hr rt 
1.3A 41% 
1.3B 13% 
 
An  increase  in  scale  appeared  to  increase  yields  of  product  (see  experiment  1,  2  and  7).  
Increasing reaction time of step 1 did not increase yields; it increased the ratio of 1.3B (see 
experiment 4 and 5).  It was observed that trimethyl orthoformate required fresh distillation 
prior to each experiment for optimal yields as with prolonged storage yields decreased.   
Changing solvent ratios did not seem to affect yields.  The optimum yield was achieved in 
experiment 9 where EtOAc and acetone was used instead of THF at room temperature for only 
one hour.  The most important condition observed was that very slow addition of Oxone® was 
required.  41% of the desired 1.3A epimer was obtained in a 3:1 ratio with 1.3B.  Although 
these yields were considered moderate, they were comparable with literature results.
25 Also, 
the results were sufficient to obtain enough material for use in the next step of the project. 
 
Compound 1.3B corresponds to the natural product (±)-1α-hydroxyisoondetianone which was 
first  isolated  from  the  aerial  parts  of  the  South  African  plant  Ondetia  linearis  in  1989.
26 
Although  it  is  possible  to  convert  the  equatorial  epimer  1.3B  to  the  axial  1.3A  via  the 
Mitsunobu process
22 (scheme 4.18), this was not carried out due to the fact that we had 
substantial amounts of enone 1.1 available. 
Scheme 4.18: Bonjoch’s conversion of stereochemistry to form 1.3A 
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4.2.2.2. Dienol acetate intermediate 
 
An alternative to the dienol ether intermediate was the formation of the dienol acetate.  It was 
anticipated the dienol acetate could be formed from enone 1.1 and this intermediate would be 
stable enough to be isolated so a yield could be obtained to ascertain which step, formation of 
the dienol ether or the oxidation, caused the low overall yields of enone 1.3. 
 
Suryawanshi and Fuchs
24 reported the use of acetic anhydride, triethylamine and DMAP at 80 
°C for 18 hours to form 90% of the enol acetate derivatives of their intermediate although no 
procedure was published.  The procedure originated from a paper by Cousineau, Cook and 
Secrist III in 1979,
27 however they reported that yields for these conditions on ketones to form 
enol acetates were not satisfactory and therefore did not disclose the yields. 
 
Further research into the literature revealed alternative methods of formation of the dienol 
acetate.  Dienol acetate intermediate 4.21 was formed from enone 1.1 (scheme 4.19) using 
two methods; firstly using acetic anhydride: acetyl chloride 2:1 reflux
 28 for a total of seven 
hours.  Secondly using acetic anhydride: acetyl chloride 1:2 and 10 mol% DMAP reflux for one 
hour.
29 
 
For both methods, no starting material was observed either by TLC or 
1H NMR spectroscopy of 
the  crude  which  appeared  clearer  than  that  of  the  previously  synthesised  dienol  ethers.  
However, after purification by column chromatography on basic alumina less than 10% of the 
dienol acetate 4.21 was isolated along with approximately 50% of starting enone 1.1.  It was 
concluded  that  the  dienol  acetate  was  not  stable  enough  to  withstand  purification  as  it 
hydrolysed back to starting material.  In further attempts at this procedure, the dienol acetate 
was assumed quantitative in yield (after ensuring no starting material was present by 
1H NMR 
spectroscopy) and used crude immediately in the next step. 
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Scheme 4.19: Formation of dienol acetate intermediate 4.21 
 
De Groot et al.
25 reported the formation of dienol acetate intermediates on similar structures 
to enone 1.1 to give good yields (4.23 80% although no procedure was published).  These were 
immediately oxidised with MCPBA in a mixture of pH 8 buffer solution with 1,4-dioxane to give 
moderate yields of hydroxy enones 4.24 and 4.25 (scheme 4.20 and table 4.7).  It is interesting 
to note that with a methyl group alpha to the carbonyl (entries c and d) some epoxidation 
occurred at the alpha double bond forming compound 4.26. 
 
Scheme 4.20: Formation of hydroxy enones on similar bicyclic systems by de Groot et al. 
 
Table 4.7: MCPBA oxidation of dienol acetate intermediates by Groot et al. 
Reactant 
4.23 
Reaction 
time, hr 
Products % 
4.24  4.25  4.26 
a. R1 = R2 = H  16  57  18  - 
b. R1 = H       R2 = OAc  24  51  17  - 
c. R1 = CH3   R2 = H  16  62  25  7 
d. R1 = CH3  R2 = OAc  16  57  28  12 
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The crude dienol acetate 4.21 was consequently oxidised with MCPBA using this procedure as 
well as using the Oxone® procedure, however only low yields of 1.3 were achieved (scheme 
4.21).  
Scheme 4.21: Oxidation of dienol acetate 4.21 
 
 
4.2.2.3. Dienol silylether intermediates 
 
The formation of dienol silylether intermediates were briefly explored (scheme 4.22).  Various 
bases (
tBuOK, KH, imidazole, DBU) were employed at room temperature in THF, however no 
success was found in forming either 4.27 or 4.28.  Since Suryawanshi and Fuchs reported lower 
yields of hydroxy enone products from dienol silylethers (compared to dienol acetates and 
dienol ethers), the formation of 4.27/4.28 was not pursued. 
 
Scheme 4.22:  Attempted formation of dienol silylether intermediates 
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4.2.3.  Conclusion to chapter 4.2 
Three successful methods for the formation of hydroxy enone 1.3 were established (scheme 
4.23). 
Scheme 4.23: Three methods of forming hydroxy enone 1.3 from enone 1.1 
 
Method A (Kishi’s method) utilises the migration of the double bond in the protection of the 
carbonyl with a ketal (4.16) to install the hydroxy group.  Although this method formed only 
the desired diastereoisomer 1.3A, the yield was inadequate and required four steps to obtain. 
 
Formation  of  hydroxy  enone  1.3  via  the  dienol  ethers  (methods  B  and  C)  also  forms  the 
undesired diastereoisomer in a 3:1 ratio (1.3A:1.3B) which is consistent with that observed in 
similar bicyclic systems.
25  Method B achieved the highest overall yield of 1.3A (table 4.8) over 
two steps therefore this was the selected method employed to synthesise hydroxy enone 1.3. 
 
Table 4.8: Overall yields obtained from three methods of formation of 1.3 
Method  Yield 1.3A (%)  Yield 1.3B (%) 
A Kishi method  34  - 
B via dienol ether  41  13 
C via dienol acetate  30  10 
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4.3.  Investigating the reactions of hydroxy enone 1.3 
 
With this substrate in hand, we decided to investigate its scope of reactions given that the 
copper catalysed intermolecular 1,4-addition reactions investigated in chapter 4.1 were found 
to be unsuccessful on these cyclic enone compounds.  Our strategy was to develop and test 
alternative  or  novel  methodology  on  compound  1.3;  for  example,  Michael  addition  or 
intramolecular Reformatsky reactions, as well as synthesise new analogues which could be 
tested in biological assays in the quest for a new insecticide.  Hence, a number of reactions of 
hydroxy enone 1.3 were concurrently investigated. 
 
4.3.1.  Modified-Reformatsky reaction 
 
As the intermolecular 1,4-additions had proved to be very challenging for enone 1.1, it was 
proposed that an intramolecular 1,4-addition could be attempted, based on the Reformatsky 
reaction.  These are generally described as “reactions resulting from metal insertions into 
carbon-halogen  bonds  activated  by  carbonyl  or  carbonyl-derived  groups  in  vicinal  or 
vinylogeous positions with practically all kinds of electrophiles”.
30 The metal most commonly 
associated  with  Reformatsky  reactions  is  zinc.    There  have  been  several  examples  of 
intramolecular  Reformatsky  reactions,  most  commonly  with  aldehydes  and  ketones,  and 
several examples of intermolecular Reformatsky reactions with α,β-unsaturated carbonyls.
31  
However, there had yet to be reported an intramolecular Reformatsky type reaction on α,β-
unsaturated carbonyls.  This novel concept was therefore of interest.  Tricyclic 4.30 could then 
be utilised to install a handle at the quaternary centre by ring opening of the lactone to give 
intermediate 4.31 which could be further elaborated into nominine (scheme 4.24). 
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Scheme  4.24:  Proposed  series  of  reactions  utilising  a  novel  intramolecular  Reformatsky  to 
install handle at C5. 
 
Although both 1,2-additions and 1,4-conjugate additions have been reported in literature for 
intermolecular Reformatsky reactions with α,β-unsaturated carbonyls, there does not appear 
to be a definitive method of predicting which outcome will occur.  However, it has been noted 
that it is more common for 1,2-addition to occur with aldehydes, and 1,4-conjugate additions 
with bulky Reformatsky  reagents (scheme 4.25).   
 
Scheme 4.25: Examples of a 1,2-addition of a Reformatsky reagent to an aldehyde
32 and a 1,4-
addition to an activated lactam
33 
 
Bromo acetylbromide undergoes nucleophilic acyl substitution with hydroxy enone 1.3 to give 
the precursor 4.29 to the proposed intramolecular Reformatsky reaction.  It was proposed that 
the  insertion  of  activated  zinc  into  the  carbon-bromine  bond  of  Reformatsky  precursor 
compound  4.29  would  form  the  intermediate  (zinc  enolate).    The  close  proximity  of  the 
reacting  partners,  with  the  zinc  enolate  also  coordinating  to  the  enone  carbonyl,  could 
increase the chances of an intramolecular 1,4-addition reaction to give tricyclic compound 4.30 
(scheme 4.26). 
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Scheme 4.26: Proposed intramolecular Reformatsky reaction on compound 4.29 
 
For the formation of Reformatsky reactions, activated zinc is required for which there are two 
main methods of formation; either by removal of the oxide layer (washing with acid) or by 
creating a fine distribution of zinc typically by reduction of anhydrous zinc halides.   
 
For the former method, zinc dust was washed with 5% HCl, H2O, acetone then Et2O before 
storing in a desiccator under vacuum overnight.
34 Compound 4.29 in THF was added to a slurry 
of  this  activated  zinc  (3  equivalents)  in  combination  with  5  mol%  CuBr.SMe2  and  two 
equivalents Et2AlCl in THF at 0 °C over half an hour.
35 Et2AlCl is reported to be essential for 
these  mild  conditions
36  forming  the  aluminium  enolate  which  is  sufficiently  activated  for 
addition to the enone partner (scheme 4.27).  Without the use of Et2AlCl, reflux conditions 
would be required for the insertion of zinc into the α-bromoester as depicted in scheme 4.24.   
 
Scheme 4.27: Mild conditions for the intramolecular Reformatsky reaction of compound 4.29. 
 
After overnight stirring at room temperature, no starting material 4.29 was observed by TLC or 
ESI+.  TLC indicated many products, however after column purification no desired product 4.30 
was isolated. 20% of the parent enone 1.1 was isolated as well as trace amounts of compound 
4.33 indicating insertion of  zinc did occur to some degree.   The 
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complex for the characterisation of the remaining fractions isolated.  While it is possible that 
1,2-addition occurred instead of 1,4-addition, compound 4.32 was not detected either (figure 
4.1).  These results indicated that the zinc was activated to some degree as reactions did occur, 
however it was unselective and the desired product was not observed in any detectable yields. 
 
Figure 4.1: Possible products from the Reformatsky reaction of compound 4.29. 
 
An alternative method of forming activated zinc is the reduction of ZnCl2 by lithium known as 
Rieke zinc.
37  2.1 equivalents of lithium wire was weighed in hexane in a two neck flask and the 
hexane replaced with 1,2-dimethoxyethane.  10 mol% naphthalene was added followed by 1 
equivalent of 1.0 M ZnCl2 in THF.  The resulting mixture was stirred at room temperature 
overnight before leaving to settle for two hours.  White solid settled at the bottom of the flask 
in a pale yellow liquid which was removed by syringe.  Compound 4.29 in THF was added and 
the resulting mixture stirred at room temperature overnight, however no reaction was seen.  
Only  starting  4.29  was  isolated.    No  other  compounds  were  isolated  indicating  that  the 
activated Rieke zinc was not formed.  Rieke’s procedure reports a fine black powder formed 
whereas we observed a white solid.   
 
However, in an alternative method of Rieke zinc formation, a fine gray dispersion of zinc was 
obtained by Boudjouk et al.
38 when ZnCl2 and lithium were sonicated in THF for one hour.  This 
method  was  carried out to  obtain  a  dark  gray  solid  which  was  suspended  in  Et2O  before 
compound  4.29  in  Et2O was  added.    The  resulting  mixture was  stirred  overnight  at  room 
temperature to give several compounds although none appeared to be the desired product 
4.30  or  starting  material  4.29  after  purification.    Trace  amounts  of  compound  4.33  was 
detected (from the COCH3 peak in 
1H NMR spectra) but once again, NMR spectra were too 
complex for conclusive identification with multiple compounds present after purification. 
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Although only trace amounts of compound 4.33 were identified, conditions could have been 
optimised to increase the insertion of the activated zinc but no evidence of 1,4 or even 1,2-
addition  compounds  was  found.  This  could  be  a  result  of  steric  hindrance  of  the  bicylic 
molecule  in  which  the  reacting  orbitals  are  not  able  to  align  appropriately  due  to  the 
conformation of the molecule.  Alternatively, compound 4.29 may not have been activated 
enough for a reaction to occur.  In comparison to other organometallic compounds derived 
from Li, Mg or Cu to enones, the zinc enolate compound is considered only a mildly reactive 
species.  Although addition of Et2AlCl was used, perhaps it was not the appropriate Lewis acid 
for this particular reaction.  Kim et al.
39 reported the use of trimethyl silyltriflate (TMSOTf) as 
an  excellent  Lewis  acid  for  the  activation  of  the  addition  of  a  Reformatsky  reagent  to  2-
cyclopenten-1-one (scheme 4.28) to give only the 1,4-addition product.  
 
Scheme 4.28: Kim et al.’s use of TMSOTf for the addition of Reformatsky reagents to enones 
 
As we were concurrently looking at other reactions of hydroxy enone 1.3, we decided at this 
point to focus on the hydrocyanation reactions as they appeared to have more scope so these 
conditions were not tested.  However, it is something to consider for future work. 
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4.3.2.  Hydrocyanation reaction  
In consideration of the congestion and steric hindrance at the β-carbon on hydroxy enone 1.3, 
it was proposed that a small nucleophile could be added in a Michael addition type reaction at 
that position.  The nitrile group is a versatile functional group which would allow for further 
functional group modification and extension, hence this was the nucleophile chosen for the 
Michael addition investigations. 
Addition of the CN
- nucleophile to an α,β-unsaturated ketone can give either a direct addition 
1,2-product  (α-cyanohydrin)  or  a  1,4-addition  product  (β-cyano  ketone)  depending  on  the 
substrate, reaction conditions and source of CN
- (scheme 4.29).  Both the 1,2 and 1,4-addition 
reactions are reversible so it is possible to obtain both types of products with some substrates.  
Formation of 1,2-addition products tend to occur in low temperature, acidic conditions as 
cyanohydrins are stabilised in acid medium, whereas high temperature, basic conditions favour 
the 1,4-addition product. Lewis acid cyanides, such as TMSCN, favour 1,2-addition whereas the 
use of alkali metal cyanides, such as KCN, have been shown to form 1,4-addition products as a 
result of the basic medium.  Literature indicated the most popular reagents for 1,4-addition of 
CN
- were the use of Et2AlCN or KCN.  Both reagents were concurrently investigated.
40 
 
Scheme 4.29: Possible products obtained from the addition of CN
- to hydroxy enone 1.3. 
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4.3.2.1. Et2AlCN reagent 
Nagata et al.
41 carried out some of the most influential early work on the addition of CN 
nucleophile to α,β-unsaturated ketones.  In 1972, they first introduced use of the neutral 
reagent Et2AlCN along with R3Al-HCN as superior reagents for the introduction of CN.  As HCN 
is extremely toxic, Et2AlCN was the preferred choice of reagent to investigate for our substrate 
1.3.   
Nagata  et  al.  illustrated  the  use  of  Et2AlCN  on  cyclic  α,β-unsaturated  ketones,  such  as 
cholesterone.    They  were  shown  to  afford  good  yields  and  stereoselectivity  under  mild 
conditions and high efficiency.  At least two equivalents of Et2AlCN were required.  The first 
equivalent  activates  the  enone  system  by  coordinating  with  the  oxygen  and  the  second 
introduces the cyano group at the β-position.  Aprotic solvents such as benzene, toluene, 
CH2Cl2  or  THF  are  required.    Nagata’s  mechanistic  studies  on  the  addition  of  Et2AlCN  on 
cholesterone  showed  that  the  reaction  is  reversible.    The  1,2-addition  product  is  initially 
formed, followed by thermodynamic equilibrium to the 1,4-addition product via the starting 
material.  The organoaluminium reagent activates the carbonyl and the cyanide nucleophile 
attacks.  With cholesterone, the cis-isomer was found to be the major product after 51 hours 
(scheme 4.30). 
Scheme 4.30: Nagata’s mechanistic studies on the addition of Et2AlCN to cholesterone 
 
Three equivalents of Et2AlCN was added to a solution of hydroxy enone 1.3 in THF at 0 °C and 
stirred at room temperature for 21 hours (scheme 4.31).  The reaction mixture was found to be 
very complex with several overlapping products by TLC.  Trace amounts of product 4.35 was 
identified by crude 
1H NMR spectroscopy but after column chromatography, no pure fractions 
could  be  isolated.    It  was  suspected  that  a  mixture  of  the  1,2-addition  and  1,4-addition 
products (possibly all cis/trans isomers) were present as well as the starting material.  It has 4. Studies towards total synthesis of nominine 
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been reported that with sterically hindered substrates, the reaction does not go to completion.  
It is possible that with a longer reaction time, the equilibrium would be in favour of the 1,4-
addition product however, this was not further investigated as more success was observed 
with the use of KCN. 
Scheme 4.31: Use of Et2AlCN on compound 1.3 
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4.3.2.2. KCN reagent 
For substrates which display poor cis/trans selectivity with the addition of Et2AlCN, Nagata
41 
advised the use of KCN which could give higher ratios of cis-products as a result of solvation of 
the polar solvent to the cyanide ion increasing the steric bulk of the cyanating moiety.  Due to 
the larger syn-axial  cyano-hydrogen    interactions   in  the  trans-isomer  transition  state than  
in    the    cis,    the  increase  in  steric  bulk   of    the cyanating  moiety  causes a  decrease    of  
formation  of  trans  isomers.   
Addition of NH4Cl was reported to be essential in the KCN cyanating conditions in aqueous 
ethanolic conditions to reduce side reactions such as reaction reversal or hydrolysis of the 
product cyanides to lactamols.
42, 43 The strong base KOH formed from the initial CN addition in 
the presence of H2O can potentially hydrolyse the product 4.35 to form lactamol 4.36 (scheme 
4.32).  NH4Cl which is mildly acidic in solution acts as a buffer to prevent this from occurring by 
neutralising the KOH formed. 
 
Scheme 4.32: In the absence of NH4Cl, lactamol product 4.36 would be formed. 
 
Two equivalents of KCN and one point eight equivalents of NH4Cl in H2O was added to a 
solution of hydroxy enone 1.3 in EtOH and heated to reflux
43(table 4.9, experiment 1).  After 
four and eight hours, starting material was found to be prominent by TLC so the reaction was 
heated to reflux overnight.  After purification, the main compound isolated (40%) was found to 
be diketone compound 4.37 which was proposed to arise from the elimination of HCN from 
the desired product due to prolonged refluxing (scheme 4.33).  Starting  material was also 
isolated (20%) indicating that the reaction did not go to completion despite prolonged reaction 
times.   
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Scheme 4.33: Elimination of HCN from compound 4.35 to form diketone 4.37.  
 
In order to prevent the hydroxy group from participating in the reaction, it was protected with 
MOMCl to give compound 4.38 in good yields.
44 However, the subsequent reaction with KCN 
yielded no product 4.39 despite varying reaction times and addition of excessive amounts of 
KCN/NH4Cl (scheme 4.34).  A possible explanation for the lack of reaction is that the MOM-
group appears to cause too much steric hindrance for the addition of CN
- to occur.  No 1,2-
addition product was observed either; only starting material was isolated.  The nitrile group 
was unable to attack from the opposite face from the mom group either, presumably due to 
steric hindrance cause by the conformation of the compound. 
 
Scheme 4.34: Attempted CN
- addition to MOM-protected hydroxy enone 4.38. 
 
As a result, investigations on the cyanation reaction resumed with hydroxy enone 1.3.  The 
initial reaction conditions were repeated with a reduced reaction time of six hours and this 
afforded 34% of the desired product 4.35 as a single isomer, 35% of the starting hydroxy 
enone 1.3 and 16% of the diketone 4.37 (scheme 4.35 and table 4.9 experiment 2).  The Rf of 
the product was found to be very similar to that of the starting hydroxy enone 1.3 causing 
complications in the isolation of pure product.  However, they could be distinguished by TLC by 
the fact that the starting enone 1.3 is UV active whereas the product 4.35 is not, but can be 
visualised  with  ceric  stain  as  a  spot  overlapping  the  starting  material.  Pure  product  was 
isolated successfully by recrystallisation with Et2O after column chromatography. 
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Scheme 4.35: Formation of cyano-ketone compound 4.35  
 
With  longer  reaction  times,  the  reaction  mixture  became  more  complex  and  the  starting 
hydroxy  enone  1.3  never  disappeared  by  TLC.    Increasing  the  number  of  equivalents  of 
KCN/NH4Cl and addition of the phase-transfer catalyst (to aid solvation of KCN), 30 mol% of 18-
crown-6, did not improve yields. It was concluded that under these conditions, the reaction 
does not go to completion as starting hydroxy enone 1.3 was always observed by TLC. 
Table 4.9: Summary of results of cyanation with KCN reagent 
Exp.#  Conditions  Result (main products isolated) 
1  2 equiv. KCN, 1.8 equiv.NH4Cl,  
1:1 EtOH:H2O, reflux 20 hr 
 
2  2 equiv. KCN, 1.8 equiv.NH4Cl,  
1:1 EtOH:H2O, reflux 6 hr 
 
3  3 equiv. KCN, 2 equiv. NH4Cl,  
1:1 EtOH:H2O, reflux 6 hr 
 
4  2 equiv. KCN, 1.8 equiv. NH4Cl, 30 mol% 
18-C-6, 1:1 EtOH:H2O, reflux 4 hr 45min  
 
The unoptimised yield of compound 4.35 from these test runs was 34% (entry 2, table 4.9).  
The cyano compound 4.35 was confirmed by CIMS (GCMS: (CI) m/z 221 [M]
+; 239 [M+NH4]
+) 
and  IR  spectroscopy  (IR  (film)  νmax  =  2227  cm
-1  (C≡N)),  and  was  obtained  as  a  single 
diastereoisomer as shown by 
1H NMR and 
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114 
 
Stereochemistry of cyano compound 4.35 
Compound 1.3 exists as a decalin ring with one six membered chair attached to the second six 
membered ring in a twisted half chair conformation as a result of the sp
2 atoms (scheme 4.36, 
structure A).  From conformational considerations, the single diastereoisomer obtained from 
these reactions was proposed to be the cis isomer 4.35c.  Attack of the cyanide nucleophile 
occurs axially (in order to achieve maximum overlap with the p orbitals of the enone) onto the 
top face (convex face) as it is more exposed resulting in the cis isomer 4.35c, with both rings in 
the stable chair conformation.  The cis isomer can exist as two possible conformers, one in 
which the nitrile group is axial, and the second in which the nitrile group is in the equatorial 
position.  The two conformers are able to interconvert by bond rotation (ring flipping).  At 
room  temperature,  the  NMR  spectrum  displays  an  average  of  the  signals  from  the  two 
conformers.  
 
Scheme 4.36: Attack of the CN nucleophile onto the top face resulting in the cis product  
 
Attack of the bottom face (concave face) is prevented by the steric hindrance from the twisted 
half chair so the trans isomer 4.35t is not formed.  Experimental evidence to support this 
proposal is observed in the experiment in which the MOM protected starting material 4.38 
failed to yield any product, neither cis addition nor trans addition of the nitrile.  The large 
MOM group caused excessive steric hindrance on the top face and the conformation of the 
starting material itself blocked attack from the bottom face resulting in no reaction (scheme 
4.34). 4. Studies towards total synthesis of nominine 
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The mechanism of this reaction is a conjugate addition in which the nucleophilic CN
- attacks 
the β-carbon of the enone followed by protonation of the α-carbon by the protic solvent 
(scheme 4.37). 
 
Scheme 4.37: Mechanism of hydrocyanation of compound 1.3 
 
 
The hydroxy group adjacent to the β-carbon could provide stereocontrol by chelating to the 
potassium ion which is also chelating to the π-system of C≡N thereby ensuring its cis addition 
by positioning it on the same side of the decalin ring.  Metalated nitriles have been shown to 
exhibit stereocontrol in previous reactions.
45 
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4.3.2.3. Future work for hydrocyanation of compound 1.3 
 
For the optimisation of reaction conditions for hydrocyanation using KCN method and Et2AlCN 
reagent,  the  temperature,  solvent  and  concentration  would  be systematically  modified on 
reactions of the same scale in order to increase yields of product.  Other aprotic solvents have 
been used in hydrocyanations such as DMF, CH2Cl2 and benzene (toluene).  As the cis product 
is  the  thermodynamically  favourable  product  using  KCN,  longer  reaction  times  should  be 
employed with a reduced temperature to avoid side reactions. 
Use of a HPLC chiral column would further confirm the compound as a single diastereoisomer 
and its high purity product could be used to grow a single crystal for X-ray crystallography, 
which would also give valuable additional conformational data. 
Further spectroscopic analysis is required, particularly the use of 2D NMR spectroscopy.  If the 
cyano group was reduced (either to an alkyl amine 4.40 with Raney nickel under high pressure 
H2, or to an aldehyde with DIBAL), a NOESY experiment should show correlations
46 between 
these  new  protons  and  the  quaternary  methyl  group  if  the  compound  was  in  a  cis 
conformation (figure 4.2). 
Figure 4.2: NOE correlation between –CH2NH2 and quat.CH3 would confirm cis isomer  
 
A  range  of  spectroscopic  methods  have  been  used  to  distinguish  between  cis  and  trans 
isomers  of  decalones  in  previously  published  literature.    However,  both  the  cis  and  trans 
isomer of each substrate is required pure in order to compare the data.  In order to determine 
the stereochemistry of the cyano group without doubt, the trans isomer should be synthesised 
(by optimising the Et2AlCN method and isolating the products by HPLC) and the following 
spectroscopic methods could be applied. 4. Studies towards total synthesis of nominine 
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1. 
1H NMR spectroscopy 
Rodig and Johnston
43 observed that the chemical shift of the quaternary methyl group in their 
bicyclic  compounds  (figure  4.3) was  found  to  be  consistently  upfield  for the  trans  isomer 
compared to the cis.  This is a result of the dihedral angle between the quaternary methyl 
group and the cyano group at the other ring junction.  In the cis isomer, the dihedral angle is 
approximately 60° whereas in the trans isomer, it is much larger at approximately 180°.  This 
relates to the deshielding effect of the cyano group on the methyl.  With the cyano group 
further away in the trans isomer, it exerts less of a deshielding effect on the CH3, therefore the 
chemical shift is lower (upfield). 
Figure 4.3: Chemical shift of quaternary methyl group of Rodig and Johnston’s bicyclic cyano 
compounds 
 
For our cyano compound 4.35, C11 CH3 has a chemical shift of δ 1.41 ppm which is similar to 
that of structure 4.  This method of comparison could aid compound identification if we had 
the trans cyano compound 4.35t. 
 
2.
13C NMR spectroscopy 
In  the  analysis  of  10-substituted  decal-2-ones  (figure  4.4)  by  2D  NMR  spectroscopic 
techniques, Vecchi et al.
47 observed several distinguishing features in the NMR spectra of the 
cis and trans isomers.  They noted that the best criterion to distinguish a cis from a trans 
isomer is the presence in the cis isomer 
13C NMR spectra of some skeletal carbon signals (in 
their case, C-4, C-5 and C-7) with broadened line width and low intensity.  This is a result of the 
two cis conformers inter-converting and indicates exchanging sites.  In contrast, all the signals 
of the trans isomer were sharp and typical.   4. Studies towards total synthesis of nominine 
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Figure 4.4: 10-substituted decal-2-ones analysed by Vecchi et al. 
 
 
In the 
13C NMR spectra of compound 4.35, C1 (CHOH) is of noticeably reduced intensity and 
broadened  linewidth  to  the  point  where  it  cannot  be  observed  unless  extra  scans  were 
implemented or a 100 MHz spectrometer was used.  C2 (CH2) and C11 (quat.CCH3) also show 
half  the  signal  intensity  expected  (when  compared  to  neighbouring  CH2  and  CH3).  These 
observations indicate the cis isomer as expected but a comparison of the 
13C NMR spectra of 
the trans isomer is required to confirm this absolutely. 
 
3. Infrared stretching bands comparison 
Nagata et al.
48 observed slightly higher C≡N stretching bands for cis isomers of polycyclic cyano 
compounds when compared to their trans counterpart (table 4.10).  The C≡N IR band for 
cyano 4.35 was observed at 2227 cm
-1.  Rodig and Johnston also used this method among 
others to confirm their compound identification. 
 
Table 4.10: Selection of C≡N stretching infrared absorption data from Nagata et al. 
 
Structure   
     
Cis cm
-1  2238  2236  2238  2236 
Trans cm
-1  2236  2234  2237  2235 
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4.3.3.  Conclusion to chapter 4.3 
 
Modified Reformatsky reaction 
Although  our  initial  results  failed  to  produce  the  desired  tricyclic  compound  4.30, we  did 
obtain  evidence  that  insertion  of  zinc  was  occurring.    Reaction  conditions  were  not  fully 
explored as more promising results were obtained from the hydrocyanation investigations.  
However,  the  concept  of  forming  a  third  ring  and  utilising  it  to  install  a  handle  at  the 
quaternary centre is similar to that of Nicolaou’s recent work (published several years after our 
investigations).
49 While Nicolaou employed an Ueno-Stark radical cyclisation, our investigations  
focused on a novel intramolecular Reformatsky reaction with an enone as the electrophile.  If 
hydrocyanation yields could not be improved, this concept would be worth revisiting. 
Hydrocyanation 
Initial  results  have  shown  hydrocyanation  is  successful  with  hydroxy  enone  1.3.    The 
regiospecific  1,4-addition  of  KCN  to  compound  1.3  was  achieved  in  which  a  single 
diastereoisomer 4.35 was isolated.  We have assigned the cyano stereocentre as cis as a result 
of the consideration of the conformation of starting enone 1.3.  Diastereoselectivity has been 
known to be achieved in conformationally restricted compounds. 
Although  yields  obtained  were  unsatisfactory,  there  was  insufficient  time  to  optimise 
conditions.  Our plan was to continue optimising hydrocyanation with KCN reaction conditions, 
as well as the alternative method utilising the Et2AlCN reagent in order to synthesise and 
isolate the trans isomer in addition to the cis isomer.  Only small amounts of the trans isomer 
would be required for spectroscopic studies in order to confirm absolutely that the product of 
the KCN hydrocyanation is indeed cis. 
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4.4.  Conclusion to Chapter 4 
 
The proposed key step to the total synthesis of nominine (1,4-addition of bromo-2-methyl-2-
pentene  followed  by  trapping  of  the  enolate)  was  thoroughly  investigated  with  a  model 
compound  then  with  enone  1.1.    However,  no  desired  product  was  obtained  with  many 
conditions investigated resulting in no reaction observed.  It was suspected that the β-carbon 
of the enone was too sterically hindered particularly for the long alkyl chain that was required 
for the natural product.  Both Bonjoch and Nicolaou reported poor results with their attempts 
at 1,4-additions with similar intermediates towards the total synthesis of (a)nominine. 
 
Three methods of installing the hydroxy group at C4 to give compound 1.3 were carried out.  
The highest yielding was found to be via a dienol ether intermediate yielding 41% of the 
desired cis isomer 1.3A and 13% of the trans isomer 1.3B which could be separated without 
difficulty.  This was a sufficient yield to synthesise gram quantities of hydroxy enone 1.3. 
 
In  the  investigations  of  reactions  of  hydroxy  enone  1.3,  hydrocyanation  was  found  to  be 
successful with the use of KCN.  Although there was insufficient time to optimise yields, this 
1,4-addition  Michael  type  reaction  was  found  to  afford  compound  4.35  as  a  single 
diastereoisomer with scope for elaboration into the desired natural product nominine. 
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Chapter 5.  Future  work  towards  the  total 
synthesis of nominine and beyond 
 
5.1.  Towards the total synthesis of nominine 
With initial studies demonstrating the success of the stereospecific hydrocyanation of hydroxy 
enone 1.3 to give cyano compound 4.35, the main steps required towards the total synthesis 
are the extension of the nitrile group into the 2-methyl-petene fragment and installation of the 
indole at C10. 
A one pot reaction consisting of the 1,4-addition of KCN followed by trapping of the enolate 
with formaldehyde to give compound 5.1 would be preferred.  This alcohol at C10 would 
provide the necessary handle to install the indole group.  However if problems arise with this 
one pot reaction, Nicolaou
1 has shown that deprotonation with LiHMDS was regiospecific and 
use of Mukiyama aldol conditions allowed the installation of an alcohol at C10.  Epimerisation 
may be required to afford the core of the natural product with all the correct stereocentres in 
place.   
A Wittig olefination with methyltriphenylphsophonium bromide would convert the carbonyl 
into alkene 5.2 followed by a DIBAL reduction of the nitrile group and subsequent hydrolysis 
into  aldehyde  5.3.  The  primary  alcohol  would  then  be  selectively  protected  with  4-
toluenesulfonyl chloride followed by protection of the secondary alcohol with a silylether (for 
example, TMSCl) to give compound 5.4. 
Using carefully controlled reaction conditions, a Grignard reaction between the aldehyde and 
bromo-3-methylbutene  would  elongate  the  quaternary  carbon  chain  5.5  but  the  resulting 
hydroxy group would need to be removed via xanthate formation and radical deoxygenation
1 
to complete the alkenyl chain at quaternary carbon C5 to afford compound 5.6.  Coupling of 
the indole Grignard and tosylate
2 would give compound 5.7 and deprotection with TBAF would 
furnish the natural product nominine (scheme 5.1).  Installing the alkenyl chain and indole via 
Grignard  reactions  allows  for  various  coupling  partners  to  be  used  in  order  to  generate 
analogues for the discovery of a novel pesticide.  The total number of steps is 22 which is 
comparable to Bonjochs’ and Nicoloau’s route to nominine. 
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Scheme 5.1: Proposed route to nominine from hydroxy enone 1.3 
 
 
 
 
 
 
 
 
 
 
 
 5. Future work towards the total synthesis of nominine and beyond 
 
127 
 
5.2.  Beyond nominine 
Nominine  has  been  proposed  to  be  the  precursor  to  a  family  of  indole  diterpenoids  for 
example, aspernomine, tubingensin A and aflavinine.  With nominine in hand, the biosynthetic 
pathway to these other natural products could be explored. 
 
For example, aspernomine was also isolated from the sclerotia of Aspergillus nomius. Spectral 
data indicated similarities with nominine, however differences in UV and 
13C NMR spectra 
indicated the lack of an indole moiety.  Further NMR experiments determined the structure of 
aspernomine containing a previously unreported ring system, so named 1,4,5,6-tetrahydro-
2,6-methano-1-benzazocin-3(2H)-one. 
 
Aspernomine was found to exhibit similar activity against Heliothis zea as nominine, in addition 
to exhibiting cytotoxicity against three human solid tumour cell lines, lung carcinoma, breast 
adenocarcinoma and colon adenocarcinoma.  A synthetic approach has yet to be reported for 
the total synthesis of aspernomine. 
During  the  total  synthesis  of  hinckdentine  A,  McWhorter  and  coworkers
4  observed  the 
rearrangement of 2-(2-bromophenyl)-3-(3-butenyl)-3H-indol-3-ol 5.8 to the uncommon ring 
system containing 5.9, also found in aspernomine (scheme 5.2). 
Scheme 5.2: Novel rearrangement of 5.7 to the uncommon ring system in 5.8 
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The proposed mechanism by McWhorter and co-workers suggested a Markovnikov addition of 
the protonated imine to the double bond in 5.7 forming a boat like intermediate 5.9.  The 
electron rich aromatic ring attacks the secondary carbocation to form intermediate 5.10 which 
breaks down to form the new ring system in compound 5.8 (scheme 5.3).  
 
Scheme 5.3: Mechanism of novel rearrangement 
 
This  mechanism  suggests  a  possible  similar  rearrangement  of  nominine  to  aspernomine.  
Nominine could be oxidized to form 3H-indol-3-ol 5.11 and would then contain the necessary 
functionalities to undergo the novel rearrangement in the presence of acid via intermediate 
5.12  to  form  aspernomine  (scheme  5.4).    Tantillo  et  al.
5  carried  out  quantum  chemical 
calculations which confirmed this proposed mechanism is energetically feasible.  Investigations 
into the conditions required for this biomimetic conversion would result in the natural product 
synthesis of another active indole alkaloid. 
 
Scheme 5.4: Proposed mechanism of nominine conversion to aspernomine 
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Chapter 6.  Conclusion 
 
At  the  commencement  of  this  project,  the  total  synthesis  of  (a)nominine  had  yet  to  be 
achieved.  However, a year after practical work had ceased on this project, Bonjoch et al. 
published  the  first  total  synthesis  of  ent-anominine  in  2010,  followed  by  a  second  total 
synthesis in 2012 by Nicolaou et al.   
 
Similarities between our synthetic route and that of Bonjoch and Nicolaou’s strategy include 
the use of enone 1.1 and hydroxy enone 1.3 as a vital intermediate at some point in their 
investigations.  Both groups investigated 1,4-addition reactions to install the alkene chain at 
the quaternary centre but also failed to yield the desired product.  Bonjoch’s solution was to 
install a propene moiety within their key Wieland-Miescher ketone analogue at the desired 
quaternary  centre  prior  to  cyclisation,  and  Nicolaou  used  hydroxy  enone  1.3  to  form  a 
pentacycle/lactol at that junction (similar to our modified Reformatsky investigations).  Our 
approach was to install a small nucleophile (the nitrile group) at that junction on hydroxy 
enone 1.3 which would allow for modification at a later stage.   
 
The key intermediate bicyclic enone 1.1 had proven to be quite problematic where several 
synthetic routes had been explored.  Several of the published procedures were found to be 
irreproducible despite several attempts.  However, the discovery of a paper by Paquette et al. 
led  to  promising  results  as  the  published  procedures  were  found  to  be  reproducible  and 
scalable.  Large scale synthesis with the aid of Pfizer laboratories was successful, stockpiling 
more  than  30  g  of  this  racemic  compound.    Two  natural  products,  dehydrofukinone  and 
fukinone were synthesised using this key intermediate showcasing its versatility.   
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Continuing  on  with  the  total  synthesis  of  nominine,  1,4-addition  reactions  on  model 
compounds  as  well  as  enone  1.1  with  the  long  chain  alkenyl  moiety  was  thoroughly 
investigated but failed to give the desired product.  It was suspected that the β-carbon of the 
enone was too sterically hindered particularly for the long alkyl chain that was required for the 
natural product.  Success was found with initial studies on the 1,4-addition of KCN to the 
intermediate  hydroxy  enone  1.3  which  formed  cyano  compound  4.35  as  a  single 
diastereoisomer which we proposed to be the desired cis isomer.  Further work towards the 
total synthesis of nominine has been outlined with scope to synthesise other active indole 
alkaloids. 
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Chapter 7.  Experimental Section 
 
7.1.  General Experimental 
1H-NMR  and 
13C-NMR  spectra  were  recorded  on  Bruker  AC300,  Bruker  AM300  or  Bruker 
DPX400 spectrometers in deuterated chloroform unless otherwise stated with chloroform (δH 
7.27 ppm 
1H, δC 77.00 ppm 
13C) as the internal standard.  Chemical shift values δ are quoted in 
ppm  (parts  per  million).  Multiplicities  are  described  using  the  abbreviations  s,  singlet;  d, 
doublet; t, triplet; q, quartet; m, multiplet and br, broad. 
Infrared spectra were recorded on a Nicolet 380 FT-IR (Thermo Electron Corporation).  Infrared 
peaks are quoted in cm
-1. 
Mass spectra were obtained on a Waters ZMD Single quadrupole mass spectroscopy with an 
electrospray  ion  source  or  a  ThermoQuest  TraceMS  Single  quadrupole  GC-MS  in  either 
chemical ionisation or electron impact ionisation mode. 
Melting points were determined using the Electrothermal melting point apparatus and are 
uncorrected. 
All air and/or moisture sensitive reactions were carried out under argon atmosphere, in oven-
dried glassware.  
Reactions  were  monitored  by  thin  layer  chromatography  using  aluminium-backed  plates 
coated  with  silica  gel  60  containing  a  fluorescence  indicator  active  at  254  nm;  the 
chromatograms  were  visualised  under  UV  light  (254  nm)  and  by  staining  with  20% 
phosphomolybdic acid in ethanol (PMA) or cerium sulphate/ ammonium molybdate in 2M 
H2SO4(aq). 
Flash chromatography was performed with 40-63 μm silica gel (Merck). 
“Brine” refers to a saturated aqueous solution of sodium chloride. 
Dichloromethane  was  dried  by  distillation  from  CaH2  and  THF  was  distilled  from 
Na/benzophenone prior to use.  All other solvents and reagents were used directly as supplied 
unless otherwise stated. 
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7.2.  Experimental details 
 
2-Bromo-2-methyl-1-cyclohexanone 2.45 
 
 
 
A  solution  of  2-methyl-1-cyclohexanone  (3.30  mL,  27.0  mmol,  1  equiv.)  and  N-
bromosuccinimide (4.81 g, 27.0 mmol, 1 equiv.) in CCl4 (30 mL) was stirred at reflux overnight.  
The reaction mixture was cooled to room temperature and filtered through celite to remove 
succinimide and the filter cake washed with Et2O (20 mL).  The filtrate was concentrated to 
afford the title compound (Rf = 0.36, 30% EtOAc in hex) (5.17 g, quantitative yield) as a brown 
oil and taken on without further purification. 
 
1H NMR (300 MHz, CDCl3) δH 3.21 (1H, td, J = 17, 8 Hz, 1H from CH2CO); 2.42-2.31 (2H, m, CH2); 
2.16-2.0 (2H, m, CH2); 1.82 (3H, s, CH3); 1.78-1.72 (2H, m, CH2); 1.68-1.52 (1H, m, 1H from CH2).  
13C NMR (75 MHz, CDCl3) δC 204.7 (C=O); 65.8 (quat.C); 43.6 (CH2); 36.7 (CH2); 28.1 (CH3); 26.8 
(CH2); 22.3 (CH2).
1 MS: ESI+ 215.0 [
81Br M+Na]
+; 213.0 [
79Br M+Na]
+. 
 
 
 
 
 
 
Data consistent  with  literature:  Hua,  D.H.;  Chen,  Y.;  Sin,  H.;  Maroto, M.J.; Robinson, P.D.; 
Newell, S.W.; Perchellet, E.M.; Ladesich, J.B.; Freeman, J.A.; Perchellet, J-P.; Chiang, P.K.  J. Org. 
Chem. 1997, 62, 6888-6896. 7. Experimental Section 
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2-Methyl-2-cyclohexen-1-one 2.31 
 
 
 
To  a  solution  of  compound  2.45  (5.47  g,  27.0  mmol,  1  equiv.),  used  without  further 
purification, in DMF (60 mL) was added Li2CO3 (6.00 g, 81.0 mmol, 3 equiv.) and LiBr (7.03 g, 
81.0  mmol, 3  equiv.).    The  resulting mixture  was  heated  at  130  °C  for  three  hours.    The 
reaction mixture was cooled to room temperature, diluted with H2O (60 mL) and extracted 
with Et2O (3 x 40 mL).  The mixture was filtered to remove insoluble foam as separation of 
phases  was  not  clear.    The  organic  extracts  were  combined,  dried  over  MgSO4  and 
concentrated  to  yield  2.03  g  of  a  crude  yellow  oil  which  was  purified  by  column 
chromatography (20% EtOAc in hexane) to afford the title compound (Rf = 0.24, 20% EtOAc in 
hex) (1.37 g, 46%) as a yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 6.68 (1H, br. s, C=CH); 2.36 (2H, t, J = 7 Hz, CH2); 2.30-2.23 (2H, m, 
CH2); 1.97-1.88 (2H, m, CH2); 1.71 (3H, q, J = 2 Hz, CH3).  
13C NMR (75 MHz, CDCl3) δC 199.8 
(C=O); 145.5 (C=CH); 135.6 (C=CH); 38.3 (CH2); 26.0 (CH2); 23.2 (CH2); 15.9 (CH3). MS: ESI+ 
133.2 [M + Na]
+. 
 
 
 
 
 
 
Data consistent  with  literature:  Hua,  D.H.;  Chen,  Y.;  Sin,  H.;  Maroto, M.J.; Robinson, P.D.; 
Newell, S.W.; Perchellet, E.M.; Ladesich, J.B.; Freeman, J.A.; Perchellet, J-P.; Chiang, P.K.  J. Org. 
Chem. 1997, 62, 6888-6896. 7. Experimental Section 
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4-Chloro-2-butanone 2.47 
 
 
 
Water (0.44 mL, 24.0 mmol, 1.0 equiv.) was added to methyl vinyl ketone (2.70 mL, 32.0 mmol, 
1.3 equiv.) and the reaction mixture stirred for five minutes before chlorotrimethylsilane (6.14 
mL, 49.0  mmol,  2.0  equiv.)  was  added  slowly  dropwise  as  reaction  was exothermic.    The 
reaction mixture was stirred overnight at room temperature with the colour turning from clear 
to  a  yellow/brown  over  time.    The  trimethylchlorosilane  and  hexamethyldisiloxane  were 
removed on the rotary evaporator and the residual taken up in CH2Cl2 (5 mL).  The solution 
was stirred with MgSO4 for half an hour to remove water and the mixture concentrated for 
half  an  hour  with  the  water  bath  at  room  temperature.    This  afforded  the  crude  title 
compound (Rf = 0.6, 20% EtOAc in hex) (2.20 g, 86%) as a dark brown oil. 
 
1H NMR (300 MHz, CDCl3) δH 3.70 (2H, t, J = 7 Hz, CH2Cl); 2.89 (2H, t, J = 7 Hz, C=OCH2); 2.18 
(3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 205.0 (C=O); 45.8 (C=OCH2); 38.2 (CH2Cl); 30.2 (CH3). 
MS: ESI+ 129.6 [M + Na]
+. 
 
 
 
 
 
 
 
 
1H NMR data is consistent with literature (no literature 
13C NMR data was available):   
Boudjouk, P.; Kim, B-K.; Han, B-H.  Synth. Commun.  1996, 26 (18), 3479-3484. 7. Experimental Section 
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Trimethyl-vinyl-silane 2.51 
 
 
 
A 3-neck flask was fitted with a condenser, stirrer and charged with Mg(s) (0.48 g, 20.0 mmol, 
1.0 equiv.) and heated with a heat gun under Ar atmosphere to activate Mg.  Mg was allowed 
to cool for 15 minutes before anhydrous THF (16 mL) and one small iodine crystal was added.  
The flask was swirled to disperse the brown colour.  A portion of 1.0 M vinyl bromide in THF 
(20 mL, 20.0 mmol, 1.0 equiv.) was added and heated gently, with no stirring until reflux was 
attained  with  solution  turning  colourless.    Gentle  heating  was  required  whilst  stirring  to 
maintain  reflux  as  remaining  vinyl  bromide  solution  was  added  dropwise.    The  solution 
remained  stirring  at  reflux  for  one  hour  before  slow  dropwise  addition  of  1.0  M 
chlorotrimethylsilane in THF (19.9 mL, 20.0 mmol, 1.0 equiv.) over half an hour.  The solution 
was stirred at reflux for two hours then stirred at room temperature overnight.  Product was 
isolated by distillation with a Vigreux column (bp. 60-65 °C) to afford the title compound (12.7 
g, 38% yield by 
1H NMR) as a colourless liquid. 
 
1H NMR (300 MHz, CDCl3) δH 6.15 (1H, m, C=CH); 5.91 (1H, dd, J = 15, 4 Hz, HC=CH2); 5.65 (1H, 
dd, J = 20, 4 Hz, HC=CH2); 0.07 (9H, s, 3 x CH3).  
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(1-Bromo-vinyl)-trimethyl-silane 2.52 
 
 
 
Bromine (0.77 mL, 15.0 mmol, 1.5 equiv) was added dropwise over half an hour to compound 
2.51 (1.0 g, 10.0 mmol, 1.0 equiv.) at -78 °C whilst stirring to form an orange solution which 
was allowed to warm to room temperature.  Et2NH (6.75 mL, 65.0 mmol, 6.5 equiv.) was added 
dropwise whilst stirring to dissipate the yellow precipitate that formed.  The reaction mixture 
was  stirred  at  reflux  overnight,  cooled  to  room  temperature  and  the  diethylamine 
hydrochloride precipitate filtered off and the solid washed with Et2O (5 mL).  The organic 
solution was washed with 10 % HCl until aqueous layer remained acidic, then washed with 
portions of H2O and brine.  The organic layer was dried over MgSO4 and concentrated to afford 
the title compound crude (0.55 g, approx. 29%) as a yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 6.27 (1H, d, J = 2 Hz, C=CH2); 6.18 (1H, d, J = 2 Hz, C=CH2); 0.20 
(9H, s, SiMe3). 
 
 
 
 
 
 
 
 
 
1H NMR data is consistent with literature: Boeckman, R.K. Jr.; Blum, D.M.; Ganem, B.; Halvey, 
N.  Org. Synth.  1978, 58, 152-156. 7. Experimental Section 
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3-Bromo-but-3-en-2-one 2.54 
 
 
 
Bromine (4.10 mL, 80.0 mmol, 1.0 equiv.) in anhydrous CH2Cl2 (10 mL) was added dropwise 
over an hour to a stirring solution of methyl vinylketone (6.6 mL, 80.0 mmol, 1.0 equiv.) in 
anhydrous CH2Cl2 (40 mL) at 0 °C.  The solution turned from colourless to a brown colour and 
was left stirring at 0 °C for half an hour.   Triethylamine (28 mL, 200 mmol, 2.5 equiv.) in 
anhydrous CH2Cl2 (20 mL) was added slowly forming a creamy yellow mixture with precipitate 
and  reaction  was  left  stirring  overnight  at  room  temperature.    The  reaction  mixture  was 
dissolved in CH2Cl2 (10 mL), washed with 2M HCl (5 mL) and H2O (5 mL).  The combined organic 
layers were dried over MgSO4 and evaporated to afford the crude title compound (Rf = 0.32, 
100% CH2Cl2) (10.7 g, 90%) as a dark yellow liquid. 
 
1H NMR (300 MHz, CDCl3) δH 6.80 (1H, d, J = 2 Hz, C=CH2); 6.42 (1H, d, J = 2 Hz, C=CH2); 2.48 
(3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 192.1 (C=O); 132.2 (quat.C); 129.8 (CH2); 26.3 (CH3). 
MS: ESI+ 172.9 [
81Br M + Na]
+; 170.9 [
79Br M + Na]
+. 
 
 
 
 
 
 
 
Data consistent with literature: Murphy, J.A.; Scott, K.A.; Sinclair, R.S.; Martin, C.G.; Kennedy, 
A.R.; Lewis, N.  J. Chem. Soc. Perkin Trans. 1 2000, 2395-2408. 7. Experimental Section 
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2-(trimethylsilyl)but-3-yn-2-ol 2.57 
 
 
 
A  solution  of  0.5  N  ethynylmagnesiumbromide  in  THF  (24  mL,  12.0  mmol,  1.2  equiv.)  in 
anhydrous  THF  (20  mL)  was  treated  dropwise  at  room  temperature  with  a  solution  of 
acetyltrimethylsilane (1.43 mL, 10.0 mmol, 1.0 equiv.) in THF (20 mL) over half an hour and 
stirred  for  20  minutes.    The  reaction  mixture  was  hydrolysed  with  dilute  aqueous  NH4Cl, 
extracted with pentane and dried over MgSO4 to afford the title compound crude (1.42 g with 
30% THF, 69%) as a brown oil. 
 
1H NMR (300 MHz, CDCl3) δH 2.59 (1H, s, C≡CH); 1.46 (3H, s, CH3); 0.13 (9H, s, SiMe3).  
 
 
 
 
 
 
 
 
 
 
 
 
 7. Experimental Section 
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Trimethyl((2-(trimethylsilyl)but-3-yn-2-yl)oxy)silane 2.58 
 
 
 
Trimethylsilyl cyanide (1.7 mL, 12.6 mmol, 2.0 equiv.) was added dropwise to compound 2.57 
(0.9g, 6.3 mmol, 1.0 equiv. with 30% THF) and the reaction mixture heated to 60 °C overnight.  
The reaction mixture was cooled and placed on a rotary evaporator at 40 °C for one hour to 
remove excess trimethylsilyl cyanide to afford the title compound crude (1.10 g, 85%) as a light 
brown oil. 
 
1H NMR (300 MHz, CDCl3) δH 2.6 (1H, s, C≡CH); 1.42 (3H, s, CH3); 0.16 (9H, s, OSiMe3); 0.07 (9H, 
s, SiMe3). 
 
 
 
 
 
 
 
 
 
 
1H NMR data is consistent with literature: Cunico, R.F.  Tetrahedron Lett.  1994, 35, 2291-2294. 
 
 7. Experimental Section 
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2-(2-Bromoethyl)-2-methyl-1,3-dioxolane 2.63 
 
 
 
Methyl vinyl ketone (1.66 mL, 20.0 mmol, 1.0 equiv.) was added dropwise to a solution of 
bromotrimethylsilane  (3.16  mL,  24.0  mmol,  1.2  equiv.)  in  benzene  (30  mL)  at  0  °C.    The 
resulting mixture was then stirred at 0 °C for 30 minutes and at room temperature for an 
additional one hour.  To the reaction mixture was added ethylene glycol (1.6 mL, 28.0 mmol, 
1.4  equiv.)  and  para-toluenesulfonic  acid  (100  mg,  catalytic  amount).    The  mixture  was 
azeotropically distilled for four hours.  After cooling, the reaction mixture was diluted with 
benzene (20 mL) and washed with NaHCO3 (saturated) and H2O.  The organic layer was dried 
with MgSO4 and concentrated to afford the title compound (Rf = 0.46, 30% EtOAc in hex.) (3.0 
g, 77%) as a dark brown/green liquid. 
 
1H NMR (300 MHz, CDCl3) δH 3.99-3.88 (4H, m, dioxolane 2 x CH2); 3.44-3.39 (2H, m, BrCH2); 
2.29-2.24 (2H, m, CH2); 1.33 (3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 109.1 (quat.C); 64.6 
(dioxolane 2xOCH2); 42.8 (CH2); 26.8 (BrCH2); 24.0 (CH3). MS: ESI+ 219.0 [
81Br M + Na]
+; 217.0 
[
79Br M + Na]
+. 
 
 
 
 
 
 
1H NMR data is consistent with literature (No published 
13C NMR data): Hsung, R.P.  Synth. 
Commun.  1990, 20, 1175-1179.   
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Ethyl 6-(2-methyl-1,3-dioxolan-2-yl)-3- oxohexanoate 2.64 
 
To NaH 60% suspension in mineral oil (0.18 g, 4.4 mmol, 3 equiv.) was added THF (5 mL) and 
the suspension was cooled in an ice-water bath and anhydrous hexamethylphosphoramide 
(0.3 mL, 2.2 mmol, 0.5 equiv.) was added.  Ethyl acetoacetate (0.2 mL, 1.5 mmol, 1.0 equiv.) 
was added dropwise to the above suspension which was stirred at 0 °C for one hour before the 
dropwise addition of n-butyllithium (2.5 mL, 4.2 mmol, 2.8 equiv.).  The resulting solution was 
stirred at 0 °C for 30 mins forming a yellow colour.  Compound 2.63 (0.82g, 4.2 mmol, 2.8 
equiv.) in THF (1 mL) was added and the reaction mixture stirred for an additional hour at 0 °C.  
The  reaction  mixture  was  quenched  with  aqueous  NH4Cl,  washed  with  NaHCO3(sat)  and 
extracted with CH2Cl2 (2 x 3 mL).  The combined organic layers were dried over MgSO4 and 
concentrated to give 1.1 g of a crude yellow oil which was purified by column chromatography 
to afford the title compound (Rf = 0.15, 30% EtOAc in hex) (0.24 g, 65%) as a yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 4.19 (2H, q, J = 7 Hz, CO2CH2CH3); 3.97-3.87 (4H, m, dioxolane 2 x 
CH2); 3.42 (2H, s, COCH2CO); 2.57 (2H, t, J = 7 Hz, COCH2CH2); 1.77-1.61 (4H, m, 2 x CH2); 1.30 
(3H, s, CH3); 1.27 (3H, t, J = 7 Hz, CO2CH2CH3).  
13C NMR (75 MHz, CDCl3) δC 202.5 (C=O); 167.2 
(CO2CH2CH3);  109.8  (quat.C);  64.6  (dioxolane  CH2);  61.3  (CH2CH3);  49.3  (COCH2CO);  42.8 
(COCH2CH2); 38.0 (CH2); 23.7 (CH3); 18.0 (CH2); 14.1 (CH2CH3). MS: ESI+ 267.3 [M + Na]
+. 
 
 
 
 
 
 
Data consistent with literature: Rychnovsky, S.D.; Mickus, D.E.  J.Org.Chem. 1992, 57, 2732-
2736. 7. Experimental Section 
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Ethyl 2-methyl-6-oxocyclohex-1-enecarboxylate 2.59 
 
 
 
To a solution of acetobutyric acid (1.13 mL, 10.0 mmol, 1.0 equiv.) in THF (50 mL) was added 
carbonyldiimidazole (1.94 g, 12.0 mmol, 1.1 equiv.).  After stirring at room temperature for six 
hours, the magnesium salt prepared from magnesium ethoxide (0.68 g, 6.0 mmol, 0.5 equiv.) 
and monoethyl malonate (1.41 mL, 12.0 mmol, 1.2 equiv.) was added.  The reaction mixture 
was stirred for 18 hours.  After filtration and evaporation, the residue was partitioned between 
Et2O (20 mL) and 0.5M HCl (10 mL).  The organic layer was washed with NaHCO3(sat), H2O, brine, 
dried over MgSO4 and evaporated to yield 1.8 g of a crude oil which was purified by column 
chromatography (gradient 20-50% EtOAc in hexane) to afford the title compound (Rf = 0.4, 
50% EtOAc in hex) (1.4 g, 74%) as a colourless oil. 
 
1H NMR (300 MHz, CDCl3) δH 4.23 (2H, q, J = 7 Hz, CH2CH3); 2.37-2.31 (4H, m, 2 x CH2); 1.99-
1.90 (2H, m, CH2); 1.92 (3H, s); 1.26 (3H, t, J = 7 Hz, CH2CH3).  
13C NMR (75 MHz, CDCl3) δC 194.9 
(C=O); 166.8 (CO2); 159.9 (C=CCH3); 133.3 (C=CCH3); 61.2 (CH2CH3); 36.9 (COCH2); 31.6 (CH2); 
22.0 (CH2); 21.7 (C=C-CH3); 14.2 (CH2CH3). MS: ESI+ 205.3 [M + Na]
+.  
 
 
 
 
 
 
 
1H  NMR  data  is  consistent  with  literature  (No  published 
13C  NMR  data):    Nishizuka,  T.; 
Hirosawa, S.; Kondo, S.; Ikeda, D.; Takeuchi, T.  J. Antibio. 1997, 50, 755-765.   7. Experimental Section 
 
145 
 
2-methyl-2-(3-oxobutyl)cyclohexane-1,3-dione 2.65 
 
 
To a well stirred suspension of 2-methyl-1,3-cyclohexanedione (12.6 g, 0.1 mol, 1.0 equiv.) in 
distilled water (90 mL) was added acetic acid (0.3 mL), hydroquinone (100 mg) and methyl 
vinyl ketone (16.6 mL, 0.2 mmol, 2.0 equiv.).  The reaction mixture was stirred at 74 °C for one 
hour, cooled to room temperature, treated with NaCl (1 g) and poured into a separating funnel 
containing EtOAc (20 mL).  The organic phase was collected and the aqueous phase was re-
extracted with EtOAc (2 x 20 mL).  The combined organic extracts were washed with brine, 
dried over MgSO4 and evaporated to afford the title compound (Rf = 0.36, 60% EtOAc in hex) 
(19.1 g, 97%) as a crude yellow oil. 
 
1H  NMR  (300  MHz,  CDCl3)  δH  2.75-2.56  (4H, m, cyclohex. 2  x  CH2); 2.32  (2H,  t,  J  =  6  Hz, 
COCH2CH2); 2.08 (3H, s, COCH3); 2.03 (2H, t, J = 6 Hz, COCH2CH2); 1.98-1.81 (2H, m, cyclohex. 
CH2); 1.22 (3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 209.9 (2 x C=O); 207.5 (C=O); 64.3 (quat.C); 
38.3 (CH2); 37.7 (2 x cyclohex CH2); 29.9 (CH2); 29.5 (COCH3); 20.1 (cyclohex CH2); 17.6 (CH3).  
MS: ESI+ 291 [M + Na]
+. 
 
 
 
 
 
 
 
 
 7. Experimental Section 
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(S)-8a-methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione 2.66 
 
 
 
L-Proline (0.24 g, 2.1 mmol, 5 mol%) was added to a stirring solution of compound 2.65 (8.15 g, 
42 mmol, 1.0 equiv.) in anhydrous DMSO (40 mL) at room temperature under N2 and stirred 
for five days.  The reaction mixture was extracted with EtOAc and washed with H2O (6 x 100 
mL)  to  remove  the  DMSO.    The  organic  layer  was  dried  over  MgSO4  and  the  solvent 
evaporated to yield 6.7 g of a purple viscous liquid which was distilled under high vacuum 
using short path cold finger distillation equipment (0.005mm Hg, 78-100 °C) to yield 5.03 g of a 
red oil.  Et2O (30 mL) was added and the solution was seeded with a few pure crystals of (S)-
(+)-Wieland-Miescher  ketone  (Sigma  Aldrich,  (S)-(+)-3,4,8,8a-Tetrahydro-8a-methyl-
1,6(2H,7H)-naphtha-lenedione) at 0 °C and left in -20 °C  freezer overnight.  The resulting 
crystals were filtered off and washed with 0 °C hexane and dried over the high vacuum pump 
for three hours to afford the title compound (Rf = 0.24, 50% EtOAc in hex) (3.10 g, 42%) as grey 
crystals (65% ee). 
1H NMR (400 MHz, CDCl3) δH 5.78 (1H, d, J = 2 Hz, C=CH); 2.73-2.60 (2H, m, C=CHCOCH2); 2.48-
2.36 (4H, m, COCH2 + CH2); 2.14-2.02 (3H, m, CH2); 1.72-1.56 (1H, m, CH2); 1.39 (3H, s, CH3).  
13C 
NMR (100 MHz, CDCl3) δC 210.9 (C=O); 198.1 (C=CHC=O); 165.8 (C=CH); 125.7 (C=CH); 50.6 
(quat.CCH3); 37.6 (COCH2); 33.6 (CH2); 31.7 (CH2); 29.7 (CH2); 23.2 (CH3); 22.9 (CH2). MS: ESI+ 
179.3 [M+H]
+; 201.3 [M+Na]
+.  Mpt 48 °C.  [a]
25
D +65.1 (c 1.00 toluene); published value of the 
pure crystals [α]D
25 +97.3 (toluene, c 1.0) Buchschacher, P.; Fürst, A.; Gutzwiller, J.  Org. Synth.  
1985, 63, 37-41. 
 
1H  NMR  data  is  consistent  with  literature:  Fuhshuku,  K.;  Funa,  N.;  Akeboshi,  T.;  Ohta,  H.; 
Hosomi, H.; Ohba, S.; Sugai, T.  J. Org. Chem. 2000, 65, 129-135. 
13C NMR data is consistent with literature: Bonjoch, J.; Díaz, S.;  González, A.; Bradshaw, B.; 
Cuesta, J.; J. Org. Chem. 2005, 70, 3749-3752. 7. Experimental Section 
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(±)-(S)-8a-Methyl-3,4,8,8a-tetrahydro-1,6(2H, 7H)-naphthalenedione 2.66 
 
 
 
Pyrrolidine  (0.82  mL,  9.8  mmol,  10  mol%)  was  added  dropwise  to  a  stirring  solution  of 
compound 2.65 (19.3 g, 98 mmol, 1.0 equiv.) in toluene (80 mL) with a colour change from 
yellow to orange/red.  The reaction was azeotropically distilled for one and a half hours during 
which all water collected was removed and reflux continued to remove an additional 10 mL 
solvent.  The resulting brown/black mixture was cooled to room temperature, diluted with 
Et2O and washed with a solution made of 10% HCl: H2O (1:6).  The aqueous layer was extracted 
with Et2O and the combined organic extracts were washed with H2O, brine, dried over MgSO4 
and  evaporated  to  yield  12.7  g  of  a  crude  brown  liquid  which  was  purified  by  column 
chromatography (50% EtOAc in hexane) to afford the title compound (Rf = 0.24, 50% EtOAc in 
hex) (12.5g, 72%) as a pale yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.85 (1H, d, J = 2 Hz, C=CH); 2.79-2.64 (2H, m, C=CHCOCH2); 2.56-
2.40 (4H, m, COCH2 + CH2); 2.22-2.06 (3H, m, CH2); 1.80-1.62 (1H, m, CH2); 1.45 (3H, s, CH3).  
13C 
NMR (75 MHz, CDCl3) δC 210.9 (C=O); 198.1 (C=CHC=O); 165.7 (C=CH); 125.8 (C=CH); 50.6 
(quat.CCH3); 37.6 (COCH2); 33.6 (CH2); 31.7 (CH2); 29.7 (CH2); 23.2 (CH3); 22.9 (CH2).  MS: ESI+ 
179.3 [M+H]
+; 201.3 [M + Na]
+. 
 
 
 
1H  NMR  data  is  consistent  with  literature:  Fuhshuku,  K.;  Funa,  N.;  Akeboshi,  T.;  Ohta,  H.; 
Hosomi, H.; Ohba, S.; Sugai, T.  J. Org. Chem. 2000, 65, 129-135. 
13C NMR data is consistent with literature: Bonjoch, J.; Díaz, S.;  González, A.; Bradshaw, B.; 
Cuesta, J.; J. Org. Chem. 2005, 70, 3749-3752. 7. Experimental Section 
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 (±)-(S)--4a'-Methyl-4',4a',7',8'-tetrahydro-3'H-spiro[[1,3]dithiolane-2,2'-naphthalen]-5'(6'H)-
one 2.67 
 
 
To a solution of compound 2.66 (20.2 g, 0.11 mol, 1.0 equiv.) in glacial acetic acid (45 mL) was 
added 1,2-ethanedithiol (10.5 mL, 0.12 mol, 1.1 equiv.), p-toluenesulfonic acid (10.15 g, 0.05 
mol, 47 mol%) and glacial acetic acid (120 mL).  The mixture was stirred at room temperature 
for six hours, poured into H2O (100 mL) and stirred for 15 minutes.  The solid was filtered off, 
washed successively with dilute aqueous NaHCO3 and H2O and then dried over MgSO4 to yield 
28.0 g of a crude yellow solid which was purified by column chromatography (5% EtOAc in 
hexane) to afford the title compound (Rf = 0.35, 20% EtOAc in hex) (26.7 g, 95%) as a colourless 
amorphous solid. 
 
1H NMR (300 MHz, CDCl3) δH 5.66 (1H, s, C=CH); 3.38-3.31 (3H, m, CH2’s); 3.30-3.18 (1H, m, 
CH2’s); 2.67-2.45 (2H, m, CH2); 2.39-2.31 (1H, m, from CH2); 2.25-2.12 (4H, m, 2 x SCH2); 2.05-
1.95 (1H, m, from CH2); 1.81-1.50 (2H, m, CH2); 1.28 (3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 
212.9 (C=O); 141.3 (C=CH); 128.1 (C=CH); 64.9 (quat.C dithiane); 49.5 (quat.CCH3); 40.2 (SCH2); 
39.7 (SCH2); 38.0 (COCH2); 37.7 (CH2); 30.9 (CH2); 30.8 (CH2); 24.8 (CH2); 24.6 (CH3). MS: ESI+ 
255.3 [M + H]
+; 531.3 [2M + Na]
+. 
 
 
 
 
 
Data consistent with literature: Paquette, L.A.; Wang, T-Z.; Philippo, C. M. G.; Wang, S.  J. Am. 
Chem. Soc.  1994, 116, 3367-3374. 7. Experimental Section 
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(±)-(S,Z)-5'-(Methoxymethylene)-4a'-methyl-4',4a',5',6',7',8'-hexahydro-3'H-
spiro[[1,3]dithiolane-2,2'-naphthalene] 2.68A 
(±)-(S,E)-5'-(Methoxymethylene)-4a'-methyl-4',4a',5',6',7',8'-hexahydro-3'H-
spiro[[1,3]dithiolane-2,2'-naphthalene] 2.68B 
 
 
To a cold (-30 °C) solution of (methoxymethyl) triphenylphosphonium chloride (18.8 g, 55 
mmol,  3.0  equiv.)  in  THF  (160  mL)  was  added  potassium  hexamethyldisilazane  (0.5  M  in 
toluene, 90.0 mL, 45 mmol, 2.5 equiv.).  The resulting red solution was stirred at 0 °C for 30 
minutes before being treated with a solution of compound 2.67 (4.65 g, 18 mmol, 1.0 equiv.) 
in THF (40 mL).  The reaction mixture was stirred at room temperature for 24 hours, quenched 
with aqueous NaHCO3 and extracted with EtOAc (3 x 50 mL).  The combined organic layers 
were washed with H2O, brine, dried over MgSO4 and concentrated to yield 26 g of a crude 
brown liquid which was first purified through a short silica plug (60% CH2Cl2 in hex) to yield 
7.83 g of a yellow liquid.  This was further purified by column chromatography (gradient 10-
50% CH2Cl2 in hexane) to afford the title compounds 2.68A (1.54 g) (Rf = 0.6, 20% CH2Cl2 in 
hex), 2.68B (2.43 g) (Rf = 0.5, 20% CH2Cl2 in hex) and mixed fractions (0.92 g); total Wittig 
product formed (4.9 g, 96%) as a yellow oil. 
 
Wittig 2.68A product: 
1H NMR (300 MHz, CDCl3) δH 5.65 (1H, s, C=CHOCH3); 5.51 (1H, s, C=CH); 
3.48 (3H, s, OCH3); 3.39-3.31 (3H, m, from SCH2); 3.28-3.18 (1H, m, from SCH2); 2.33-2.13 (5H, 
m, from CH2); 2.10-1.97 (2H, m, from CH2); 1.93-1.84 (1H, m, from CH2); 1.73-1.61 (1H, m, from 
CH2); 1.54-1.40 (1H, m, from CH2); 1.27 (3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 144.9 (C=CH); 
140.8 (C=CHCH3); 125.5 (C=CH); 122.6 (C=CHCH3); 65.8 (quat.C dithiane); 59.5 (OCH3); 39.9 
(SCH2); 39.6 (SCH2); 39.2 (quat.CCH3); 38.4 (CH2); 35.2 (CH2); 31.3 (CH2); 28.6 (CH2); 26.3 (CH2); 
24.1 (CH3).  MS: ESI+ 283.3 [M + H]
+.  IR (film): νmax = 2926, 2836 (OCH3), 1660, 1437 cm
-1.   7. Experimental Section 
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Wittig 2.68B product: 
1H NMR (300 MHz, CDCl3) δH 5.81 (1H, d, J = 2 Hz, C=CHOCH3); 5.46 (1H, 
s, C=CH); 3.55 (3H, s, OCH3); 3.40-3.32 (3H, m, from SCH2); 3.28-3.18 (1H, m, from SCH2); 2.83-
2.76 (1H, m, from CH2); 2.33-2.22 (3H, m, from CH2); 2.09-1.68 (5H, m, from CH2); 1.34-1.24 
(1H,  m,  from  CH2);  1.21  (3H,  s,  CH3).   
13C  NMR  (75  MHz,  CDCl3)  δC  145.0  (C=CH);  139.9 
(C=CHCH3); 125.2 (C=CHCH3); 124.2 (C=CH); 65.9 (quat.C dithiane); 59.4 (OCH3); 40.0 (SCH2); 
39.5 (SCH2); 38.1 (CH2); 37.3 (quat.CCH3); 34.6 (CH2); 32.7 (CH2); 27.4 (CH2); 26.6 (CH3); 21.9 
(CH2).  MS: ESI+ 283.3 [M + H]
+.  IR (film): νmax = 2926, 2837 (OCH3), 2360, 1664 cm
-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7. Experimental Section 
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(±)-(4a'R,5'S)-4a'-Methyl-4',4a',5',6',7',8'-hexahydro-3'H-spiro[[1,3]dithiolane-2,2'-
naphthalene]-5'-carbaldehyde 2.69 
 
 
A solution of MeOH in THF (1:1,  30 mL) and 4N HCl (30 mL) was added to a solution of 
compound 2.68A and 2.68B (3.56g, 12.6 mmol, 1.0 equiv.) in THF (30 mL) at 0 °C and the 
resulting solution was stirred at room temperature for 48 hours, forming precipitate.  The 
reaction was poured into H2O (40 mL) and extracted with Et2O (4 x 30 mL).  The combined 
organic layers were washed with brine, dried over MgSO4 and concentrated to yield 3.53 g of a 
yellow solid which was purified by column chromatography (gradient 20-70% CH2Cl2 in hexane) 
to  afford  the  title compound  (Rf = 0.37,  70%  CH2Cl2  in  hex)  (3.24  g,  96%)  as  a colourless 
amorphous solid. 
 
1H NMR (300 MHz, CDCl3) δH 9.81 (1H, d, J = 2 Hz, CHO); 5.56 (1H, s, C=CH); 3.41-3.33 (3H, m, 
from SCH2); 3.28-3.18 (1H, m, from SCH2); 2.23-2.10 (4H, m, CHCHO + from CH2); 2.06-1.97 (3H, 
m, from CH2); 1.92-1.83 (1H, m, from CH2); 1.77-1.72 (2H, m, from CH2); 1.40-1.21 (1H, m, from 
CH2); 1.14 (3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 204.4 (CHO); 143.3 (C=CH); 125.9 (C=CH); 
65.1 (quat.C dithiane); 60.6 (CHCHO); 40.1 (SCH2); 39.6 (SCH2); 37.3 (CH2); 37.2 (CH2); 36.8 
(CCH3); 31.7 (CH2); 25.9 (CH2); 22.1 (CH2); 19.6 (CH3). MS: ESI+ 291.3 [M + Na]
+. 
 
 
 
 
 
Data consistent with literature: Paquette, L.A.; Wang, T-Z.; Philippo, C. M. G.; Wang, S.  J. Am. 
Chem. Soc.  1994, 116, 3367-3374. 7. Experimental Section 
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(±)-((4a'R,5'S)-4a'-Methyl-4',4a',5',6',7',8'-hexahydro-3'H-spiro[[1,3]dithiolane-2,2'-
naphthalen]-5'-yl)methanol 2.70 
 
 
 
To a cold solution (0 °C) of compound 2.69 (1.38 g, 5.0 mmol, 1.0 equiv.) in MeOH (25 mL) and 
THF (20 mL) was added sodium borohydride (0.4 g, 10.0 mmol, 2.0 equiv.) portionwise.  The 
reaction mixture was warmed to room temperature until disappearance of starting material by 
TLC then quenched with saturated aqueous NH4Cl and concentrated.  The residue was taken 
up  in  EtOAc,  washed  with  H2O,  dried  over  MgSO4  and  concentrated  to  afford  the  title 
compound (Rf = 0.46, 50% EtOAc in hex) (1.5 g, quantitative yield) as a colourless amorphous 
solid and used in the next step without further purification.   
 
1H NMR (300 MHz, CDCl3) δH 5.52 (1H, s, C=CH); 3.82 (1H, d, J = 9 Hz, from CH2OH); 3.40-3.32 
(4H, m, from CH2OH + from SCH2); 3.27-3.19 (1H, m, from SCH2); 2.19-2.11 (3H, m, from CH2); 
2.04 (1H, m, CH2); 1.91-1.68 (4H, m, CHCH2OH + from CH2); 1.36-1.33 (3H, m, from CH2); 0.98 
(3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 145.5 (C=CH); 124.9 (C=CH); 65.5 (quat.C dithiane); 
63.7 (CH2OH); 51.4 (CHCH2OH); 40.0 (SCH2); 39.6 (SCH2); 37.8 (CH2); 37.3 (CH2); 36.4 (CCH3); 
32.6 (CH2); 26.8 (CH2); 25.5 (CH2); 18.7 (CH3).  MS: ESI+ 271.3 [M + H]
+; 293.3 [M + Na]
+. 
 
 
 
 
 
Data consistent with literature: Paquette, L.A.; Wang, T-Z.; Philippo, C. M. G.; Wang, S.  J. Am. 
Chem. Soc.  1994, 116, 3367-3374. 7. Experimental Section 
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(±)-((4a'R,5'S)-4a'-Methyl-4',4a',5',6',7',8'-hexahydro-3'H-spiro[[1,3]dithiolane-2,2'-
naphthalen]-5'-yl)methyl methanesulfonate 2.71 
 
 
 
To a cold (0 °C) solution of compound 2.70 (1.20 g, 4.4 mmol, 1.0 equiv.) in CH2Cl2 (22 mL) and 
triethylamine (1.26 mL, 9.1 mmol, 2.0 equiv.) was added methanesulfonyl chloride (0.65 mL, 
3.4 mmol, 1.9 equiv.).  The reaction mixture was warmed to room temperature for 30 minutes 
and washed with water and brine prior to drying over MgSO4.  Evaporation of the solvent 
afforded the title compound crude (Rf = 0.36, 20% EtOAc in hex) (1.6 g, quantitative yield) as a 
yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.54 (1H, s, C=CH); 4.34 (1H, dd, J = 10, 4 Hz, from CH2SO3CH3); 
3.99 (1H, t, J = 10 Hz, from CH2SO3CH3); 3.40-3.32 (3H, m, from SCH2); 2.27-3.18 (1H, m, from 
SCH2); 3.00 (3H, s, SO3CH3); 2.19-2.00 (4H, m, from CH2’s); 1.89-1.70 (3H, m, CHCH2OH + from 
CH2’s); 1.65 (1H, m, from CH2); 1.48-1.27 (3H, m, from CH2); 1.01 (3H, s, CH3).  
13C NMR (75 
MHz,  CDCl3)  δC  144.2  (C=CH);  125.7  (C=CH);  70.6  (CH2SO3);  65.2  (quat.C  dithiane);  48.0 
(SO3CH3); 40.1 (SCH2); 39.6 (SCH2); 37.6 (CH2); 37.4 (CHCH2OH); 37.2 (CH2); 36.3 (CCH3); 31.5 
(CH2); 26.4 (CH2); 25.5 (CH2); 18.7 (CH3).  MS: ESI+ 349.3 [M + H]
+; 371.3 [M + Na]
+. 
 
 
 
 
 
Data consistent with literature: Paquette, L.A.; Wang, T-Z.; Philippo, C. M. G.; Wang, S.  J. Am. 
Chem. Soc.  1994, 116, 3367-3374. 7. Experimental Section 
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(±)-(4a'R,5'S)-4a',5'-Dimethyl-4',4a',5',6',7',8'-hexahydro-3'H-spiro[[1,3]dithiolane-2,2'-
naphthalene] 2.72 
 
 
 
To a cold (0 °C) solution of compound 2.71 (20.3g, 58.0 mmol, 1.0 equiv.) in THF (200 mL) was 
added Superhydride® (167 mL, 1.0M in THF, 3.0 equiv.).  The reaction mixture was stirred at 
reflux for two hours, cooled and quenched with H2O and extracted with Et2O.  The organic 
layers were combined, washed with H2O, brine, dried over MgSO4 and concentrated to yield 
17.8 g of a crude viscous yellow oil which was purified by column chromatography (gradient 0-
60% EtOAc in hex) to afford the title compound (Rf = 0.69, 50% EtOAc in hex) (14.2 g, 96%) as a 
colourless amorphous solid. 
 
1H NMR (300 MHz, CDCl3) δH 5.50 (1H, s, C=CH); 3.42-3.31 (3H, m, from SCH2); 3.29-3.18 (1H, 
m, from SCH2); 2.20-2.07 (3H, m, from CH2); 2.03-1.94 (1H, m, from CH2); 1.84-1.68 (2H, m, 
CHCH3 +  from  CH2);  1.65-1.51  (1H,  m,  from  CH2);  1.47-1.26  (4H,  m,  CH2’s);  0.94  (3H,  s, 
quat.CCH3); 0.84 (3H, d, J = 6 Hz, CHCH3).  
13C NMR (75 MHz, CDCl3) δC 146.5 (C=CH); 124.4 
(C=CH); 66.0 (quat.C dithiane); 43.4 (CHCH3); 39.9 (SCH2); 39.5 (SCH2); 38.0 (CH2); 37.1 (CH2); 
33.2 (CCH3): 32.5 (CH2); 30.9 (CH2); 27.4 (CH2); 17.2 (quat.CCH3); 15.5 (CHCH3). GCMS (CI) m/z 
255 [M+H
+]. 
 
 
 
 
Data consistent with literature: Paquette, L.A.; Wang, T-Z.; Philippo, C. M. G.; Wang, S.  J. Am. 
Chem. Soc.  1994, 116, 3367-3374. 7. Experimental Section 
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(±)-(4aR,5S)-4a, 5-Dimethyl-4,4a, 5, 6, 7, 8-hexahydronaphthalen-2(3H)-one 1.1 
 
 
 
To a solution of 2.72 (1.00g, 3.9 mmol, 1.0 equiv.) in MeOH/H2O (22 mL, 10:1) was added 
methyl iodide (0.73 mL, 11.7 mmol, 3.0 equiv.) and the reaction mixture was heated to reflux 
for 24 hours.  The resulting solution was cooled to room temperature and concentrated to give 
0.69 g of a crude yellow oil which was purified by column purification (gradient 10-50% EtOAc 
in hex) to afford the title compound (Rf = 0.24, 20% EtOAc in hex) (0.62 g, 90%) as a clear oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.70 (1H, s, C=CH); 2.47-2.19 (3H, m, from CH2’s); 2.04-1.97 (1H, 
m, from CH2); 1.87-1.37 (7H, series of m, CH2’s); 1.08 (3H, s, quat.CCH3); 0.89 (3H, d, J = 6 Hz, 
CHCH3).  
13C NMR (75 MHz, CDCl3) δC 199.6 (C=O); 171.3 (C=CH); 124.0 (C=CH); 43.1 (CHCH3); 
39.0 (quat.CCH3); 35.5 (CH2); 34.0 (CH2); 33.3 (CH2); 30.5 (CH2); 26.5 (CH2); 16.0 (quat.CCH3); 
15.2 (CHCH3). MS: ESI+ 395.4 [2M + K]
+. 
 
 
 
 
 
 
 
 
 
Data consistent with literature: Paquette, L.A.; Wang, T-Z.; Philippo, C. M. G.; Wang, S.  J. Am. 
Chem. Soc.  1994, 116, 3367-3374. 7. Experimental Section 
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(±)-((4aR,5S)-4a,5-Dimethyl-4,4a,5,6,7,8-hexahydro-naphthalen-2-yloxy)-trimethyl-silane 
3.73 
 
 
To a solution of 1.78 M LDA (3.37 mL, 6.0 mmol, 3.0 equiv.) in THF (10 mL) at -78 °C was slowly 
added compound 1.1 (340 mg, 1.9 mmol, 1.0 equiv.) in THF (10 mL).  The resulting solution 
was stirred at -78 °C for 45 min followed by the dropwise addition of trimethylsilyl chloride 
(0.80 mL, 6.3 mmol, 3.2 equiv.).  The reaction mixture was subsequently warmed to room 
temperature over one and a half hours and quenched with H2O (2 mL).  The reaction mixture 
was concentrated and Et2O (20 mL) was added.  The organic layer was extracted with ice cold 
saturated aqueous NaHCO3 (5 mL) and brine (2 mL), dried over MgSO4 and concentrated to 
yield 910 mg of a crude brown oil (Rf = 0.83, 30% EtOAc in hex) to afford the title compound 
which was used without purification in the next step. 
 
1H NMR (300 MHz, CDCl3) δH 5.13 (1H, m, C=CH); 4.53 (1H, m, C=CHCH2); 0.00 (9H, s, SiMe3).  
 
 
 
 
 
 
 
 
 
 
 7. Experimental Section 
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(±)-(4aR,5S)-3-(2-hydroxypropan-2-yl)-4a,5-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-
2(3H)-one 3.5 
 
To  a  stirred  solution  of  anhydrous  acetone  (0.15  mL,  2.0  mmol,  1.0  equiv.)  and  titanium 
chloride (0.22 mL, 2.0 mmol, 1.0 equiv.) in CH2Cl2 (2 mL) at 0 °C was added compound 3.73 
(500 mg, 2.0 mmol, 1.0 equiv.) dropwise.  The solution turned from a bright yellow solution to 
a dark brown/black colour.  This was stirred at 0 °C for two hours and a following one hour at 
room temperature.  The reaction solution was quenched with H2O (2 mL) and stirred for 15 
minutes at room temperature.  The organic layer was isolated with CH2Cl2 (10 mL), washed 
with H2O, brine, dried over MgSO4 and concentrated to yield 420 mg of a crude brown oil 
which  was  purified  by  column  chromatography  (0-10%  EtOAc  in  hex)  to  afford  the  title 
compound (Rf = 0.37, 30% EtOAc in hex) (220 mg, 48%) as a brown oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.71 (1H, s, C=CH); 5.20 (1H, s, OH); 2.53 (1H, dd, J = 15, 4 Hz 
CHC(CH3)2OH); 2.40-2.23 (2H, m, CH2); 2.02 (1H, dd, J = 13, 4 Hz, CHCH3); 1.92-1.82 (1H, m, 
from CH2); 1.63-1.39 (5H, m, from CH2); 1.23 (6H, s, C(CH3)2OH); 1.14 (3H, s, quat.CCH3); 0.93 
(3H, d, J = 6 Hz, CHCH3).  
13C NMR (75 MHz, CDCl3) δC 203.4 (C=O); 172.0 (CHC(CH3)2OH); 124.6 
(C=CH); 72.5 (C=CH); 51.2 (CHC(CH3)2OH); 43.6 (CHCH3); 39.6 (quat C.CH3); 38.6 (CH2); 32.9 
(CH2); 30.3 (CH2); 28.3 (CH3); 26.2(CH2); 24.6 (CH2); 15.9 (quat.CCH3); 15.1 (CHCH3). MS: ESI+ 
259.2 [M + Na]
+. 
 
 
 
 
 
 
Data consistent with literature: Torii, S.; Inokuchi, T.; Yamafuji, T.  Bull. Chem. Soc. Jpn. 1979, 
52, 2640-2645. 7. Experimental Section 
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 (±)-Dehydrofukinone 
 
 
 
To a cold (0 °C) solution of compound 3.5 (0.17 g, 0.72 mmol, 1.0 equiv.) in CH2Cl2 (5.0 mL) and 
triethylamine (0.40 mL, 2.8 mmol, 4.0 equiv.) was added methanesulfonyl chloride (0.22 mL, 
2.7 mmol, 3.8 equiv.).  The reaction mixture was warmed to room temperature for five and a 
half hours during which time the solution went from clear to cloudy yellow.  The reaction 
mixture was washed with H2O, dilute HCl, H2O and brine prior to drying with MgSO4 and 
concentrated  to  yield  0.25  g  of  a  crude  brown  oil  which  was  purified  by  column 
chromatography (0-5% EtOAc in hex) to afford the title compound (Rf = 0.6, 30% EtOAc in hex) 
(0.1 g, 66%) as a yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.71 (1H, s, C=CH); 2.86 (1H, d, J = 13 Hz, from CH2); 2.36-2.19 
(2H, m, CH2); 2.12 (1H, m, from CH2); 2.07 (3H, d, J = 2 Hz, C=C(CH3)2); 1.82 (4H, s within m, 
C=C(CH3)2 + from CH2); 1.55-1.33 (4H, m, CHCH3 + from CH2); 0.95 (3H, s, quat.CCH3); 0.94 (3H, 
d, J = 6 Hz, CHCH3).  
13C NMR (75 MHz, CDCl3) δC 192.2 (C=O); 168.6 (C=CH); 142.1 (C=C(CH3)2); 
128.1 (C=C(CH3)2); 126.1 (C=CH); 42.5 (CHCH3); 41.8 (quat.CCH3); 41.0 (CH2); 32.5 (CH2); 30.5 
(CH2); 26.5 (CH2); 22.5 (C=C(CH3)2); 22.0 (C=C(CH3)2); 16.0 (quat.CCH3); 15.4 (CHCH3).  GCMS (EI) 
m/z 219 [M
+].  IR (film): νmax = 3020, 1665, 1220, 1040 cm
-1. 
 
 
 
 
Data consistent with literature: Tenius, B. S. M.; Schenato, R. A.; dos Santos, E. M.; Costa, P. R. 
R.; Caracelli, I.; Zukrtman-Schpector, J.  Tetrahedron: Asymmetry 2001, 12, 579-584. 7. Experimental Section 
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(±)-Fukinone 
 
 
Pd/C (15 mg, 15wt%) was added to a solution of compound 3.5 (100 mg, 0.42 mmol, 1.0 
equiv.) in EtOH (2 mL) and stirred under H2 atmosphere at room temperature for 16 hours.  
The reaction mixture was filtered through celite to remove the catalyst and concentrated to 
afford compound 3.75 crude (Rf = 0.54, 30% EtOAc in hex) as a clear oil which was used 
without purification in the next step.  
1H NMR (300 MHz, CDCl3) δ 4.18 (1H, s, OH); 1.21 (6H, d, 
J = 3 Hz, C(CH3)2OH); 0.95 (3H, s, quat.CCH3); 0.87 (3H, d, J = 6 Hz, CHCH3). MS: ESI+ 261 
[M+Na]
+. 
 
To a cold (0 °C) solution of crude compound 3.75 (100 mg, 0.42 mmol, 1.0 equiv.) in CH2Cl2 (3.0 
mL) and triethylamine (0.23 mL, 1.68 mmol, 4.0 equiv.) was added methanesulfonyl chloride 
(0.12 mL, 1.6 mmol, 3.8 equiv.).  The mixture was warmed to room temperature for six hours 
during which time the solution went from clear to cloudy yellow.  The crude was washed with 
H2O, dilute HCl, H2O and brine prior to drying with MgSO4 and concentrated to yield 90 mg of a 
crude orange oil which was purified by column chromatography (0-5% EtOAc in hex) to afford 
the title compound as the minor compound in a mixture of two isomers (Rf = 0.6, 30% EtOAc in 
hex) (49 mg, 1:3 ratio 53%) as a pale yellow oil. 
 
1H NMR of minor product, cis isomer (13%) (300 MHz, CDCl3) δH 2.75 (1H, d, J = 15 Hz, from 
CH2CO); 2.55 (1H, dd, J = 16, 11 Hz, from CH2CO); 2.28-2.23 (1H, m, from CH2C=C); 1.94 (3H, s, 
C=C(CH3)2); 1.78 (3H, s, C=C(CH3)2); 1.72-1.15 (9H, series of m, CHCH3, quat.CH, CH2’s); 0.96 
(3H, s, quat.CCH3); 0.85 (3H, d, J = 6 Hz, CHCH3).  
13C NMR (75 MHz, CDCl3) δC 206.2 (C=O); 
139.9  (C=C(CH3)2);  131.2  (C=C(CH3)2);  44.1  (CH2CO);  41.4  (quat.CH);  40.6  (CH2C=C);  36.7 
(quat.CCH3); 32.2 (CHCH3); 30.1 (CH2); 27.2(CH2); 22.6 (C=C(CH3)2); 21.6 (C=C(CH3)2); 21.6 (CH2); 
20.4 (Quat.CCH3); 16.0 (CHCH3).
15  MS: ESI+ 243 [M+Na]
+; 463 [2M+Na]
+.  IR (film) 2930, 2870, 
1670, 1605, 1460 cm 
-1. 7. Experimental Section 
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Data consistent with literature of minor product for fukinone: Kozmin, S.A.; Reddy, D.S.  J. Org. 
Chem. 2004, 69, 4860-4862.   
 
1H NMR of major product, trans isomer (40%) (300 MHz, CDCl3) δH 2.76 (1H, d, J = 14 Hz, from 
CH2CO); 2.25-2.11 (2H, m, from CH2CO + CH2C=C); 1.98 (3H, d, J = 2 Hz, C=C(CH3)2); 1.77 (3H, d, 
J = 2 Hz, C=C(CH3)2); 1.72-1.15 (9H, series of m); 0.89 (3H, d, J = 6 Hz, CHCH3); 0.74 (3H, s, 
quat.CCH3).  
13C NMR (75 MHz, CDCl3) δC 204.5 (C=O); 142.6 (C=C(CH3)2); 131.5 (C=C(CH3)2); 
45.5 (CH2CO); 44.0 (quat.CH); 43.0 (CH2C=C); 42.5 (CHCH3); 36.9 (quat.CCH3); 30.7 (CH2); 29.0 
(CH2); 26.2 (CH2); 23.0 (C=C(CH3)2); 22.0 (C=C(CH3)2); 15.7 (CHCH3); 10.1 (quat.CCH3).   
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3-Methyl-3-(4-methylpent-3-en-1-yl)cyclohexanone 4.6 
3-Methyl-1-(4-methylpent-3-en-1-yl)cyclohex-2-enol 4.7 
 
 
 
A 3-neck flask was fitted with a condenser, stirrer and charged with Mg(s) (272 mg, 11.4 mmol, 
3.2 equiv.) then heated with a heat gun under Ar atmosphere to activate Mg.  Mg was allowed 
to cool for 15 minutes before one small iodine crystal was added followed by anhydrous THF 
(10.0 mL).  The flask was swirled to disperse the brown colour.  A few drops of bromo-2-
methyl-2-pentene (1.00 mL, 7.46 mmol, 2.1 equiv.) was added and the reaction mixture was 
heated  to  60  °C  until  solution  turned  colourless  indicating  reaction  was  activated.  The 
remaining bromo-2-methyl-2-pentene in anhydrous THF (1.00 mL) was added dropwise over 
10 minutes.  The reaction mixture was stirred at reflux for one and a half hours to form the 
Grignard compound, then allowed to cool to room temperature. 
 
Copper bromide dimethylsulphide complex (74.0 mg, 0.36 mmol, 10 mol%) was suspended in 
anhydrous THF (6.00 mL) and cooled to
 -20 C and the Grignard solution added via syringe over 
five minutes.  After 30 minutes at -20 C 3-methyl-2-cyclohexenone (0.40 mL, 3.55 mmol, 1.0 
equiv.)  was  added  over  10  minutes  and  the  reaction  mixture  stirred  for  15  minutes  and 
allowed to warm to room temperature.  MeI (0.44 mL, 7.10 mmol, 2.0 equiv.) in anhydrous 
THF (1.00 mL) was added and the mixture stirred for 30 minutes before reaction was quenched 
with aqueous saturated NH4Cl and the organic layer separated.  The aqueous solution was 
extracted with Et2O and the organic layers combined, washed with brine, dried over MgSO4 
and  concentrated  to  give  99  mg  of  a  crude  yellow  liquid  which  was  purified  by  column 
chromatography (2% EtOAc in hex) to afford the title compound 4.6 (Rf = 0.62, 50% EtOAc in 
hex) (630 mg, 91%) as a colourless oil, followed by the minor 1,2-addition product 4.7 (Rf = 
0.45, 50% EtOAc in hex) (7.00 mg, 1%) as a colourless oil. 7. Experimental Section 
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1H NMR of compound 4.6 (300 MHz, CDCl3) δH 5.06 (1H, tt, J = 1, 7 Hz, C=CH); 2.26 (2H, t, J = 7 
Hz, CH2); 2.22–2.05 (2H, m, CH2); 1.97-1.79 (4H, m, from CH2); 1.69-1.49 (8H, m including 2 s, 
C=C(CH3)2 + CH2); 1.30-1.21 (2H, m, CH2); 0.92 (3H, s, CH3).  
13C NMR (75 MHz, CDCl3) δC 212.0 
(C=O); 131.4 (C=CH); 124.3 (C=CH); 53.6 (cyclohex. CH2); 41.6 (cyclohex. CH2); 40.9 (cyclohex. 
CH2); 38.5 (quat.C); 35.8 (CH2); 25.6 (C=C(CH3)2); 24.8 (C=C(CH3)2); 22.1 (cyclohex.CH2); 22.0 
(CH2); 17.5(CH3). GCMS (EI) m/z 194 [M
+].   
Data consistent with literature: Williams, C.M.; Tilly, D.P.; Bernhardt, P.V.  Org. Lett.  2005, 7, 
5155-5157. 
 
1H  NMR  of  compound  4.7  (300  MHz,  CDCl3)  δH  5.36  (1H,  s,  CH=CCH3);  5.17-5.09  (1H,  m, 
(CH3)2C=CH); 2.12-2.00 (2H, m, cyclohex. CH2); 1.95-1.85 (2H, m, CH2); 1.74-1.42 (7H, m, CH2’s + 
OH);  1.68  (6H,  s,  CH=C(CH3)2);  1.62  (3H,  s,  CH=CCH3). 
13C  NMR  (75  MHz,  CDCl3)  δC  137.8 
(CH3C=CH); 131.5 (CH=C(CH3)2); 127.2 (CH3C=CH); 124.7 (CH=C(CH3)2); 70.6 (quat.COH); 42.5 
(CH2); 35.1 (cyclohex. CH2); 30.3 (cyclohex. CH2); 25.7 (CH=C(CH3)2); 23.7 (CH=C(CH3)2); 22.4 
(CH2); 19.4 (cyclohex. CH2); 17.7 (CH=CCH3).  GCMS (EI) m/z 194 [M
+].   
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5-Methyl-1-phenylhex-4-en-1-ol 4.10 
 
To a solution of 5-bromo-2-methyl-2-pentene (0.10 mL, 0.75 mmol, 1.4 equiv.) in anhydrous 
Et2O (2.0 mL) at -78 °C was slowly added tert-butyllithium 1.5 M (0.80 mL, 1.2 mmol, 2.2 
equiv.) over five minutes.  This mixture was stirred at -78 °C for five minutes, followed by the 
slow  addition  of  benzaldehyde  (0.05  mL,  0.55  mmol,  1.0  equiv.)  in  Et2O  (1  mL)  over  five 
minutes.  The mixture was subsequently warmed to room temperature over 15 minutes and 
hydrolysed with brine (2 mL).  The aqueous layer was extracted with Et2O (2 x 2 mL) and the 
combined organic layers were washed with brine (2 mL), dried over MgSO4 and concentrated 
to yield 190 mg of a clear oil which was purified by column chromatography (0-20% EtOAc in 
hex) to afford the title compound (Rf = 0.35, 20% EtOAc in hex) (44.0 mg, 44%) as a colourless 
oil. 
 
 
1H NMR (300 MHz, CDCl3) δH 7.39 - 7.27 (5H, m, phenyl H);  5.16 (1H, tt, J = 7 Hz, (CH3)2C=CH); 
4.69  (1H,  dd,  J  =  7, 5  Hz,  CHOH); 2.16  –  2.00  (2H,  m,  CHCH2); 1.93  – 1.73 (3H, m,  OH + 
CHOHCH2); 1.71 (3H, s, CH=C(CH3)2); 1.60 (3H, s, CH=C(CH3)2).  
13C NMR (75 MHz, CDCl3) δC 
144.7 (phenyl quat.CCHOH); 132.3 ((CH3)2C=CH); 128.4 ( 2 x phenyl CH); 127.4 ((CH3)2C=CH); 
125.9 (2 x phenyl CH); 123.8 (phenyl CH);  74.2 (CHOH); 39.0 (CHOHCH2); 25.7 ((CH3)2C=CH); 
24.5 (CH2CH=C); 17.7 ((CH3)2C=CH).  GCMS (EI) m/z 190 [M
+].  
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(±)-(4a'R,5'S)-4a',5,5,5'-tetramethyl-3',4',4a',5',6',7'-hexahydro-1'H-spiro[[1,3]dioxane-2,2'-
naphthalene] 4.16 
 
To a solution of compound 1.1 (2.00 g, 11.2 mmol, 1.0 equiv.) in benzene (30 mL) was added 
2,2-methyl-1,3-propanediol (2.92 g, 28 mmol, 2.5 equiv.) and camphorsulfonic acid (13.0 mg, 
0.11 mmol, 0.01 equiv.)  The reaction mixture was stirred at reflux and water was removed 
using  Dean-Stark  apparatus  for  24  hours.    The  resulting  solution  was  cooled  to  room 
temperature and quenched with solid NaHCO3.  The solids were filtered off and the precipitate 
was washed with 20:1 hex:EtOAc (20 mL).  The filtrates were combined and concentrated to 
give 3.81 g of a crude yellow solid which was purified by column chromatography (gradient 0-
30% EtOAc in hex) to afford the title compound (Rf = 0.93, 50% EtOAc in hex) (2.58 g, 79%) as a 
colourless amorphous solid. 
 
1H NMR (300 MHz, CDCl3) δH 5.38 (1H, ddd, J = 5, 2, 2 Hz, C=CH); 3.54 (2H, ABq, J = 11 Hz, 
OCH2); 3.51 - 3.41 (2H, m, OCH2); 2.58 (1H, dd, J = 14, 3 Hz, from CH2); 2.20 - 2.36 (2H, m, from 
CH2); 2.03 - 2.17 (1H, m, from CH2); 1.99 – 1.68 (1H, m, CHCH3); 1.71 (1H, dt, J = 13, 3 Hz, from 
CH2); 1.50 - 1.61 (1H, m, from CH2); 1.48 – 1.36 (3H, m, from CH2); 1.25 (1H, dt, J = 13, 4 Hz, 
from CH2); 1.01 (3H, s, quat.CCH3); 0.94 (s, 3 H, CCH3); 0.92 (s, 3 H, CCH3); 0.88 (3H, d, J = 6 Hz, 
CHCH3);  
13C NMR (75 MHz, CDCl3) δC 139.8 (C=CH); 123.0 (C=CH); 98.5 (quat.C(OCH2)2); 70.2 
(OCH2); 69.9 (OCH2); 40.2 (CH3CH); 39.9 (CH2); 37.1 (quat.CCH3); 34.8 (CH2); 30.1 (quat.C(CH3)2); 
27.6 (CH2); 27.2 (CH2); 25.8 (CH2); 22.8 (CH3); 22.7 (CH3); 17.4 (CCH3); 15.8 (CH3CH).  MS: ESI+ 
287.5 [M+Na]
+.  IR (film): νmax = 2920, 2840, 1660, 868 cm
-1. 
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(±)-(1a'R,4'S,4a'R,8a'S)-4',4a',5,5-tetramethyloctahydrospiro[[1,3]dioxane-2,7'-naphtho[1,8a-
b]oxirene] 4.18 
 
 
 
To  compound  4.16  (1.45  g,  5.48  mmol,  1.1  equiv.)  in  EtOAc  (24  mL)  was  added  sodium 
bicarbonate (2.08 g, 24.8 mmol, 5 equiv.), water (23 mL) and acetone (10 mL).  This biphasic 
mixture was stirred vigorously as an aqueous Oxone® solution (3.05 g, 4.96 mmol, 1.0 equiv.) 
in water (21 mL) was added dropwise over one hour at room temperature.  The reaction 
mixture was stirred vigorously for an additional two hours.  The organic layer was separated, 
washed with brine, dried over MgSO4 and concentrated to give 1.51 g of a crude colourless oil 
which was purified by column chromatography (gradient 0-30% EtOAc in hex) to afford the 
title compound (Rf = 0.84, 50% EtOAc in hex) (1.32 g, 95%) as a colourless amorphous solid.  
 
1H NMR (300 MHz, CDCl3) δH 3.54-3.40 (4H, m, 2 x OCH2); 3.05 (1H, t, J = 2 Hz, epoxide CH); 
2.08 (1H, d, J = 14 Hz, from CH2); 2.04 - 1.91 (2H, m, CHCH3 + from CH2); 1.82 – 1.53 (5H, m, 
from CH2’s); 1.39 – 1.28 (m, from CH2); 1.27 – 1.10 (2H, m, from CH2); 1.00 (3H, s, quat.CCH3); 
0.95 (3H, s, C(CH3)2); 0.91 (3H, s, C(CH3)2); 0.83 (3H, d, J = 7 Hz, CHCH3); 
13C NMR (75 MHz, 
CDCl3)  δC  99.1  (quat.C(OCH2)2);  70.3  (OCH2);  70.2  (OCH2);  63.1  (epoxide  CH);  62.6  (quat.C 
epoxide); 38.8 (CH3CH); 38.5 (CH2); 35.5 (quat.C(CH3)2); 33.7 (CH2); 30.1 (quat.CCH3); 29.4(CH2); 
25.5 (CH2); 24.2 (CH2); 22.7 (CH3); 22.6 (CH3); 16.2 (quat.CCH3); 16.1 (CH3CH). MS: ESI+ 303 
[M+Na]
+.  IR (film): νmax = 3055 (epoxide CH), 2900, 2843, 1642 cm
-1. 
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(±)-(1aR,4S,4aR,8aS)-4,4a-dimethylhexahydro-1aH-naphtho[1,8a-b]oxiren-7(8H)-one 4.19 
 
 
 
An aqueous Oxone® solution (6.31 g, 10.2 mmol, 1.1 equiv.) in water (38 mL) was added 
dropwise to a stirring solution of sodium bicarbonate (1.44 g, 17.1 mmol, 1.8 equiv.) and 
compound 4.16 (2.50 g, 9.46 mmol, 1.0 equiv.) in acetone (20 mL).  The reaction mixture was 
stirred for 52 hours at room temperature and then extracted with EtOAc (5 x 20 mL).  Brine (20 
mL) was added to the aqueous layer to aid separation of organic compounds.  The organic 
fractions were combined, dried over MgSO4 and concentrated to give 2.84 g of a crude yellow 
solid which was purified by column chromatography (gradient 20-50% EtOAc in hex) to afford 
the title compound (Rf = 0.12, 50% EtOAc in hex) (1.55 g, 85%) as a colourless amorphous solid.  
 
1H NMR (300 MHz, MeOD) δH
 3.45 (1H, t, J = 3 Hz, epoxide CH); 3.18 (1H, d, J = 15 Hz, from 
CH2); 2.56 – 2.41 (1H, m, from CH2); 2.29 – 2.19 (1H, m, from CH2); 2.17 – 2.07 (1H. m, from 
CH2); 2.03 (1H, dd, J = 15, 2 Hz, from CH2); 1.99 – 1.83 (2H, m, from CH2); 1.76 – 1.62 (2H, m, 
from  CH2);  1.61  –  1.52  (1H,  m,  from  CH2);  1.33  –  1.26  (1H,  m,  from  CH2);  1.25  (3H,  s, 
quat.CCH3); 0.85 (3H, d, J = 7 Hz, CHCH3); 
13C NMR (75 MHz, MeOD) δC 215.9 (C=O); 79.0 
(quat.C epoxide); 76.1 (epoxide CH); 50.4 (CH2); 40.2 (quat.CCH3); 39.0 (CH2); 36.3 (CH3CH); 
35.2 (CH2); 29.9 (CH2); 26.8 (CH2); 16.2 (quat.CCH3); 15.1 (CHCH3).GCMS (EI) m/z 194 [M
+].  IR 
(film): νmax = 3050 (epoxide CH), 2910, 2860, 1690 (C=O) cm
-1. 
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(±)-(4aR,5S,8R)-8-hydroxy-4a,5-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one 1.3 
 
 
 
To a solution of compound 4.18 (1.32g, 4.7 mmol, 1.0 equiv.) in freshly distilled anhydrous 
acetone  (20 mL)  was  added  ρ-toluenesulfonic  acid (15 mg, 0.08 mmol, 0.02 equiv.).    The 
resulting mixture was stirred at room temperature for 24 hours then concentrated to remove 
80% of the acetone.  TLC of reaction mixture indicated loss of 4.18 and a new major polar spot 
corresponding to compound 4.19.   Triethylamine (1 mL) was added to the crude oil and stirred 
for seven hours at room temperature.  The reaction mixture was concentrated to give 1.4 g of 
a crude orange oil which was purified by column chromatography (gradient 20-50% EtOAc in 
hex) to afford the title compound (Rf = 0.3, 50% EtOAc in hex) (0.36 g, 40%) as a pale yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.83 (1H, s, C=CH); 4.34 (1H, t, J = 3 Hz, CHOH); 2.62 – 2.15 (2H, m, 
CH2C=O); 2.10 – 1.61 (5H, m, from CH2’s); 1.49 – 1.36 (2H, m, from CH2 + CHCH3); 1.30 (3H, s, 
quat.CCH3); 0.95 (3H, d, J = 7 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC 200.6 (C=O); 168.4 
(C=CH); 126.6 (C=CH); 73.4 (CHOH); 43.1 (CHCH3); 38.4 (quat.CCH3); 36.9 (CH2); 34.3 (CH2); 32.8 
(CH2); 24.8 (CH2); 18.0 (quat.CCH3); 15.2 (CHCH3). MS: ESI+ 217.2 [M + Na]
+. 
 
 
 
 
 
Data consistent with literature: Bonjoch, J.; Díaz, S.;  González, A.; Bradshaw, B.; Cuesta, J.; J. 
Org. Chem. 2005, 70, 3749-3752. 7. Experimental Section 
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(±)-(4aR,5S,8R)-8-hydroxy-4a,5-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one 1.3A 
(±)-1α-Hydroxyisoondetianone 1.3B (4aR,5S,8S)-8-hydroxy-4a,5-dimethyl-4,4a,5,6,7,8-
hexahydronaphthalen-2(3H)-one) 
 
 
 
To a solution of compound 1.1 (1.4 g, 7.8 mmol, 1.0 equiv.), trimethyl orthoformate (12 mL), 
methanol (2.8 mL) in DMF (15 mL) was added ρ-toluenesulfonic acid (30 mg, 0.16 mmol, 0.02 
equiv.) and the resulting mixture was stirred for 24 hours at room temperature in the dark.  
Triethylamine (0.87 mL) was added, and the  reaction mixture diluted with Et2O (100 mL), 
washed with aqueous saturated NaHCO3 (3 x 50 mL), brine (50 mL), dried over MgSO4 and 
concentrated to give 1.63 g of the dienol ether intermediate 4.20 as a yellow oil which was 
used immediately in the following reaction.  
1H NMR of crude dienol ether 4.20 (300 MHz, 
CDCl3) δ 5.27 (1H, t, J = 4 Hz, C=CH); 5.16 (1H, d, J = 1 Hz, C=CH); 3.58 (3H, s, OCH3); 0.94 – 0.90 
(3H, m, CHCH3); 0.89 (3H, s, quat.CCH3). 
 
To a rapidly stirring biphasic mixture of the crude dienol ether (7.8 mmol), sodium bicarbonate 
(3.3 g, 39.2 mmol, 5.0 equiv.) in EtOAc (30 mL), acetone (10 mL) and water (30 mL) at 0 °C, was 
added a solution of Oxone
® (4.8 g, 7.8 mmol, 1.0 equiv.) in H2O (28 mL) over 30 minutes.  The 
mixture was stirred at 0 °C for one hour.  The reaction mixture was allowed to separate and 
the aqueous layer extracted with EtOAc (3 x 20 mL) and washed with brine.  The combined 
organic layers were dried over MgSO4 and concentrated to give 1.5 g of a crude yellow oil 
which was purified by column chromatography (gradient 0-30% EtOAc in hex) to afford the 
title compound 1.3A (Rf = 0.3, 50% EtOAc in hex) (0.62 g, 41%) as a pale yellow oil followed by 
the trans epimer compound 1.3B (Rf = 0.25, 50% EtOAc in hex) (0.20 g, 13%) as a pale yellow 
oil.  
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1H NMR for cis isomer 1.3A (300 MHz, CDCl3) δH 5.80 (1H, s, C=CH); 4.32 (1H, t, J = 3 Hz, CHOH); 
2.61 – 2.28 (2H, m, COCH2); 2.13 – 1.94 (3H, m, OH + CH2); 1.92 – 1.58 (3H, m, CH2’s); 1.52 – 
1.33 (2H, m, CHCH3 + from CH2); 1.29 (3H, s, quat.CCH3); 0.94 (3H, d, J = 7 Hz, CHCH3). 
13C NMR 
(75 MHz, CDCl3) δC 200.7 (C=O); 168.6 (C=CH); 126.5 (C=CH); 73.4 (CHOH); 43.0 (CHCH3); 38.4 
(CCH3); 36.9 (CH2); 34.3 (CH2); 32.8 (CH2); 24.8 (CH2); 18.0 (CCH3); 15.2 (CHCH3). MS: ESI+ 195.3 
[M + H]
+.  
 
1H NMR for trans isomer 1.3B (300 MHz, CDCl3) δH 6.17 (1H, d, J = 2 Hz, C=CH); 4.33 - 4.25 (1H, 
m, CHOH); 2.49 – 2.28 (3H, m, OH + CH2); 2.21 – 2.14 (1H, m, from CH2); 2.04 – 1.96 (1H, m, 
from  CH2);  1.82  –  1.70  (1H,  m,  from  CH2);  1.66  –  1.36  (5H,  m,  from  CH2’s);  1.09  (3H,  s, 
quat.CCH3); 0.91 (3H, d, J = 6 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC 199.7 (C=O); 171.8 
(C=CH); 119.9 (C=CH); 69.0 (CHOH); 42.8 (CHCH3); 39.3 (quat.CCH3); 36.1 (CH2); 35.9 (CH2); 33.7 
(CH2); 28.7 (CH2); 16.9 (quat.CCH3); 14.8 (CHCH3). MS: ESI+ 195.3 [M + H]
+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data consistent with literature: Bonjoch, J.; Díaz, S.;  González, A.; Bradshaw, B.; Cuesta, J.; J. 
Org. Chem. 2005, 70, 3749-3752. 7. Experimental Section 
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(±)-(1R,4S,4aR)-4,4a-dimethyl-7-oxo-1,2,3,4,4a,5,6,7-octahydronaphthalen-1-yl 2-
bromoacetate 4.29 
 
To a stirring solution of compound 1.3 (200 mg, 1.03 mmol, 1 equiv.) in anhydrous CH2Cl2 (4 
mL) at 0 °C was added anhydrous pyridine (90 μL, 1.13 mmol, 1.1 equiv.) followed by the 
dropwise addition of bromoacetyl bromide (98 μL, 1.13 mmol, 1.1 equiv.) in anhydrous CH2Cl2 
(3  mL)  over  five  minutes.    The  clear  yellow  solution  turned  cloudy  white.    The  resulting 
reaction  mixture was  stirred  at  room  temperature for  one  hour, then  quenched  with  the 
addition of H2O (10 mL) and extracted with CH2Cl2 (2 x 5 mL). The combined organic extracts 
were washed with brine, dried over MgSO4 and concentrated to give 420 mg of a crude yellow 
oil which was purified by column chromatography (gradient 5-10% EtOAc in hex) to afford the 
title compound (Rf = 0.35, 30% EtOAc in hex) (217 mg, 68%) as a yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.97 (1H, s, C=CH); 5.49-5.42 (1H, m, CHOC=O); 3.84 (1H, d, J=12 
Hz, from CH2Br); 3.80 (1H, d, J=12 Hz, from CH2Br); 2.61 - 2.47 (1H, m, from CH2); 2.46 - 2.36 
(1H, m, from CH2); 2.14 - 2.02 (2H, m, CHCH3 + from CH2); 1.88 - 1.64 (3H, m, from CH2’s); 1.55 - 
1.42 (2H, m, CH2); 1.25 (3H, s, quat.CCH3); 0.97 (3H, d, J = 7 Hz, CHCH3); 
13C NMR (75 MHz, 
CDCl3)  δC  200.0  (C=O);  165.8  (OC=O);  161.5  (C=CH);  129.4  (C=CH);  76.6  (CHOC=O);  42.6 
(CHCH3); 38.4 (quat.CCH3); 36.8 (CH2); 34.2 (CH2); 30.8 (CH2); 25.9 (CH2Br); 25.2 (CH2); 17.4 
(quat.CCH3); 15.1 (CHCH3); MS: ESI+ 339.0 [
81Br M+Na]
+; 337.0 [
79Br M+Na]
+; IR (film) νmax = 
2949 (CH3, CH2), 2366, 1735 (α-Br ketone), 1682 (C=O), 1262 cm
-1.   
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(±)-(4aR,5S,8R)-8-(methoxymethoxy)-4a,5-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-
2(3H)-one 4.38 
 
 
 
To a stirring solution of compound 1.3 (100 mg, 0.52 mmol, 1 equiv.) in CH2Cl2 (2 mL) at 0 °C 
was added disopropylethylamine (100 μL, 0.57 mmol, 1.1 equiv.) dropwise, followed by the 
addition of methylchloromethyl ether (50 μL, 0.62 mmol, 1.2 equiv.).  The resulting reaction 
mixture was stirred at 0 °C for one hour and at room temperature overnight.  The reaction 
mixture was quenched with aqueous saturated NH4Cl (1 mL), extracted with CH2Cl2 (2 mL) and 
the organic fractions combined, washed with H2O, brine, dried over MgSO4 and concentrated 
to give 145 mg of a crude yellow oil which was purified by column chromatography (10% 
EtOAc in hex) to afford the title compound (Rf = 0.58, 50% EtOAc in hex) (100 mg, 85%) as a 
pale yellow oil. 
 
1H NMR (300 MHz, CDCl3) δH 5.80 (1H, s, C=CH); 4.58 (1H, d, J = 7 Hz, from CH2OCH3); 4.49 (1H, 
d, J = 7 Hz, from CH2OCH3); 4.15 (1H, t, J = 3 Hz, CHOMOM); 3.34 (3H, s, OCH3); 2.60 - 2.47 (1H, 
m, from CH2); 2.43 - 2.33 (1H, m, from CH2); 2.03 (2H, ddt, J = 13, 5, 2 Hz, CH2); 1.91 – 1.59 (3H, 
m, from CH2’s); 1.50 – 1.36 (2H, m, CH2); 1.19 (3H, s, quat.CCH3); 0.94 (3H, d, J = 7 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC 200.1 (C=O); 164.3 (C=CH); 128.1 (C=CH); 93.1 (OCH2OCH3); 75.5 
(CHOCH2); 55.3 (OCH3); 43.1 (CHCH3); 38.4 (quat.CCH3); 36.9 (CH2); 34.3 (CH2); 31.9 (CH2); 25.4 
(CH2); 17.1 (quat.CCH3); 15.2 (CHCH3); MS: ESI+ 216.2 [M+Na]
+; 499.4 [2M+Na]
+; IR (film) νmax = 
2933 (CH2), 2884, 2824 (OCH3), 1678, 1444 cm
-1.   
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(±)-(1S,4R,4aR,8aR)-4-hydroxy-1,8a-dimethyl-6-oxodecahydronaphthalene-4a-carbonitrile 
4.35 
 (±)-(4S,4aR)-4,4a-dimethyloctahydronaphthalene-1,7-dione 4.37 
 
 
 
A solution  of potassium  cyanide  (64 mg, 1.0 mmol, 2.0 equiv.) and ammonium  chloride (46 
mg, 0.9 mmol, 1.8 equiv.) in water (1.0 mL) was added to a solution of compound 1.3 (100 mg, 
0.5 mmol, 1.0 equiv.) in EtOH (2.0 mL) and the resulting mixture was stirred at reflux for six 
hours.  The reaction mixture was cooled to room temperature and concentrated to remove 
EtOH.  The yellow residue was taken up in EtOAc (2.0 mL) and washed with H2O, brine, dried 
over MgSO4 and concentrated to give 83 mg of a pale yellow oil which was purified by column 
chromatography (15% EtOAc in hex) to afford side product 4.37 (Rf = 0.52, 50% EtOAc in hex) 
(31 mg, 16%) as a yellow oil, followed by the title compound 4.35 in a mixture with starting 
material 1.3 (85 mg) as a yellow amorphous solid.  A second purification of this mixture by 
recrystallisation from Et2O afforded the title compound 4.35 (Rf = 0.25, 50% EtOAc in hex) (37 
mg, 34%) as a colourless amorphous solid. The resulting crystallisation liquor was concentrated 
to afford recovered starting material 1.3 (Rf = 0.3, 50% EtOAc in hex) (35 mg, 35%) as a yellow 
oil.    
 
Compound 4.37 
1H NMR (400 MHz, CDCl3) δH 2.65 – 2.53 (2H, m, CH2’s); 2.47 – 2.28 (5H, m, CH2’s); 2.11 – 1.57 
(5H, m, CH2’s); 0.99 (3H, d, J = 7 Hz, CHCH3); 0.89 (3H, s, quat.CCH3).  
13C NMR (100 MHz, CDCl3) 
δC 211.1 (C=O); 209.5 (C=O); 56.7 (quat.C); 41.9 (CHCH3); 41.2 (CH2); 41.0 (quat.C); 38.4 (CH2); 
37.3 (CH2); 37.0 (CH2); 31.2 (CH2); 14.8 (quat.CCH3); 10.8 (CHCH3).  MS: ESI+ 217.2 [M+Na]
+.  IR 
(film) νmax = 2933 (CH2), 2884, 2824, 1680, 1444 cm
-1.   
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Compound 4.35 
1H  NMR  (400  MHz,  CDCl3)  δH  3.73  (1H,  t,  J  =  4.7  Hz,  CHOH);  2.88  (1H,  d,  J  =  15  Hz, 
(CN)CCH2C=O); 2.55 (1H, d, J = 15 Hz, (CN)CCH2C=O); 2.49 – 2.30 (2H, m, CH2); 2.22 – 2.04 (2H, 
m, CH2); 1.92 – 1.83 (3H, m, CH2 + OH); 1.78 – 1.66 (3H, m, CH2, CHCH3); 1.41 (3H, s, quat. 
CCH3); 1.12 (3H, d, J = 7.0 Hz, CHCH3).  
13C NMR (100 MHz, CDCl3) δC 206.2 (C=O); 120.9 (CN); 
71.0 (CHOH); 51.1 (quat.CCN); 43.7 ((CN)CCH2C=O); 38.0 (quat.CCH3); 36.5 (CH2); 34.3 (CH2); 
33.0 (CHCH3); 27.8 (CH2); 25.3(CH2); 20.6 (quat.CCH3); 15.7 (CHCH3).  GCMS (CI) m/z 221 [M]
+; 
239 [M+NH4]
+.  IR (film) νmax = 3459 (OH), 2945 (CH2), 2227 (C≡N), 2140, 1977, 1712 (C=O), 
1467 cm
-1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 